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 ABSTRACT 
________________________________________ 
 
 
Dans la majorité des projets de recherche en Protéomique, il faut, à un moment où un autre, 
déterminer l’identité des protéines présentes dans l’échantillon biologique étudié. Lorsque 
l’identification porte sur un grand nombre de protéines, il est essentiel de pouvoir disposer de 
techniques automatisées et fournissant des résultats non ambigus. De nos jours, la méthode la plus 
répandue est la corrélation de spectres de protéines ou peptides (obtenus par spectrométrie de masse) 
avec des séquences protéiques théoriques répertoriées dans des banques de données. Bien que de 
nombreux développements aient été réalisés dans ce domaine, l’identification de protéines par 
spectrométrie de masse rencontre un certain nombre de difficultés liées, entre autres, à la présence de 
modifications non attendues sur les peptides analysés. 
Notre travail avait donc deux objectifs: fournir un algorithme d’identification qui soit robuste à la 
présence de modifications non prévues sur les peptides et, pour autant que les spectres contiennent 
suffisamment d’information, préciser la position sur la séquence peptidique et la nature des 
modifications présentes. Notre approche, Popitam peut être définie comme une méthode 
d'identification à "modification ouverte". La taille de l'espace de recherche étant agrandie, nous nous 
sommes également concentrés sur la conception de fonctions de score optimisées par programmation 
génétique.  
 
 
 
Protein identification by tandem mass spectrometry (MS/MS) is key to most proteomics projects and 
has been widely explored in bioinformatics research. Obtaining good and trustful identification results 
has important implications for biological and clinical work. Although well matured, automated 
identification of proteins from MS/MS data still faces a number of obstacles due to the complexity of 
the proteome or to procedural issues of mass spectrometry data acquisition. Expected or unexpected 
modifications of the peptide sequences, polymorphisms, errors in databases, missed or non-specific 
cleavages, unusual fragmentation patterns and co-eluting peptides are many pitfalls for identification 
algorithms. A lot of research work has been carried out in recent years; this has given rise to new 
strategies designed to handle a number of these issues. In this work, we describe a new approach for 
identifying and characterizing modified peptides using MS/MS data. Our method, Popitam, does not 
require to give a list of suspected modifications and is therefore classified as an “open-modification 
search” algorithm. The size of the search space is much greater with such an approach, so we also 
focused our work on the conception of optimized scoring functions. We defined a set of subscores 
describing different aspects of similarity between an MS/MS spectrum and a theoretical sequence. 
Then we used Genetic Programming to explore the different ways of combining these subscores, so 
that the built scoring function can efficiently identify and discriminate the correct peptide amongst a 
list of candidate peptide sequences. 
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 FRENCH SUMMARY 
________________________________________ 
 
INTRODUCTION 
 
Les protéines sont des constituants essentiels des organismes et leurs fonctions sont aussi nombreuses 
que variées. Elles régulent l’expression des gènes ainsi que l’activité d’autres protéines, transportent 
des molécules à l’intérieur ou à l’extérieur des cellules, délivrent des messages et permettent aux 
muscles de se contracter. Elles ont un rôle de structure, de mémoire immunologique et peuvent même 
être utilisées comme réserves d’énergies. Les protéines sont codées dans les gènes. Leur synthèse 
comprend la transcription des gènes en ARN messager, puis la traduction des molécules d’ARN en 
séquence d’acides aminés. Lors de ce processus, les acides aminés sont liés les uns aux autres et 
forment une chaîne peptidique. Après plusieurs étapes de maturation, les protéines sont dirigées dans 
leur compartiment cible où elles remplissent leur fonction, avant d’être dégradées et recyclées. 
Lors de leur maturation, les protéines subissent des modifications post-traductionnelles (PTMs), 
incluant des coupures de la chaîne peptidique en des endroits spécifiques, la formation de liaisons 
(ponts disulfures) intra ou inter-chaînes, et l’ajout de molécules (par exemple un groupe acétate ou 
phosphate, un sucre, un lipide)  sur des acides aminés. Ces modifications permettent à la protéine de 
devenir complètement fonctionnelle. De nombreux processus biologiques en sont dépendants, comme 
le repliement de la protéine, la régulation de son activité, sa capacité d’interagir avec d’autres 
protéines, sa localisation dans la cellule et sa durée de vie.  
 
Dans la majorité des projets de recherche sur les protéines, il faut, à un moment où un autre, 
déterminer l’identité des protéines présentes dans l’échantillon biologique étudié. Lorsque 
l’identification porte sur un grand nombre de protéines, il est essentiel de pouvoir disposer de 
techniques automatisées et fournissant des résultats non ambigus. De nos jours, la méthode la plus 
répandue est la corrélation de spectres de protéines ou peptides (obtenus par spectrométrie de masse) 
avec des séquences protéiques théoriques répertoriées dans des banques de données. Bien que de 
nombreux développements aient été réalisés dans ce domaine, l’identification de protéines par 
spectrométrie de masse rencontre un certain nombre de difficultés liées, entre autres, à la nature 
complexe du protéome.  
 
Notre travail a consisté à créer et implémenter une nouvelle méthode d’identification et de 
caractérisation de peptides portant des modifications post-traductionnelles non attendues, voire 
inconnues, à partir de données de spectrométrie de masse en tandem (MS/MS). L’enjeu était 
particulièrement motivant. En effet, déterminer la présence de modifications et mieux encore, préciser 
leur emplacement sur la séquence protéique ainsi que leur type, est d’un intérêt majeur pour la 
recherche en biologie à cause de l’implication des modifications dans de nombreux processus 
cellulaires, physiologiques et pathologiques. 
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Notre travail avait donc deux objectifs: fournir un algorithme d’identification qui soit robuste à la 
présence de modifications non prévues sur les peptides et, pour autant que les spectres contiennent 
suffisamment d’information, préciser la position sur la séquence peptidique et la nature des 
modifications présentes.  
 
TECHNIQUES DE PROTEOMIQUE 
 
La protéomique se définit comme la science qui étudie le contenu en protéines d’échantillons 
biologiques (par exemple, un tissu). La préparation des échantillons inclut la cassure des parois 
cellulaires, l’extraction d’impuretés (comme l’ADN ou les lipides), la dénaturation des protéines, 
ainsi que des étapes de fractionnements et de séparations, jusqu’à obtenir, dans certains cas, une seule 
–ou quelques- espèces de protéines à analyser. Ces dernières sont ensuite clivées en peptides par 
l’action d’une enzyme de digestion et analysées par spectrométrie de masse. 
 
Séparation de protéines 
Il existe deux classes majeures de techniques de séparation de protéines en protéomique: la 
chromatographie et l’électrophorèse. Le principe, pour l’une comme pour l’autre, est une migration 
différentielle des molécules dans un milieu gazeux, liquide ou semi-liquide (gel).  
 
En chromatographie, la force de migration est mécanique. Une solution (phase mobile) contenant les 
analytes (protéines ou peptides) circule de manière continue dans une colonne remplie avec un 
support (phase stationnaire) dont les propriétés physico-chimiques se caractérisent par une certaine 
affinité avec les analytes. En modifiant de manière graduelle les caractéristiques du buffer dans la 
colonne, les analytes sont soit retenus sur le support, soit libérés et soumis au flux qui les dirige vers 
la sortie. La nature de l’interaction entre les analytes et le support est variable. En chromatographie 
hydrophobe, les protéines sont séparées selon leur degré d’hydrophobicité. La colonne est remplie 
avec des billes contenant des chaînes hydrophobes sur lesquelles les protéines viennent se coller. Sous 
l’action d’un détergent, les protéines se solubilisent et, selon leur degré d’hydrophobicité, se décollent 
plus ou moins vite, quittant ainsi séparément la colonne. En chromatographie ionique, les protéines 
sont séparées selon leurs propriétés électriques. Dans ce cas, la phase stationnaire est une résine 
chargée négativement. Les protéines, chargées positivement, sont introduites dans la colonne et se 
lient à la résine. En modifiant progressivement le pH de la solution, les protéines se libèrent de 
manière différentielle, suivant leur charge. En chromatographie par affinité, ce sont des interactions 
spécifiques protéines-ligands qui sont exploitées (par exemple, une enzyme et son substrat). Enfin, en 
chromatographie par exclusion, la séparation s’effectue en fonction de la taille des protéines. La 
colonne est remplie d’un support poreux dans lequel les protéines pénètrent ou non, selon leur taille. 
Les molécules les plus grandes sont les premières à quitter la colonne alors que les plus petites sont 
retenues plus longtemps. 
 
En électrophorèse, la force de migration provient d’un champ électrique entre deux électrodes. Ainsi, 
en électrophorèse SDS-PAGE, les protéines dénaturées sont placées à l’extrémité d’un gel de 
polyacrylamide dont la taille des pores forme un gradient continu entre les deux extrémités. Le 
potentiel électrique provoque la migration des analytes d’une extrémité du gel vers l’autre. Selon leur 
taille, les analytes migrent plus ou moins vite et se dispersent dans la longueur du gel. En 
électrophorèse IEF, le gel contient un gradient de pH. Les protéines qui le traversent s’arrêtent à 
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l’endroit précis où leur charge est neutre. En utilisant des gels rectangulaires plutôt que longilignes, il 
est possible de combiner les deux technologies: les protéines sont séparées dans une première 
dimension selon leur point isoélectrique, et dans une deuxième dimension selon leur poids 
moléculaire. La séparation produit une constellation de points (plusieurs milliers par gel), chacun 
d’eux représentant une ou quelques protéines différentes. 
 
Spectrométrie de masse 
La technique la plus utilisée en Protéomique pour identifier les protéines est la spectrométrie de 
masse. Un spectromètre est composé de deux éléments principaux: une source et un analyseur. La 
source sert à ioniser les peptides, qui sont ensuite transmis à l’analyseur. Il existe plusieurs types de 
sources. Les plus répandues sont la source MALDI (“matrix-assisted laser desorption ionization »), 
dans laquelle les ions sont créés par l’action d’un faisceau laser, et la source ESI (« electrospray 
ionization »), dans laquelle les ions sont formés par un effet de répulsion électrostatique due à un 
champ électrique. De même que pour les sources, il existe plusieurs types d’analyseurs, dont les 
« ion-traps » (IT), les « time-of-flights » (TOF), les « quadrupoles » (Q) ou encore les « fourier 
transforms» (FT). Les analyseurs permettent de mesurer la valeur masse/charge des peptides ionisés,  
produisant un spectre MS, caractérisé par un ensemble de pics d’intensités variables. Un spectre MS 
correspond donc à une protéine, et les pics représentent les valeurs masse/charge de ses peptides. 
L’intensité des pics est fonction du nombre de peptides détectés à une certaine valeur masse/charge. 
Puisque la composition en pics est spécifique pour une protéine, les spectres sont appelés « peptide 
mass fingerprint » (PMF) pour « empreinte par masses de peptides ». L’identification d’une protéine 
se fait en corrélant son spectre MS avec des spectres virtuels construits à partir de séquences 
protéiques provenant de banques de données (identification par PMF). 
 
Lorsque l’échantillon analysé contient plusieurs, voir un grand nombre de protéines, la digestion 
résulte en une mixture complexe de peptides. Dans un tel cas, ainsi que lorsque l’on veut obtenir de 
l’information sur la séquence de la protéine, une deuxième étape de MS vient se superposer à la 
première. On parle alors de « spectrométrie de masse en tandem »  (MS/MS). Des exemples de 
configurations de spectromètres sont le « time-of-flight/time-of-flight » (TOF-TOF), le 
«quadrupole/time-of-flight » (Q-TOF) ou encore le « quadrupole/ion trap » (Q-IT). La première étape 
de spectrométrie permet d’isoler les peptides selon leur valeur masse/charge. Puis, chacun leur tour, 
les peptides sont fragmentés. La fragmentation se fait généralement par collision avec un gaz rare et 
est aléatoire, la coupure ayant lieu plus ou moins entre les acides aminés et conduisant à des 
fragments ioniques. Une même position de fragmentation sur la séquence (par exemple entre le 
deuxième et le troisième acide aminé) peut produire plusieurs pics différents, selon l’état de charge 
des fragments obtenus, leur type ionique (par exemple N-terminal et C-terminal) et d’éventuelles 
pertes de molécules (comme des molécules d’eau ou des ions ammoniums). Les valeurs masse/charge 
des fragments obtenus sont mesurées et produisent un spectre MS/MS appelé «Peptide Fragment 
Fingerprint » (PFF). Cette fois-ci, le spectre correspond à un peptide (appelé peptide précurseur), et 
les pics représentent la valeur masse/charge de fragments de peptides. De la même manière que pour 
les spectres MS, un peptide ayant produit un spectre MS/MS peut être identifié par corrélation avec 
des séquences peptidiques théoriques (identification par PFF). Les peptides identifiés mènent alors à 
une liste de protéines identifiées. 
 
 
 x
IDENTIFICATION MS 
 
Identification par « peptide mass fingerprinting » (PMF) 
L’identification par PMF implique la digestion de la protéine d’intérêt (de préférence purifiée) en 
peptides (les coupures se font en des endroits spécifiques, selon l’enzyme utilisée), la mesure des 
masses des peptides par spectrométrie de masse et la comparaison du spectre MS obtenu avec des 
spectres virtuels. Ces derniers sont construits à partir de protéines candidates filtrées parmi 
l’ensemble de séquences protéiques répertoriées dans une banque de donnée choisie et digérées de 
manière virtuelle. Ainsi, si la trypsine a été utilisée pour digérer les protéines de l’échantillon 
biologique, la digestion virtuelle coupera les séquences après chaque lysine et arginine, sauf si ces 
dernières sont suivies d’une proline. Selon les paramètres choisis, la digestion pourra permettre de 
« sauter » une lysine ou arginine (« missed-cleavage »). La sélection des protéines candidates se fait 
généralement sur la base d’attributs spécifiques connus, tels que l’espèce ayant produit l’échantillon, 
la masse totale de la protéine ou son point isoélectrique. La similarité entre le spectre expérimental et 
les spectres virtuels est quantifiée par une fonction de score. C’est la protéine candidate qui obtient le 
meilleur score qui est présumée représenter la protéine ayant produit le spectre. Si tous les scores se 
situent en dessous d’une valeur seuil, le spectre est considéré comme non-identifié. Une situation 
comme celle-ci peut s’expliquer par des différences inattendues entre la protéine expérimentale et son 
double théorique, ou par l’absence de ce dernier de la banque de donnée (protéine inconnue). 
 
 
IDENTIFICATION MS/MS 
 
L’identification de protéines à partir de spectres MS/MS présente plusieurs avantages. Premièrement, 
puisque plusieurs spectres MS/MS sont généralement obtenus pour chaque protéine, l’identification 
est plus robuste et moins équivoque. Elle est plus robuste, car il n’est pas nécessaire d’identifier tous 
les peptides de la protéine pour suspecter sa présence dans l’échantillon; et elle est moins équivoque, 
car l’identification de plusieurs peptides pour une protéine donnée tend à confirmer le résultat de 
l’identification. Un second avantage est que l’analyse par spectrométrie de masse en tandem permet 
d’analyser des échantillons contenant des mélanges complexes de protéines, contrairement à 
l’identification par PMF qui nécessite un niveau de purification élevé. Si les étapes de séparations 
s’en trouvent simplifiées, il faut, par contre, ajouter une étape de compilation de résultats, lors de 
laquelle une liste de protéines identifiées est construite à partir de la liste des peptides identifiés. Or 
cette étape n’est pas toujours simple, car différentes protéines peuvent produire des peptides 
identiques. Enfin, une caractéristique intéressante des spectres MS/MS est qu’ils contiennent de 
l’information sur la séquence du peptide précurseur, la séquence d’acides aminés pouvant être inférée 
à partir d’écarts de masses entre pics (séquençage de novo).  
 
Identification par séquençage de novo 
Le séquençage de novo est particulièrement intéressant lorsque la séquence de la protéine d’origine 
est absente des banques de données ou lorsqu’il y a suspicion de remplacements d’acides aminés 
(mutations ou erreurs dans la banque de données) entre le peptide ayant produit le spectre et son 
représentant théorique dans la banque de données. La plupart des méthodes de séquençage de novo 
commencent par structurer le spectre en un graphe dont les nœuds représentent des masses de 
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fragments potentiels. Tous les nœuds ayant un écart de masse équivalent à la masse d’un (ou 
plusieurs) acides aminés sont connectés par des ponts. Deux nœuds particuliers sont créés 
artificiellement pour inclure dans le graphe la masse de la séquence vide et celle de la séquence 
complète (masse du précurseur). L’ensemble des chemins permettant de relier ces deux nœuds 
représente l’ensemble des séquences d’acides aminés qu’il est possible d’inférer à partir de la 
distribution des pics dans le spectre et ayant une masse totale similaire à celle du précurseur. Le 
problème du séquençage de novo est de repérer, parmi toutes ces séquences, celle qui correspond au 
peptide précurseur et donc est à l’origine du spectre. En séquençage de novo, les modifications 
éventuelles d’acides aminés sont prises en compte en ajoutant des résidus à masses modifiées dans 
l’alphabet des acides aminés possibles. Afin de ne pas augmenter de manière exagérée le niveau de 
connexion du graphe, et donc le nombre de chemins à explorer et évaluer, il est nécessaire de 
restreindre le nombre des résidus modifiés à quelques unités.  
 
Identification par «peptide fragment fingerprinting» (PFF) 
Mais lorsque l’on s’attend à ce que la séquence du précurseur soit présente dans la banque de 
données, une approche par comparaison de spectres (PFF) est généralement préférée. Toute méthode 
d’identification par PFF partage les mêmes étapes-clés, à savoir le filtrage des peptides candidats, la 
construction des spectres virtuels et la comparaison de spectres. Les différences se situent dans la 
manière d’effectuer chacune de ces tâches. 
 
Choix des peptides candidats 
Comme pour l’identification par PMF, les séquences protéiques sont digérées virtuellement afin de 
produire des peptides. L’utilisation de filtres basés sur des attributs connus permet de limiter la 
comparaison à une sous-partie des peptides, ce qui réduit d’une part le temps de calcul et d’autre part 
le nombre d’identifications faux-positives (peptides produisant par chance des scores élevés). 
Généralement, on utilise comme filtre l’espèce ayant produit l’échantillon et la similarité entre la 
masse du précurseur et celle des peptides candidats. Ce type de filtrage est très efficace, mais il 
présente le désavantage d’écarter le peptide correct si sa masse ne correspond pas, pour une raison ou 
une autre, à celle du précurseur. Or, une telle situation est loin d’être rare. En voici quelques 
exemples: 
a) la masse du précurseur n’est pas suffisamment précise et l’erreur paramétrée trop petite 
b) le précurseur porte une modification post-traductionnelle ou est muté 
c) la séquence théorique contient une erreur 
d) les sites de coupure ne suivent pas les règles établies (par exemple, présence de deux « missed-
cleavages », ou peptide tronqué) 
Il est possible de remplacer –ou complémenter- le filtrage avec de courtes séquences, appelées 
« tags », extraites des spectres par séquençage de novo. Les peptides issus de la digestion virtuelle 
sont alors sélectionnés selon leur séquence (ils doivent contenir le tag) et non plus uniquement selon 
leur masse.  
 
Prédiction de spectres 
Les spectres virtuels sont construits en simulant le processus de fragmentation sur les séquences des 
peptides théoriques. Les paramètres généralement utilisés sont la séquence en acides aminés du 
peptide, l’état de charge du précurseur, le type de spectromètre utilisé et des hypothèses ioniques 
(décrivant le type ionique d’un fragment, son état de charge et d’éventuelles pertes de molécules). Les 
prédictions concernent d’une part l’emplacement des pics et d’autre part leur intensité.  
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Mesure de la similarité entre un spectre expérimental et un spectre théorique 
La similarité entre deux spectres se mesure à partir du nombre de pics qu’ils ont en commun. Cela 
revient à compter les pics apparaissant dans les deux spectres, étant donné un seuil d’erreur autorisé. 
Deux mesures couramment utilisées sont la corrélation-croisée, qui permet de mesurer la similarité de 
deux signaux continus ou discrets, et le produit vectoriel. Pour ce dernier, les spectres sont 
représentés comme des vecteurs dans un espace N-dimensionel (N est le nombre de pics en 
communs), la direction et la longueur des vecteurs étant déterminées par les valeurs masse/charge et 
les intensités des pics. Si les spectres sont égaux, l’angle entre les vecteurs est nul. S’ils sont très 
différents, l’angle approche les 90 degrés.  
Afin d’exploiter de manière plus intensive l’information présente dans les spectres, et donc de réduire 
le nombre d’identifications faux-positives, les méthodes d’identifications incluent souvent d’autres 
paramètres dans la fonction de score, comme l’erreur observée entre les fragments appariés, la 
présence de séries ioniques (fragmentation de positions successives sur la séquence du précurseur), la 
composition en acide aminés du peptide théorique, le nombre de « missed-cleavages », etc.  
 
La présence de modifications du peptide précurseur peut être, du moins dans une certaine mesure, 
prise en compte par les méthodes PFF pour autant qu’elles soient prévisibles. Il suffit de générer des 
peptides modifiés à partir des séquences de la banque de donnée et d’une liste de modifications 
possibles. Plus la liste est fournie, plus l’augmentation du nombre de peptides possibles est 
importante. Par exemple, dans une banque de donnée comprenant 800'000 peptides tryptiques (ce qui 
correspond à environ 10'000 protéines), la prise en compte d’un seul type de modification pouvant 
survenir sur les acides aminés D, K, N, P, F et Y (comme l’hydroxylation) mène à la création d’un 
total de 7.4 millions de peptides si l’on autorise 0, 1 ou 2 évènements de modification par peptide. Si 
tous les acides aminés peuvent être modifiés, ce nombre monte à près de 45 millions. Il ne reste plus 
qu’à imaginer le nombre de peptides différents si plusieurs types de modifications sont pris en compte 
pour chaque acide aminé. Heureusement, le filtrage des peptides candidats par rapport à la masse du 
précurseur permet de réduire fortement le nombre de peptides finalement analysés. Néanmoins, il est 
tout de même nécessaire de restreindre le nombre de modifications différentes à quelques unités afin 
de rester dans des temps de calcul raisonnables. 
 
 
METHODES D'IDENTIFICATION A "MODIFICATIONS 
OUVERTES" 
 
Mais qu’en est-il lorsque le peptide précurseur porte une modification qui n’est pas répertoriée dans la 
liste des modifications possibles ? Les méthodes de séquençage de novo se trouvent face à un graphe 
dont le chemin correspondant à la séquence du précurseur est coupé en deux, puisque le pont 
représentant la masse de l’acide aminé modifié n’existe pas. Deux cas peuvent se présenter: soit les 
deux sous-parties de chemin ne sont pas connectées du tout, et il est alors impossible de parcourir 
l’ensemble du chemin (du premier au dernier noeud). Dans ce cas, l’algorithme de séquençage de 
novo ne peut aboutir à un résultat valide. Soit les deux sous-parties sont connectées par un chemin 
alternatif empruntant un ou plusieurs ponts n’appartenant pas au chemin correct. Dans ce cas, 
l’algorithme trouve une séquence proche de celle du peptide d’origine, mais non exacte sur la partie 
du chemin alternatif. 
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Pour ce qui est des méthodes de PFF, la présence d’une modification non-attendue a deux 
conséquences. Premièrement, la masse du précurseur est modifiée; il n’est donc pas possible de filtrer 
les peptides candidats en utilisant cette dernière. Deuxièmement, la modification affecte la position 
des pics (en moyenne, la moitié des pics sont décalés vers la gauche si la modification provoque une 
perte de masse, vers la droite sinon), ce qui a pour conséquence de réduire les scores de comparaison. 
 
Une première solution à ce problème consiste à utiliser un filtre basé sur des tags à la place de la 
masse du précurseur. De cette manière, le nombre de peptides candidats analysés est fortement réduit, 
et même si un certain nombre d’appariements de pics est perdu lors de la comparaison, le score suffit 
encore à départager le bon peptide des autres candidats. Le point faible de cette méthode est que ses 
atouts résident dans le filtrage plutôt que dans la procédure de comparaison, puisqu’elle n’essaye pas 
d’apparier des pics de fragments modifiés avec des pics de fragments non-modifiés. 
Une deuxième méthode étend le concept de PFF en autorisant la présence de décalages de masses 
entre pics appariés. Ceux-ci ne sont plus appariés selon leur valeur absolue, mais selon l’écart entre 
leur valeur masse/charge et celle des pics précédemment appariés.  
Enfin, une troisième méthode utilise des séquences de novo (séquences complètes produites par un 
algorithme de séquençage de novo et donc, contenant forcément un chemin alternatif). L’alignement 
entre la séquence de novo et les séquences théoriques est initié par appariement sur une courte région 
non ambiguë, puis l’alignement est étendu vers la gauche et la droite en se basant sur la 
correspondance des masses des acides aminés (simples ou en combinaison) tout en autorisant si 
nécessaire des acides aminés non-appariés. Les écarts de masses relevés aux endroits non-appariés 
sont expliqués par des modifications possibles. 
 
 
ALGORITHME DE POPITAM 
 
Popitam est un outil d’identification de peptides à partir de spectres MS/MS. Il ressemble aux 
méthodes de PFF parce qu’il utilise une banque de donnée de séquences pour guider l’interprétation 
du spectre. Mais il emprunte aux méthodes de séquençage de novo la structure de graphe. Ce dernier 
est utilisé pour extraire du spectre tous les tags qui représentent des sous-séquences du peptide 
candidat en train d’être analysé. Les tags sont ensuite combinés en respectant des règles de 
compatibilité, conduisant à la création de scénarios d’interprétation composés d’un ou plusieurs tags 
séparés par des trous (appelés gaps). Puis Popitam évalue si les gaps proviennent d’un manque 
d’information dans le spectre (dans ce cas, ils sont dénommés lackGaps), ou s’ils sont dus à une 
modification ou à une différence de séquence (dans ce cas, ils sont dénommés modGaps). Pour 
chaque peptide candidat, plusieurs scénarios sont créés et évalués. Le candidat avec le meilleur 
scénario est proposé comme résultat de l’identification. Les paragraphes qui suivent décrivent les 
trois processus-clés de l’algorithme, à savoir l’extraction de tag, la création des scénarios et leur 
évaluation. 
 
Filtrage des peptides de la banque de donnée 
Popitam utilise, pour le moment, quatre types de filtres. Le premier est taxonomique. Le second est 
basé sur les règles de coupures de l’enzyme utilisée pendant la digestion de l’échantillon. Le 
troisième est basé sur l’intervalle de masse autorisé pour les modifications (cet intervalle peut être de 
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plusieurs centaines de Daltons). Enfin, un quatrième filtre est basé sur une liste restreinte de 
protéines. Seuls des peptides provenant des protéines spécifiées sont analysés. Nous prévoyons 
d’ajouter prochainement un filtre basé sur une liste de tags.  
 
Construction du graphe  
La construction du graphe nécessite de ré-exprimer les valeurs masse/charge lues dans le spectre en 
masses de fragments N-terminaux « standards », ou PRMs (Prefix Residue Masses). La procédure 
revient à énoncer un certain nombre d’hypothèses ioniques pour chaque pic. Au plus, l’une de ces 
hypothèses sera correcte, toutes les autres donnant forcément des PRMs erronées. Afin de pouvoir 
mieux distinguer les PRMs correctes des erronées, on attribue à chacune d’elles un score basé sur la 
probabilité que l’hypothèse ionique attribuée soit correcte. Par hypothèse, les PRMs de même masses 
sont supposées représenter le même fragment et sont réunies en un nœud unique (toute l’information 
originale est cependant maintenue dans chaque nœud). Les nœuds peuvent donc contenir une ou 
plusieurs PRMs. Seuls les nœuds avec au moins une PRM ayant un score élevé sont sélectionnés pour 
former le graphe. Enfin, les nœuds qui ont au moins une PRM dont la différence de masse correspond 
à celle d’un ou deux acides aminés (étant donné une erreur autorisée) sont connectés par un pont. Plus 
l’erreur autorisée est grande, plus le graphe sera connecté et le nombre de chemins possibles 
important. 
 
Extraction des tags 
L’extraction des tags est faite indépendamment pour chaque peptide candidat de la banque de donnée. 
Les sous-séquences de ce dernier sont tout d’abord indexées par un arbre des suffixes. L’extraction se 
fait en parcourant simultanément le graphe et l’arbre. La recherche  est lancée indépendamment à 
partir de chaque nœud du graphe et procède de manière récursive. Au fur et à mesure qu’un chemin 
est exploré, la séquence d’acides aminés est complétée par les acides aminés correspondant au pont 
parcouru. Tant que le tag correspond à une sous-séquence du peptide candidat, l’exploration continue 
en profondeur. Dans le cas contraire, le tag est stocké dans une liste (pour autant qu’il ait atteint une 
longueur minimale de trois nœuds) et la récursivité permet de remonter et dans le graphe et dans 
l’arbre des suffixes. 
 
Création des scénarios 
Une fois les tags extraits, Popitam cherche les différents moyens de les combiner afin de former des 
scénarios d’interprétation de spectre pour la séquence peptidique analysée. Un scénario correspond à 
un « run-and-jump path », c’est-à-dire à un parcours qui emprunte les ponts du graphe tout en 
pouvant sauter d’un nœud à un autre (de masse plus élevée) sans qu’ils soient connectés. Les chemins 
parcourus sur les ponts sont les tags, et les sauts sont les modGaps et les lackGaps. Un certain nombre 
de règles de compatibilité sont énoncées et définissent si un tag peut cohabiter avec un autre dans un 
scénario. Ainsi, les tags chevauchants ou recouvrants sont incompatibles, de même que les tags 
continus. Pour déterminer les combinaisons de tags compatibles, les tags sont structurés en un graphe 
de compatibilité, dans lequel les nœuds représentent des tags et les ponts relient les tags qui sont 
compatibles. Il suffit alors de rechercher les sous-graphes complets (cliques) dans le graphe de 
compatibilité pour construire les différents scénarios. En comparant les masses des gaps avec celles 
qu’on attendrait selon la séquence du peptide candidat, Popitam les classifie soit en modGaps (lorsque 
la différence excède un certain seuil) soit en lackGaps. 
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Evaluation des scénarios 
Pour chacun des peptides candidats, zéro, un ou plusieurs scénarios sont construits. Il faut alors 
pouvoir repérer, parmi tous les scénarios, le ou lesquels correspondent au peptide candidat correct. 
Idéalement, un scénario correct devrait posséder les caractéristiques suivantes: les tags devraient 
couvrir une grande partie du peptide candidat; les modGaps devraient se limiter à un seul acide 
aminé; les nœuds parcourus devraient inclure des PRMs à scores élevés; les nœuds qui contiennent 
plusieurs PRMs devraient être favorisés par rapport à ceux qui n’en contiennent qu’une seule; les pics 
à l’origine des nœuds devraient avoir des intensités plutôt élevées; les erreurs observées entre les 
PRMs et les masses attendues calculées d’après la séquence peptidique devraient être minimisées; les 
scénarios incluant des nœuds de même type ionique devraient être favorisés. Enfin, différents tags ne 
devraient pas inclure plusieurs fois un même pic. Afin de décrire au mieux chacun de ces différents 
aspects, nous avons défini un ensemble de 12 sous-scores. Encore fallait-il trouver la manière de les 
combiner afin d’optimiser au mieux cette information et de pouvoir identifier et discriminer le bon 
peptide parmi la liste de tous les peptides candidats. Dans un premier temps, nous avons utilisé une 
fonction empirique (multiplication des sous-scores); puis nous avons utilisé la Programmation 
Génétique pour explorer de multiples combinaisons possibles de sous-scores afin de produire une 
fonction de score optimisée. 
 
 
 
UTILISATION DE LA PROGRAMMATION GENETIQUE 
POUR APPRENDRE DES FONCTIONS DE SCORE 
 
La programmation génétique (GP) est une approche non-déterministe, inspirée de l’évolution 
naturelle des espèces et permettant de résoudre des problèmes d’optimisation combinatoire. La GP 
modélise les principes-clés de l’évolution, à savoir la reproduction différentielle et la variation des 
caractères héritables. Ces principes sont appliqués sur une population de solutions spécifiques au 
problème considéré et codées sous la forme d’arbres. A chaque génération, les solutions de la 
population courante sont évaluées par une fonction objective. Les solutions « se reproduisent » pour 
former une nouvelle population, les fonctions les mieux évaluées ayant plus de chance de transmettre 
leur descendance à la nouvelle génération, selon le principe de la survie des meilleurs. Pendant la 
reproduction, des opérateurs génétiques tels que la recombinaison (échange d’information entre deux 
solutions) ou la mutation (remplacement aléatoire d’un terme de la solution) sont utilisés pour générer 
de la variabilité. Au cours des générations, l’algorithme converge vers des solutions toujours plus 
adaptées et performantes. A la fin du processus, les meilleures solutions découvertes au cours des 
générations sont reportées comme résultat de l’apprentissage. 
 
Dans notre cas, les solutions sont des fonctions de score de scénarios. Les nœuds internes des arbres 
représentent des opérateurs mathématiques et logiques, tandis que les feuilles représentent les sous-
scores. L’évaluation d’une fonction se fait en exécutant Popitam avec cette fonction sur un set 
d’apprentissage composé de spectres dont les identifications sont connues et en « comptant » le 
nombre de spectres correctement identifiés. Nous avons opté pour une évaluation multi-objective, ce 
qui nous a permis d’optimiser simultanément trois critères : a) la capacité de la solution à placer le 
peptide correct en tête de liste (rang du peptide correct); b) la capacité de la fonction à discriminer le 
score du peptide correct des scores des autres peptides; et c) enfin, la taille des solutions engendrées 
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(qui doit être minimisée). L’objectif de ce troisième critère est d’éviter que les fonctions ne 
deviennent trop complexes, ce qui limite le risque de sur-apprentissage.  
 
 
RESULTATS 
 
Les résultats présentés concernent deux aspects: l’apprentissage de fonctions de score de scénarios 
par programmation génétique, et le potentiel de Popitam à identifier et caractériser des peptides 
modifiés. Tout d’abord, nous montrons, par une procédure de dix runs et validations croisées, que la 
programmation génétique est une méthode robuste pour apprendre des fonctions adaptées à notre 
problème. Selon le principe de la multi-objectivité, chaque run de GP produit non pas une fonction, 
mais un ensemble de fonctions co-dominantes. Ces dernières peuvent être variées et présenter des 
tailles très différentes (d’une dizaine de noeuds à plus d’une centaine). Nous suspections les fonctions 
complexes d’être sur-apprises et d’avoir par conséquent perdu leur pouvoir de généralisation sur des 
données non vues. En montrant que ces fonctions donnent également de bons résultats sur les 
ensembles de test, nous avons pu écarter l’hypothèse de sur-apprentissage. Ensuite nous avons 
comparé la performance des fonctions apprises par rapport à des fonctions empiriques et montré que 
les premières donnaient de meilleurs résultats. Nous avons également relevé la difficulté croissante de 
trouver des fonctions performantes pour des scénarios avec un, puis deux modGaps.  
Dans un deuxième temps, nous avons montré le potentiel de Popitam sur des spectres MS/MS 
provenant d’expériences indépendantes. Popitam a ainsi pu identifier et caractériser un peptide 
portant deux cystéines carbamidomethylées. Le spectre venait d’une étude portant sur les protéines 
nucléolaires humaines. Puis, à partir de spectres provenant d’une étude sur la chaîne A de l’Alpha 
crystalline de souris, Popitam a pu identifier et caractériser des spectres provenant de peptides 
modifiés (N-acétylation, caractérisée par un modGap en position N-terminal de 42.0106 Daltons), 
semi-tryptiques et transpeptidés sans qu’aucune indication ne soit donnée à priori à Popitam 
concernant le type de modification recherchée (excepté un intervalle de masse autorisées allant de –
100 à 400 Daltons). 
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FOREWORD 
________________________________________ 
 
 
The present document is a thesis in Bioinformatics on protein identification and characterization by 
tandem mass spectrometry. It is the result of four years of research and learning at the Swiss Institute 
of Bioinformatics in Ron Appel’s group, in Geneva.  
 
The beginning of this work was specially exciting: the draft sequence of the human genome had just 
been published, the new sciences in "ics" were blooming, the enthusiasm was palpable and the 
technology boom that followed was heady. We felt like living a particular epoch and participating at 
something very important. One year before, in 2000, the Swiss Institute of Bioinformatics, based in 
Geneva and Lausanne, organized the first DEA study cursus in Bioinformatics (DEA means 
“Diplôme d’Etudes Approfondies”) of Switzerland. This one-year cursus gave students a taste of 
genomics, transcriptomics and proteomics and has been a springboard to start a PhD work at the 
Proteome Informatics group.  
 
We tackled a tricky subject, the automated identification and characterization of peptides with 
unexpected amino acid modifications or mutations using tandem mass spectrometry. Four years ago, 
this topic was practically virgin territory, with only an orphan publication on the subject dating from 
years before. This probably explains why our method, Popitam, matured slowly, roaming in a desert 
valley. But soon, a new interest started growing for this subject. Recently, at least two new 
approaches for “open-modification search” have been described. Even now the coverage of this field 
is poor. Nevertheless, second sight is not required to foretell that new developments will come to this 
field in the near future. 
 
The thesis is organized as follows:  
Chapter I gives a general introduction to the subject. It presents the context of protein identification, 
brings up the difficulties of identifying modified peptides and briefly presents Popitam’s approach. 
Chapter II gives basic notions about proteins. It describes their structure, explains how they are coded 
and synthesized. A particular emphasis is given to post-translational modifications of proteins. 
Chapter III describes techniques applied to the analysis of proteins. In the chapter’s first part, various 
methods for separating and purifying proteins are introduced. A second part describes the principles 
of mass spectrometry (MS), and more particularly shows how tandem mass spectra can be obtained 
by combining several mass spectrometry stages. 
Chapter IV presents existing protein identification approaches using mass spectrometry. It shortly 
introduces MS-based identification, and then explains in greater detail different MS/MS identification 
approaches. 
Chapter V is devoted to “open-modification search” methods that directly concern the subject of this 
thesis.  
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Chapter VI gives a detailed description of Popitam’s algorithm.  
Chapter VII describes Genetic Programming, an approach we used to elaborate optimized scoring 
functions for Popitam. As a starter, it introduces the theory of evolution, which inspired the Genetic 
Programming optimization approach. Then the chapter charts the methodology in detail.  
Chapter VIII presents some results we obtained with Popitam and different scoring functions. The 
potential of the method is shown and discussed in this chapter. 
Finally, Chapter IX outlines future perspectives and brings concluding remarks.  
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C H A P T E R  
I 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
This chapter introduces the subject of protein identification and its context. It 
depicts the techniques employed to transform proteins detected in a biological 
sample into computer readable data, and tackles the different approaches used 
to correlate the obtained data to known protein sequences. It brings up the 
difficulties of identifying modified peptides and introduces Popitam’s approach 
to bypass this issue. 
 2
 
I. Introduction 
 
Proteins are essential constituents of all living organisms. They are constituted of amino acids linearly 
assembled to form polypeptide chains. Interactions between non-adjacent amino acids allow proteins 
to acquire a 3-dimensional (3-D) structure. The tasks of proteins are many and various: among other, 
they regulate gene expression and other protein activity, they transport molecules inside and outside 
the cell, they play a role of messengers as well as signal receptors, they allow muscles to contract, 
they are structural components maintaining the shape and integrity of organisms, they are part of the 
immune memory and can be used as energy stocks. Proteins are encoded by genes. When a given 
protein is synthesized, the gene coding for that protein is transcribed into molecules called 
messengers RNAs (mRNAs), which are then translated into amino acid chains. Newly produced 
proteins then follow several maturation steps, take their 3-D structure and are directed towards their 
working compartment, where they fulfill their function, until degradation. Most Eukaryote proteins 
undergo post-translational modification events after their synthesis. One type of modification consists 
in linking molecular groups (e.g. small molecules like acetates and phosphates, but also sugars, lipids, 
and even peptides) on amino acids. These modifications, denoted as PTMs, are mediated by specific 
proteins, called enzymes and allow proteins to be fully functional. Many biological processes are 
PTM related, including protein folding, enzymatic activity regulation, protein-protein interaction, 
subcellular localization and protein turnover.  
Alteration of a protein function may potentially cause observable perturbations –or diseases- in the 
living organisms. Such alterations are often due to mutational events, either in the very genes coding 
for the altered protein or in genes coding for any protein implicated into the expression, maturation 
and functioning of the altered one. As techniques to study proteins, and more particularly PTMs, 
evolve, researchers start to consider diseases from a biochemist’s point of view rather than from the 
molecular biologist’s view. As a matter of fact and with no doubts, proteins are the very actors in 
diseases. This new interest results in new studies that emphasize the extent of PTM importance in 
diseases. For example, Castegna et al. (Castegna et al. 2003) showed that nitration of amino acid 
tyrosine is a pathological event associated with several neurodegenerative diseases, such as 
amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer’s disease. Another study (Yang 
2004) showed the correlation between mutation of the gene coding for the acetyltransferase – an 
enzyme that promotes lysine acetylation- and leukemia.  
 
The present study is precisely about the identification and characterization of modified and mutated 
peptides using tandem mass spectrometry (MS/MS). An example of "bottom-up" protein 
identification workflow is outlined in Figure I-1. Although variations may occur at various steps, 
either in the experimental protocol (e.g. no purification, no digestion and so on) or in the applied 
techniques, the general framework remains similar. The first step is sample preparation. It consists in 
breaking the cells and isolating cellular compartments of interest. Impurities, like lipids or DNA, are 
discarded, and the proteins are dissolved and denaturated –i.e. proteins are unfolded by breaking 
hydrogen bonds, hydrophobic interactions and salt linkages–. Then, one or several separation 
techniques are applied to reduce the sample complexity. Thus, in a systematic analysis of nucleolar 
constituents, the sample will contain several hundreds of proteins, while in a targeted analysis of 
proteins that reveal differential expression rates as a response to given stimuli, the sample will be of 
very few –and even only one– purified protein. A very common separation technique is 2-D gel 
electrophoresis, which scatters proteins in a rectangular polyacrylamide gel by applying two 
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separation steps in two orthogonal dimensions. Usually, the proteins are separated with respect to 
their charge (isoelectric point1) in the horizontal dimension, and with respect to their mass in the 
vertical one. Proteins to be identified are isolated from the gel and digested, i.e. cleaved into shorter 
pieces, called peptides. This is made possible by using endoproteases, which are molecular scissors 
able to cut protein sequences at particular amino acid patterns. The resulting peptide mixture can then 
be analyzed by mass spectrometry.  
 
 
 
Figure I-1: A typical workflow for "bottom-up" protein identification 
Steps (1) and (2) is preparing the sample and targeting proteins to analyze. Then the proteins are 
digested (3) and the resulting peptides undergo mass spectrometry analysis (4) yielding to an MS 
spectrum that can be identified by an MS identification algorithm (5). The analysis can go further by 
isolating peptides, fragmenting them (6) and measuring the resulting fragment masses (second stage 
of mass spectrometry) (7), yielding to an MS/MS spectrum for each isolated peptide. The obtained 
MS/MS spectra are then correlated with theoretical peptide sequences using an MS/MS identification 
algorithm (8). 
 
 
"Top-down" identification workflows apply mass spectrometry on intact proteins without prior 
digestion step. This approach will not be discussed in the present document, although it represents 
nowadays an attractive alternative to "bottom-up" proteomics and has proven to be particularly 
powerful for detailed protein characterization. A review of the subject can be found in (Reid and 
McLuckey). 
 
Mass spectrometers are kinds of scales for biomolecules designed to isolate analytes and determine 
their mass. When applied to the identification of highly purified proteins, the mass spectrometer is 
used to produce a raw MS spectrum (a spectrum composed of a raw measured signal), from which a 
list of peaks is extracted by peak detection software, leading to an MS spectrum (a spectrum 
                                                 
1 The isoelectric point of a protein is the pH at which the protein has an equal number of positive and negative 
charges. 
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composed of discrete signals). Each peak in a MS spectrum represents the mass of a peptide, and, 
since each protein has a different sequence, the composition of all obtained masses represents a 
unique key -a “fingerprint”- of the protein. The identification by “Peptide Mass Fingerprinting” 
(PMF) (see Figure I-2) then consists in comparing the experimental spectrum with theoretical 
fingerprints (obtained by virtually digesting protein sequences and computing the theoretical masses 
of the obtained peptides). For each comparison (or match), a similarity quality is measured according 
to a scoring function leading to an identification score. The best scoring theoretical spectrum is then 
proposed as the identification. When the sample contains a protein mixture or the database is too 
large, the PMF identification method can often not be efficiently applied. In such cases, a first stage 
of mass spectrometry is applied to isolate peptides, which are subsequently fragmented. A second 
stage of mass spectrometry measures, for each peptide, the mass of the obtained fragments, and 
produces an MS/MS spectrum, in which peaks represent masses of peptide fragments. As for MS 
spectra, MS/MS spectra can be interpreted and correlated with theoretical peptide sequences obtained 
from protein databases, using a similar approach denoted as “Peptide Fragment Fingerprinting” 
(PFF). Then a list of identified proteins is proposed based on combinations of peptide identifications.  
MS/MS spectra are more informative than MS spectra. In particularly, since a peptide preferably 
fragments on the peptide bonds, information about its sequence can be deduced from the pattern of 
peaks present in MS/MS spectra without using database information, and post-translational 
modifications or mutations can be precisely mapped on the peptide sequence. This explains the 
greater diversity in MS/MS identification approaches, expounded in Chapter IV, compared to MS 
identification methods.  
 
 
 
Figure I-2: MS and MS/MS identification procedures 
MS identification by peptide mass fingerprinting (PMF) correlates an MS spectrum (or peptide mass 
fingerprint) with theoretical spectra obtained from virtually digested protein sequences. MS/MS 
identification by peptide fragment fingerprinting (PFF) correlates an MS/MS spectrum (or peptide 
fragment fingerprint) with theoretical spectra obtained from virtually fragmented peptide sequences. 
In both cases, candidate sequences are selected according to filtering criteria like protein mass or 
isoelectric point (pI) in the case of PMF, and digestion rules, peptide mass or a short amino acid 
sequence (a tag) extracted from the spectrum for PFF.  
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The identification of peptides carrying unexpected modifications is a major challenge for MS/MS 
identification algorithms, due to an increase of the search space and to the need for special 
comparison routines. One (or several) modifications or mutations will cause the mass of the peptide 
(called precursor mass) to be shifted compared to the corresponding theoretical peptide mass. 
Consequently, those algorithms that filter candidate peptides based on the experimental precursor 
mass will inevitably miss the correct theoretical sequence, leading to an unsuccessful identification. It 
is therefore necessary, for identifying peptides carrying unexpected modifications, to relax precursor 
mass constraints. An alternative is to extract short unambiguous sequences (called tags) from peak 
succession patterns that usually appear in MS/MS spectra, and to use those as a sequence-based filter 
(instead of a precursor mass-based filter). Even if an adapted filter is used (the correct peptide is thus 
presented as candidate), the comparison will probably produce low scores. The reason is that every 
peak in the experimental spectrum that comes from a modified fragment has a measured mass that is 
shifted compared to its expected position computed from the corresponding theoretical database 
sequence. Unexpected modifications can only be taken into account when considering all possible 
mass shifts between the experimental and theoretical spectra, consequently significantly increasing 
the comparison procedure complexity, and thus requiring new specific identification strategies. These 
considerations led us to develop a new identification algorithm, called Popitam2, which can be 
designated as an “open-modification search” identification method. Popitam’s approach allows 
considering any type and a reasonable number of modifications and mutations when comparing a 
theoretical peptide with an MS/MS spectrum. The core process of Popitam is the following: it 
performs, for each candidate peptide, a sequence-guided tag extraction from the spectrum. Then it 
analyses the various tag combinations and builds scenarios composed of tags separated by gaps. 
Popitam considers two types of gaps: the lackGaps, which are due to missing information in the 
spectrum and the modGaps, which are characterized by a mass shift and correspond to one (or 
several) modifications (or mutations). A scenario can then be considered as a possible interpretation 
of the spectrum peak patterns for a theoretical peptide. Each scenario is evaluated according to a 
scoring function optimized by Genetic Programming, the candidate peptide with the overall best 
scoring scenario being proposed as identification. 
 
 
                                                 
2 Popitam has been made available through the ExPASy server (www.expasy.org/tools/popitam/) 
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Figure adapted from "Monsieur Hippopotame" by Tanikawa Shuntarô 
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C H A P T E R  
II 
 
 
 
 
 
 
BIOLOGICAL BASES 
 
 
 
 
This chapter gives basic notions about proteins. It describes their structure, 
explains how they are coded and synthesized. A particular emphasis is given to 
post-translational modifications of proteins.  
 8
 
II. Biological bases 
II.1. Proteins  
II.1.1. Protein structures 
 
Proteins are composed of chemical molecules called amino acids. Each amino acid is constituted of a 
carboxyl group (-COOH), an amine group (-NH2) and a lateral side chain denoted by R. There are 20 
common naturally occurring types of amino acids (see Figure II-1) that differ by their side chain 
structure. Each of them is denoted by a three-letter and a one-letter code.   
 
 
 
Figure II-1: Names and structures of the 20 standard amino acids 
 
Amino acids can be bound by covalent bonds (called peptide bonds), and form oriented linear chains 
(see Figure II-2). Usually, short amino acid chains (less than 50 amino acids) are called peptides, 
while longer chains are called proteins. 
 
 
 
Figure II-2: Formation of a tetrapeptide  
Peptides are formed by linking amino acids together through peptide bonds (in red). The reaction 
involves the carboxyl carbon atom of one amino acid and the amino nitrogen atom of another amino 
acid, and the release of a water molecule. 
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As each amino acid can be labeled by a letter, protein sequences can be written as a suite of 
alphabetic characters. For example, the insulin precursor sequence can be represented as follows: 
 
 
 
Each type of protein consists in a unique sequence of amino acids with a length generally comprised 
between a few and several hundred amino acids. The first amino acid is always the N-terminal amino 
acid, and the last one is the C-terminal one. 
 
 
II.1.2. Protein synthesis 
II.1.2.1. Protein sequences are coded in genes 
 
Genes are portions of chromosomes that code for a protein. They are linear molecules, located in the 
cell nucleus (for Eukaryote organisms) and composed of two complementary and anti-parallel strands 
of deoxyribonucleic acids (DNA) coiled around each other in a double helix. The subunits of DNA 
are the deoxyribonucleotides. Each of them is composed of a phosphate, a deoxyribose (a ribose that 
lost an oxygen) and a heterocyclic base that comes in four flavors: adenine, thymine, guanine and 
cytosine. The two DNA strands are maintained together by complementary base-pairing between 
adenine and thymine, and between guanine and cytosine (see Figure II-3). Polarity is given by the 
deoxyribose linkages. By convention, the strand 5’Æ 3’ is considered as the coding strand, while the 
strand 3’Æ 5’ is the complementary one (the template). The human genome contains three billions 
base-pairs for less than 30’000 genes. But human genes represent only a small part (one to a few 
percent) of genomic DNA. Non-coding DNA include for example structural material, repeated 
sequences and transposable elements.  
 
 
 
Figure II-3: Schematic representation of DNA structure 
The two DNA strands are maintained together by base-pairing and arranged in a double helix.  
 
 
The synthesis of a protein involves two processes: transcription of the coding DNA strand into a 
ribonucleotide acid (RNA) molecule and further translation of the RNA into amino acid sequences. 
Transcription of a gene (see Figure II-4) is catalyzed by an enzyme called RNA polymerase. The 
process is initiated by the binding of a polymerase to a gene promoter region. Then, the polymerase 
opens the DNA helix and proceeds in the 5’Æ 3’ direction, “reading” the template strand and using 
the complementary base-pairing principle to correctly assemble free-swimming ribonucleotides on 
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the growing RNA molecule. Ribonucleotides are very similar to the deoxyribonucleotides used for 
DNA, except that they are attached to riboses instead of deoxyriboses, and that the thymine base is 
replaced by a slightly different one, called uracil (U). Elongation proceeds until a termination site on 
the gene is encountered, causing dissociation of the polymerase from the DNA and the relaxing of the 
completed RNA. The obtained RNA, called pre-mRNA, is single stranded, and its nucleotide 
sequence is exactly similar to the coding DNA strand it was built from (with Us in place of Ts). In 
Eukaryote organisms, the pre-mRNA must be processed into a mature RNA (mRNA or messenger 
RNA) before translation. During this process, regions from the genes that are not necessary to the 
proteins (called introns) are excised from the pre-mRNA, and the remaining RNA portions (the 
exons) are spliced together. By using alternative excision combinations (alternative splicing), a pre-
mRNA can give rise to different proteins. 
 
 
 
Figure II-4: Transcription of a gene into a mature RNA (mRNA) 
Transcription starts in the promoter region and goes on until a termination site is met. The obtained 
primary transcript is an exact copy of the coding DNA strand, except that it contains riboses instead 
of deoxyriboses, and uracil (U) bases in place of thymine bases. In addition, it has a cap that is added 
during the transcription, and a tail composed of 100-200 adenylic acids. The primary transcript is 
then processed into a mature mRNA by excision of unnecessary RNA regions (called introns). 
 
 
II.1.2.2. Translation of mRNA into proteins 
 
After maturation, the mRNA molecules leave the nucleus and gain the cytosol of the cell, where they 
are interpreted into protein sequences according to specific rules known as the genetic code (Figure 
II-5). 
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Figure II-5: The standard genetic code 
Nucleotide triplets (codons) in RNA are translated into amino acids according to the genetic code. 
There are 64 possible codons, coding for the 20 amino acids plus three codons (UAA, UAG, UGA) 
that code for a termination signal. (Copied from Alberts et al., Molecular biology of the cell, Garland 
Publishing, Inc. New York&London, 1983) 
 
 
Translation is undertaken by the ribosomes, which are complex machineries that include more than a 
hundred different proteins associated with structural RNA molecules (rRNAs). Interface between 
mRNA and amino acids is assured by adaptor molecules called tRNAs (for transfer RNAs). These 
molecules are composed of 75 to 95 ribonucleotides and contain two important sites: an acceptor site 
and an anticodon loop. The anticodon loop is made of three adjacent ribonucleotides and is used to 
read the mRNA sequence by complementary base-pairing. The acceptor site binds the amino acid 
coded by the anticodons (e.g. tRNA with anticodons UUU will recognize codon AAA, and then 
carries an lysine amino acid). Initiation of the translation involves the binding of a subunit of the 
ribosome to the mRNA. The subunit proceeds downstream the mRNA (in direction 5’Æ 3’) until it 
encounters a specific codon (AUG, coding for methionine). An initiator tRNA, carrying a methionine, 
binds to the complex ribosome-mRNA and initiates the polypeptide chain. From this point, the 
mRNA is read codon by codon until a stop codon is met. The elongation phase, illustrated in Figure 
II-6, consists in linking new amino acids to the growing polypeptide chain, using the complementary 
base pairing between codons of the mRNA and corresponding anticodons of the tRNAs. When a stop 
codon is met, the ribosome complex dissociates and the complete polypeptide is released.  
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Figure II-6: Elongation of a polypeptide chain 
The mRNA strand is read by the ribosome from one end to the other, codon per codon. Amino acids 
to be incorporated are carried to the ribosome by “adaptors”, denoted as transfer RNAs (tRNAs) 
(box 1) and bind the A-site of the ribosome (box 2). A new peptide bond is formed between the amino 
acid located at the P-site and the new one (box 3). Then, the ribosome moves three nucleotides 
towards the 3’ end of the mRNA (box 4) and the cycle is repeated until a stop codon is reached. 
(Adapted from Alberts et al., Molecular biology of the cell, Garland Publishing, Inc. New 
York&London, 1983). 
 
 
After its synthesis, the polypeptide chain undergoes post-translational modifications (see Section 
II.2), including possible cleavages and adjunction of chemical groups to given amino acid residues, 
and takes its 3-D shape. Then, the mature protein travels to its destination and fulfills its function until 
it is targeted for degradation. All its amino acids are then cleaved and re-used for the synthesis of new 
proteins. 
 
 
II.2. Post-translational modifications 
II.2.1. Introduction 
 
Many proteins are permanently or reversibly modified during or after their synthesis. Co- and post-
translational modifications include proteolytic cleavage events, inter- or intra-peptidic linkages and 
adjunction of chemical groups at specific amino acid residues.  
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II.2.2. Cleavages of polypeptide chains 
II.2.2.1. N-terminal methionine removal 
 
As the translation is initiated by an AUG codon, the first amino acid incorporated in the protein is 
methionine. Most proteins undergo the removal of this amino acid during their synthesis.  
 
II.2.2.2. Signal sequence and transit peptide cleavage 
 
Proteins to be secreted out of the cell are labeled by a signal sequence, which directs them inside a 
particular cell compartment, called endoplasmic reticulum (ER). Once inside the ER, the signal 
sequence becomes useless and is cleaved. A similar targeting mechanism (called transit peptide) 
allows proteins to be directed into chloroplast, mitochondria as well as other cell compartments. 
About 20% of human proteins are annotated in the Swiss-Prot database (Section II.4 introduces the 
concept of protein databases) as containing a signal sequence, and about 2.5% human proteins are 
annotated as containing a transit peptide. 
 
II.2.2.3. Internal peptide sequence processing 
 
Proteins may also have internal portions –called propeptides- cut off. A very known example of such 
an event is maturation of insulin (see Figure II-7), which involves signal sequence cleavage, as well 
as propeptide excision and formation of disulfide bonds between cysteines. The function of insulin is 
to regulate the glucose concentration in the blood. Its precursor is produced in pancreatic cells and, 
since the protein is to be secreted, it contains a signal sequence that targets it into the ER. Once in the 
ER, the signal sequence is cleaved, and an internal 31 amino acid long stretch is excised. The mature 
form of insulin is then stored in secretory granules that accumulate in the cell cytosol. In case of high 
glucose concentration, it is secreted and binds specific receptors on the cell surface causing an 
increase of the cell permeability to monosaccarides. 
 
 
 
Figure II-7: Post-translational processing of the preproinsulin 
The maturation of the preproinsulin includes removal of the signal sequence, folding of the protein by 
formation of disulfide bonds and excision of a 31 amino acid peptide from the center of the chain.  
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II.2.3. Addition of chemical groups 
 
Post-translational modifications that consist in adding chemical groups to amino acid residues are 
common events in Eukaryotes. We shall from now on denote this kind of events PTMs. The Swiss-
Prot database reports predicted or experimentally observed post-translational modifications of protein 
sequences and classifies them into three classes: MOD_RES (adjunction of a small chemical group), 
CARBOHYD (adjunction of a glycan) and LIPID (adjunction of a lipid group). Table II-1 reports 
some statistics collected from these annotations. The statistics show that, if PTMs are quite rare 
events in bacteria, they are much more common in Eukaryotes.  
 
 
 
Table II-1: Post-translational modifications in Swiss-Prot 
Statistics about various post-translational modifications annotated in release 46.5 of Swiss-Prot. 
Three types of residue modifications are taken into account: a) adjunction of a small chemical group 
(MOD_RES), including for example acetylation, hydroxylation or phosphorylation; b) attachment of 
a glycan (mono- or polysaccharides) (CARBOHYD); and c) binding of a lipid group (LIPID). It 
should be noted that most annotations are not based on experimentally proven findings but rely on 
predictive cirteria (e.g. the modification has been experimentally observed in other protein family 
members). 
 
 
Glycosylation primarily concerns cell surface associated proteins as well as secreted proteins, and 
consists in the attachment of oligosaccharide chains to certain amino acids. It affects processes like 
protein folding, targeting, turnover and antigenicity (Blom et al. 2004). Lipidation allows proteins to 
anchor in the cell membrane. Anchored proteins can act as signal receptors and transmit information 
from outside the cell to the cytoplasm, thus the signal does not have to enter the cell (Casey 1995). 
But a great number of modifications imply less complex molecules than lipids and carbohydrates. 
One of the most studied (and certainly most common) such PTM is phosphorylation. Phosphorylation 
is considered as a fundamental regulatory cellular mechanism. It consists in a reversible attachment of 
a phosphate moiety to an acceptor residue (serine, threonine, tyrosine and –rarely- histidine). The 
reaction is catalyzed by two antagonist enzymes: the protein kinase, which binds the phosphate to the 
residue and the protein phosphatase, which removes them from the residue. Another example of PTM 
is acetylation. In Eukaryotes, acetylation is known to play an important role in gene expression. The 
mechanism involves acetylation of lysines and N-terminal groups (see Figure II-8) of histones, the 
proteins that assure DNA compaction. Acetylation induces the loosening of the histone-DNA 
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interaction, thus making accessible binding sites on the DNA for transcription factors, and then the 
genes to be transcribed. 
 
 
 
Figure II-8: Acetylation of a protein amino terminus 
 
 
Other common modifications are given in Table II-2. Several databases documenting known 
modification types are available through the web. Delta Mass (www.abrf.org/index.cfm/dm.home) 
lists about 350 modifications and associated mass shifts (as integer values). The RESID database 
(Garavelli 2003) (http://pir.georgetown.edu/pirwww/dbinfo/resid.html) contains 344 entries (release 
35.00, 30-Sep-2003) and provides detailed information about the modification (i.e. amino acid sites, 
position on the sequence, elemental composition, and so on). A third protein modification database, 
UniMod (Creasy and Cottrell 2004) (www.unimod.org), is specifically designed for mass 
spectrometry applications. It records accurate mass shifts, derived from elemental compositions of the 
modifications, and some useful knowledge, as amino acid modification sites and positions. The 
database being implemented as an open access, anybody can add new records using a web form.  
 
Not all modifications behave the same during fragmentation. Some are very labile and fall off, while 
others remain linked to the peptide sequence. Examples of stable modifications are N-terminus 
acetylation (+42 Da) and arginine methylation (+14 Da). Examples of labile modifications are O-
linked N-acetylglucosamine (GlcNAc, +203 Da) and sulfation (+80 Da) (Mann and Jensen 2003).  
When the modification breaks apart, it may be seen as a signature in the spectrum, yielding 
information about the nature of the modification, but not its location on the peptide sequence.  
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Table II-2: Some common post-translational modifications. 
Taken from (Mann and Jensen 2003) 
 
 
II.3. Changes in protein sequences: mutations and polymorphisms 
 
A mutation is defined as any change of a DNA sequence. Mutations may appear in somatic cells and 
lead for example to aging diseases. If they appear in germ cells, they can be inherited by the 
offspring, leading for example to hereditary diseases (i.e. Huntington’s disease, a neurodegenerative 
disease due to a mutation in a protein called Huntingtin and whose various symptoms include 
uncontrolled movements and loss of intellectual faculties), but also to evolution and adaptation of 
species to new environments. Mutations can affect a single nucleotide base pair (point mutations) or 
add or delete entire stretches of DNA (chromosomal mutations). Point mutations may be induced by 
chemical substances or radiations, but they also spontaneously arise during DNA replication, at a rate 
of about 1 in every 50 million nucleotides. This means that every new human cell contains about 120 
new mutations, most of them luckily occurring in non-coding DNA regions. If it occurs inside a gene, 
a mutation may –or may not- affect the protein encoded (see Figure II-9). Thus, when the mutated 
codon codes for the same amino acid than the original one (“silent” mutation), the protein is not 
affected at all. “Missense” mutations occur when the mutated codon codes for a different amino acid 
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than the original one. In this case, the protein function may be maintained (for example, when the 
new amino acid has similar biochemical and/or physical properties than the original one), or may be 
modified (for example, when the mutated amino acid destabilizes the 3-D conformation of the 
protein). “Nonsense” and “frameshift” mutations are usually much more dramatic. In the first case, 
the mutation changes the original codon into a stop codon, causing premature release of the 
polymerase, and therefore a truncated protein. In the second one, the deletion or insertion of one base 
(or of “any but non multiple of three” number of bases) results in changes of large portions of the 
amino acid sequence. 
 
 
 
Figure II-9: Point mutations and their consequences 
-“ silent” mutations do not affect the amino acid sequence 
- “missense” mutations convert an amino acid into a different amino acid 
- “nonsense” mutations convert an amino acid codon into a stop codon, causing truncated proteins 
- “frameshift” mutations occur when a nucleotide is deleted or added, causing changes in a large 
portion of the protein 
 
 
For various reasons, including individual fitness and population size, a mutation can become, with 
time, more common. When a mutation is present in more than one per cent of a population, it is 
considered as a sequence variation (one of the multiple forms on an allele) and is denoted as 
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polymorphism. Examples of polymorphisms are hair color or height. Swiss-Prot counts a total of 
23’313 sequence variations in 3’605 human proteins (over a total of 12’861 human proteins) as of 
Release 48.0 of 13-Sep-2005. 
 
 
II.4. Protein databases 
 
The first protein sequence database was published in 1965 by Dayhoff in a book named “The First 
Atlas of Protein Sequences and Structure” (1965-1978) and contained, in its initial edition, 65 protein 
sequences. Nowadays, various protein sequence databases exist and are accessible via internet, 
ranging from simple sequence repositories to non-redundant highly curated protein knowledgebases. 
The creation, and then exponential development of protein databases occurred because of two factors: 
first, the development of 2-D gel electrophoresis, which sparked off the desire to catalogue and 
describe all expressed proteins of living organisms, and second, the various genome sequencing 
projects, which fuelled protein sequences with kilometers of DNA to translate. In (Apweiler et al. 
2004a), Apweiler et al. review the major protein sequence databases. The oldest of them is PIR-PSD 
(George et al. 1986) (http://pir.georgetown.edu/home.shtml). It grew up from the Dayhoff’s Atlas and 
its final release (80.00) contains about 280’000 annotated entries. The Swiss-Prot knowledgebase  
(Boeckmann et al. 2003) (http://www.ebi.ac.uk/swissprot/), is garnished with 194’317 sequence 
entries (Release 48.0) highly annotated and manually curated entries from 9479 different species. 
Annotations include information about the function of the protein, post-translational modifications, 
domains, similarities to other proteins, sub-cellular localization, alternative splicing, polymorphisms, 
diseases associated with deficiencies of the protein, and more. Before being manually validated and 
incorporated into the Swiss-Prot database, protein sequences obtained from automatic translation of 
coding genomic sequences are computer-annotated and stored in a “buffer” database, trEMBL 
(Boeckmann et al. 2003) (http://www.ebi.ac.uk/trembl/). Release 31.0 of trEMBL contains 2'105’517 
entries. Recently, PIR-PSD, Swiss-Prot and TrEMBL have been combined into a single resource, 
UniProt (Apweiler et al. 2004b) (http://www.expasy.uniprot.org/), thus providing scientists with the 
world’s most complete and comprehensive protein knowledgebase.  
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Figure adapted from "Monsieur Hippopotame" by Tanikawa Shuntarô 
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C H A P T E R  
III 
 
 
 
 
 
PROTEOMIC 
TECHNIQUES 
 
 
 
 
 
This chapter tackles two major techniques involved in proteomic experiments: 
protein separation techniques and mass spectrometry.  
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III. Proteomic techniques 
III.1. Introduction 
 
Proteomics can be defined as the systematic study of the protein content –the proteome- of a given 
cell, tissue or organism, at a given time and under specific conditions (Wilkins et al. 1997). 
Proteomic research encompasses the identification, characterization and quantification of proteins and 
involves various techniques, including biochemical techniques, mass spectrometry and protein chips. 
In addition, important computing resources are generally required, associated with the use of 
specialized software to analyze, store and make available the obtained data. Plebani describes in 
(Plebani 2005) four applications of proteomics: a) protein mining; b) protein expression profiling; c) 
protein network mapping; and d) protein modification mapping. Protein mining is the cataloging of 
proteins present in a sample; protein expression profiling involves the identification of proteins 
differentially expressed as a response to chemical or physical stimuli, or to pathophysiological states; 
protein network mapping tries to describe how proteins interact with each others; and finally, 
mapping of protein modifications  
 
Studying proteins is a particularly challenging task. Proteins are neither homogenous nor static, like 
genes. Genes are confined in the cell nucleus (for Eukaryote organisms), while proteins are present in 
all cell compartments, on the cell surface and even in extracellular fluids. Gene quantity is constant, 
while protein concentration may change according to a multitude of variables including 
developmental, pathological and physiological conditions. Genes are composed of 4 different types of 
subunits, called nucleotides, while proteins are composed of 20 different types of subunits, called 
amino acids, and exhibit more diversified biochemical properties than genes. One gene can give rise 
to several different protein sequences by mechanisms like alternative splicing and post-translational 
cleavages. Protein sequences are dressed with various ornaments that act upon their 3-D 
conformation, their function and their turnover. In addition, proteomic analysis techniques must cope 
with limited sample amounts, as proteins cannot be amplified using polymerase chain reaction-type 
technologies. Despite these difficulties, Proteomics is a very attractive research field. Much work 
needs to be done to catalogue protein sequences, structures and functions of numerous species and 
tissues. Great hopes are placed in Proteomics for discovering potential diagnostic markers and 
therapeutic targets. For example, techniques like 2-D gel separation, associated with mass 
spectrometry, allow for the rapid identification of proteins associated with particular disease states.   
 
 
III.2. Protein and peptide separation procedure 
III.2.1. Introduction 
 
In proteomic studies, the samples to analyze can contain a huge number of different proteins in 
various abundances. Protein separation can help in targeting proteins of interest, and therefore 
alleviates further analysis procedures. In shotgun Proteomics, separation techniques are applied on 
large mixtures of peptides and are coupled on-line with a mass spectrometer, so that peptides are 
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continuously introduced into the machine and analyzed. When necessary, multiple separation 
procedures, based on different physico-chemical properties of proteins and peptides, can be 
successively performed to obtain better separation capacities. This approach is referred to as 2-D, 3-D 
and multi-dimensional separation, according to the number of separation steps. The next sections 
introduce two major classes of separation techniques: chromatography-based techniques, where the 
analytes migrate due to a mechanical flux, and electrophoresis-based techniques, where the analytes 
are submitted to an electrical field and migrate because of a difference of potential. A more complete 
presentation of separation methods can be found in (Scopes 1993). 
 
III.2.2. Chromatography-based separation techniques 
 
In column chromatrographic separation methods, a solution containing the protein or peptide mixture 
passes continuously through a column (this is called the mobile phase). The column is packed with 
material having some binding properties for the proteins (this is the static phase). Changing 
experimental conditions in the solution (e.g. pH) differently retains or releases one or another type of 
proteins and causes proteins to elute separately from the column. The nature of interaction between 
the proteins and the packed material can be of various types. For example, in reversed phase 
chromatography, proteins are separated based on their hydrophobicity. In this case, the tube is filled 
with small beads carrying long hydrophobic carbon chains. When the protein solution passes through 
the tube, proteins stick more or less tightly to the surface of the beads depending of their 
hydrophobicity. By continuously adding an organic solvent, proteins of higher and higher 
hydrophobicity get detached and separately leave the column. In ion-exchange chromatography, 
proteins are separated based on electrical properties. The stationary phase is a negatively charged 
resin, and the mobile phase is a buffered aqueous solution. Positively charged proteins bind to the 
resin and are successively eluted out by varying the buffer’s pH. In affinity chromatography, proteins 
are isolated by exploiting specific binding interactions between a protein and a ligand (e.g. an enzyme 
and its substrate, an antibody and an antigen, and so on). The ligand, immobilized in a matrix is the 
static phase. The column is loaded with the sample containing the protein mixture. The target protein 
specifically binds to the ligand while the other proteins leave the column. The bound protein can 
finally be collected by changing experimental conditions to favour its desorption. In size exclusion 
chromatography, the proteins are separated according to their size. They migrate through a tube filled 
with porous material. Large proteins pass easily and are the first to elute, while smaller ones get 
trapped in the pores and get delayed. 
 
III.2.3. Separation based on electrophoresis 
 
Electrophoresis is a separation technique that involves the generation of an electric field between two 
electrodes to move charged molecules through a matrix. One of the most common electrophoresis 
techniques used with proteins is Sodium Dodecyl Sulfate – PolyAcrylamide Gel Electrophoresis 
(SDS-PAGE). SDS is a detergent employed to denature proteins, and the polyacrylamide gel is an 
inert polymer, whose pore size can be controlled to create a continuous gradient into the gel. Proteins 
are loaded at one side of the gel and migrate, more or less fast and more or less far, through the gel to 
the opposite side. A possible variation is isoelectrofocusing (IEF) gels, in which the gel contains a pH 
gradient. In such gels, proteins travel until they reach a place where their net charge is zero. Two-
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dimensional gel electrophoresis combines both technologies and separates proteins in a first 
dimension according to their isoelectric point, and in a second dimension according to their molecular 
weight. The procedure results into a constellation of spots (up to a few thousands), each of them 
representing one or a few purified protein types. 
 
 
III.3. Mass spectrometry 
III.3.1. Introduction 
 
Mass spectrometry (MS) is a technique whose beginnings date back to the nineteenth century and 
which is designed to measure mass-to-charge ratios (m/z) of gas-phase ions. Mass spectrometers are 
composed of three elements: a source, a mass analyzer and a detector. The source is the component 
where the analytes are introduced into the spectrometer and are ionized. The mass analyzer separates 
the ions with respect to their mass-to-charge ratios, and the detector reports the number of ions that 
emerge from the analyzer. The next sections describe the different parts of a mass spectrometer. The 
reader will find more details in Lane’s review (Lane 2005). 
 
III.3.1.1. Ion sources 
 
To be analyzed by MS, peptides have to be ionized. Two soft ionisation methods, that suit well for 
non-volatile large biomolecules, are used in mass spectrometry-based proteomics: electrospray 
ionization (ESI) (Fenn et al. 1989) and matrix-assisted laser desorption ionization (MALDI) (Karas 
and Hillenkamp 1988).  
 
In a MALDI source, the analytes are embedded into a crystalline matrix. Pulses of UV laser light 
(typically a nitrogen laser at 337 nm) are absorbed by the matrix, causing vibrational excitation and 
ejection of the analyte molecules surrounded by matrix components. As the matrix evaporate, 
analytes are liberated and ionized.  
 
In an ESI source, the sample, in aqueous phase, flows through a needle subjected to high-voltage (1-6 
kV). A difference of potential is applied between the needle tip and the inlet of the mass spectrometer, 
leading to an accumulation of charges of same polarity. Due to electrostatic repulsion, the solvent 
containing the analytes blow apart into a fine spray of highly charged droplets. The flow is directed 
through a counter current flow of heated gas, causing the solvent to evaporate and the droplets to 
shrink, increasing the charge concentration at the droplet’s surface. As the electrical charge reaches a 
critical state (known as the Rayleigh limit), the droplets explode into smaller and lower charged 
particles. The process of shrinking and explosion is repeated until individually charged analyte 
molecules are left over. Since the sample is introduced in a liquid state at atmospheric pressure, ESI 
sources can easily be associated with liquid-phase separation techniques, such as liquid 
chromatography (LC). Contrary to MALDI, which generates singly charged ions, ESI technique 
generates singly- and multi-charged ions.  
 
 25
Preference for MALDI or for ESI mass spectrometry depends on several factors. Traditionally, 
MALDI was used to analyze proteins separated by 2-D gel electrophoresis and combined with TOF 
mass analyzers. It leads to spectra that are easier to interpret, because they contain only singly 
charged ions. Another advantage of the technique is that a very small quantity of sample is consumed 
during the analysis, thus permitting repeated analyses of the same spot. On the other hand, the 
susceptibility of ESI to produce multiply charged analytes allows the detection of peptides with 
masses exceeding the operating mass range of the mass spectrometer. An advantage of ESI source is 
that it involves the generation of peptide ions from aqueous solution and therefore can be easily 
coupled to liquid chromatography and capillary electrophoresis separation systems.  
 
III.3.1.2. Mass analyzers 
 
Mass analyzers are instruments that separate charged molecules according to their mass-to-charge 
ratio m/z, where m is the mass of the molecule and z is its number of elementary charges. Four basic 
types of mass analyzers are currently in use in proteomic research: ion trap (IT), time-of-flight (TOF), 
quadrupole (Q) and ion cyclotron resonance (ICR) analyzers.  
 
Ion traps mass analyzers are devices that can store charged molecules for a long time. Ions are 
trapped in time varying electric potentials ~ U+Vcos(ωt), produced by a ring electrode and two end 
cap electrodes in a space of 2-3 cm3 filled with dilute helium. Ions of different m/z values enter the 
trap at one of the cap electrode and remain trapped, oscillating at frequencies that are related to their 
m/z values. By changing U, V and ω, ions of certain m/z become turn-to-turn exited and are ejected 
from the opposite end cap.  
 
In time-of-flight mass analyzers, ions are accelerated by a potential down a field-free flight tube until 
they impact a detector. All ions in the source are given the same initial amount of energy, but the time 
needed to travel the distance between the source and the detector is dependent on their m/z values, 
which can be calculated using the kinetic energy equation, given the tube length and the measured 
flight times. 
 
Quadrupole mass analyzers (Figure III-1) consist of four parallel and symmetrically arranged metallic 
rods. One couple of opposite rods has a positive electrical potential +(U+Vcos(ωt)) while the other 
couple of opposite rods has a negative potential –(U+Vcos(ωt)). Ions that traverse the field along the 
central axis of the rods oscillate. Depending on the values U, V and ω, ions of a certain m/z are either 
destabilized and deviated, or enter in resonance and follow a stable trajectory through the quadrupole 
to the detector.  
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Figure III-1: Schematic representation of a quadrupole rod system 
 
 
Ion cyclotron resonance mass spectrometers consist of a cubic cell inside a strong magnetic field. 
Injected ions rotate around the magnetic field with a frequency typical for their m/z. By varying the 
electric fields, changes in the ion frequency of rotation can be measured and converted into m/z using 
Fourier transformation. 
 
These analyzers differ in speed, operating mass range, resolution, accuracy and cost. Resolution 
indicates the ability of the instrument to discriminate between ions with different m/z values. It is 
defined by the m/z divided by the peak width at half its maximum height. Mass accuracy refers to the 
extent to which a mass analyzer reflects the correct m/z values. It is usually measured in daltons or, 
better, in parts per million (ppm).  
The most accurate mass spectrometer is the FT mass spectrometer, with a resolution of more than 
100’000 and an accuracy of a few parts per million for a mass range of 250-1000 [Da]. Unfortunately, 
FT mass spectrometers are also more expensive and technically demanding. Modern TOF and 
quadrupole instruments have a resolution of 10’000 and can easily reach accuracies around 10 ppm. 
Despite a modest resolution and accuracy (they barely resolve the isotopes of doubly charged ions, 
which are separated by 0.5 Da), ion traps mass spectrometers are particularly appreciated, because 
they are robust and relatively inexpensive.  
 
III.3.2. MS/MS analysis 
 
Tandem mass spectrometry is achieved by performing two mass analyses, either “in space” or “in 
time”. The first MS analysis step is used to measure ions according to their m/z. Then, ions (called 
precursors) are selected and fragmented. The resulting fragment ions are separated in the second mass 
analysis step with respect to their m/z values and are recorded as a fragment ion spectrum (MS/MS 
spectrum). For “in space” configurations, such as triple quadrupole (TQ), quadrupole/time-of-flight 
(Q-TOF) or time-of-flight/time-of-flight (TOF-TOF), the primary and secondary analyses are 
performed sequentially as ions travel through the instrument. For example, in TQ configuration, the 
first quadrupole selects the peptides to fragment according to their m/z. The second quadrupole is 
used to fragment peptides by collision with a dilute inert gas (e.g. He). Finally, the fragment masses 
are scanned by the third quadrupole. A possible variation consists in replacing the last quadrupole by 
 27
a TOF analyzer (Q-TOF). For “in time” configurations, such as quadrupole ion trap (Q-IT), they are 
performed consecutively within the same analyzer (see Figure III-2).  
For a detailed review, see (Aebersold and Mann 2003). 
 
 
 
 
Figure III-2: Tandem MS: “in time” and “in space” configurations 
 
 
III.3.2.1. Fragmentation 
 
Several techniques to fragment ions are available. According to Roepstorff’s nomenclature 
(Roepstorff and Fohlman 1984), the product ions are denoted as a, b, and c, when the charge is 
retained on the N-terminal side of the fragmented peptide, and x, y and z when the charge is retained 
on the C-terminal side. As shown in Figure III-3, ion types differ by the position of the fragmentation 
in respect with the peptide bond.  
In “Collision-induced fragmentation" (CID), peptides are fragmented by collision with an inert gas 
yielding to mainly a, b and y ions. An alternative is "electron capture dissociation" (ECD), which uses 
a beam of electron and produces mainly c and z ions. An advantage of ECD is that labile modified 
groups are not dissociated upon fragmentation of the peptide backbone, thus allowing their mapping 
(Zubarev et al.). 
Additional fragment ions may also be generated, including internal fragments formed by breakage of 
two peptide bonds, as well as side-chain specific ions (denoted as d, v and w) formed by the loss of 
all or parts of side-chains (Johnson et al. 1988).   
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Figure III-3: Fragmentation 
Various possibilities of fragmentation for a tetrapeptide (top) and the produced fragment structures 
(bottom). The mass of an ideal N-terminal fragments is computed by adding the mass of the N-
terminal group (H) and all amino acid nominal masses before the cleavage position. The mass of an 
ideal C-terminal fragments is computed by adding the mass of the C-terminal group (OH) and all 
amino acid nominal masses after the cleavage position. Each ionic type is characterized by an offset 
that represents the mass difference in Daltons between the observed mass and the corresponding N- 
or C-terminal ideal fragment. For example, b-ion type offset is 0 [Da] because the mass of a b-ion 
type corresponds exactly to an ideal N-terminal fragment, while a-ion type offset is –28 [Da] because 
a-ion types lost a carbonyl and an oxygen atom compared to an ideal N-terminal fragment. 
 
 
Numerous studies have investigated the fragmentation pathway and support a model called “mobile 
proton hypothesis” (Dongré et al. 1996) (Wysocki et al. 2000) (Figure III-4). This model states that 
under low-energy collisional activation conditions, most fragmentation pathways are triggered by 
protonation of the amide nitrogen or carbonyl oxygen at the cleavage site (Jonsson 2001). 
 
The presence –or absence– of mobile proton greatly influences the fragmentation quality of the 
peptide. Basic amino acids in the peptide act as traps for protons. Consequently, when the number of 
protons on the peptide is lower or equal to its number of strong basic amino acids (Lys, Arg, and His), 
no mobile proton will be available to trigger fragmentation, resulting in poor quality spectra. On the 
contrary, when the number of charges is larger than the number of basic sites, the supplementary 
protons migrate along the backbone, possibly initiating fragmentation at every amide site, thus giving 
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rise to highly informative spectra. In addition, some amino acid residues may greatly influence the 
fragmentation at their N-terminal or C-terminal side. For example, enhanced cleavage is observed at 
proline C-terminal side (due to basic properties) while it is strongly decreased at its N-terminal side 
(due to steric hindrance) (Tabb et al. 2003c).  
 
 
 
Figure III-4: Migration of a mobile proton  
The mobile proton migrates from the  N-terminal amine group to an amide carbonyl oxygen along the 
peptide backbone. 
 
 
III.3.2.2. MS/MS spectra 
 
MS/MS spectra represent peptides that are produced by proteolysis of a protein prior to MS/MS 
analysis. Raw MS/MS spectra are composed of a raw signal and need to be processed to transform the 
signal into generic peak lists. Peak detection includes centroiding (reducing the raw signal into 
discrete values), noise filtering, calibration (shift of the m/z scale), and deisotoping (removal of 
isotopic peaks). Examples of algorithms are given in (Gentzel et al. 2003). Processed MS/MS spectra 
are finally composed of the mass and charge state of the precursor peptide, as well as of a list of 
peaks. Each peak is characterized by two values: the measured fragment mass-to-charge ratio (m/z) 
and an intensity value that represents the number of detected fragments of the given m/z. The number 
of peaks composing an MS/MS spectrum varies from about ten to several hundreds depending on 
factors like peptide length, fragmentation quality, mass spectrometer type or parameters used to 
extract the peaks from the raw spectrum. Interpreting a spectrum is not a straightforward procedure, 
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as many parameters have to be taken into account. Thus, the measured m/z of a peak depends among 
other things on its ionic type, on the number of charges carried by the fragment and on its isotopic 
distribution. In addition, a fragment can lose specific molecules (like ammonium and water 
molecule), or its interpretation can be complicated by the presence of supplementary molecules (such 
as post-translational modifications). Also, the calibration and internal error of the mass spectrometer 
have to be taken into account. Finally, certain peaks may represent noise and disrupt the spectrum 
interpretation by diluting informative peaks, while some fragmentation positions may not be 
represented at all.  
 
Spectra obtained by tandem mass spectrometry contain series of peaks that come from successive 
fragmentation positions in the peptide sequence. This is a key property of MS/MS spectra, since 
information about the peptide sequence can be inferred from the mass differences between peaks 
(Figure III-5).  
 
 
 
Figure III-5: An annotated MS/MS spectrum  
Information about the peptide sequence can be inferred from peak differences. Peaks that are not 
labeled should nevertheless not be systematically associated with noise. Many of them originate from 
the peptide sequence and could be correctly interpreted by taking into account more ion types. A peak 
series is a set of peaks of similar ion-types that represent consecutive fragmentation positions on the 
peptide sequence (e.g. the peaks b4, b5, b6 and b7 represent a b-ion series). 
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Figure adapted from "Monsieur Hippopotame" by Tanikawa Shuntarô 
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C H A P T E R  
IV 
 
 
 
 
 
 
MASS SPECTROMETRY 
BASED IDENTIFICATION 
 
 
 
 
This chapter presents existing protein identification approaches using mass 
spectrometry. It shortly introduces MS-based identification, and explains in 
greater detail various MS/MS identification methods. 
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IV. Mass spectrometry-based identification 
IV.1. Introduction 
 
Thanks to advances in mass spectrometry, new approaches appeared in the last 20 years for the 
identification of proteins or peptides present in biological samples. First, in the eighties, strategies 
were developed for the sequencing of peptides from MS/MS spectra; then, the growth of protein and 
genomic databases, brought forth two major identification approaches: “peptide mass fingerprinting” 
(PMF) in the nineties, and soon after that, “peptide fragment fingerprinting” (PFF). These three mass 
spectrometry-based identification approaches are now routinely used.  
The next sections introduce the PMF identification method, and review in detail de novo and PFF 
identification approaches. 
 
 
IV.2. MS protein identification 
 
The PMF approach (see Figure IV-1) has been described for the first time in 1993 by five 
independent groups (Henzel et al. 1993;James et al. 1993;Mann et al. 1993;Pappin et al. 1993;Yates, 
III et al. 1993). It involves digesting a protein of interest (purified from a mixture) using a site-
specific proteolytic enzyme and then measuring the masses of the obtained peptides by MS. One of 
the favorite enzymes used for mass spectrometry-based protein identification is trypsin. This protease 
can be found naturally, for example in the small intestine of Mammalians, where, together with other 
proteases, it participates to the degradation (digestion) of proteins into amino acids. Trypsin 
specifically cleaves protein sequences at carboxyl side of lysine and arginine residues. The median 
length of the produced peptides is about 15 residues. This corresponds to a mass of about 1600 
Daltons that suits well the optimal operating mass range of many mass spectrometers (typically up to 
4000 Daltons for most instruments). The masses of the obtained peptides are reported as an MS 
spectrum. The experimental spectrum is compared with theoretical ones computed from protein 
sequences stored in databases and “in silico” digested using the same cleavage specificity of the 
protease employed in the experiment. This procedure roughly amounts to counting overlapping 
masses between the experimental and theoretical spectra, leading to “similarity scores” for each 
candidate protein. The candidate proteins are then sorted according to their score. The top-ranked 
protein is considered as the identification of the spectrum. 
 
The key step of the procedure lies in the scoring function. The latter must take into account many 
factors to produce a robust score, like dissimilarities in the peak positions due to internal or 
calibration errors, expected peak intensities, noise, contaminant or missing peaks, presence of post-
translational modifications, and so on.  A variety of different scoring functions have been 
implemented in various algorithms. Appendix A2 gives the names and URLs of a certain number of 
available PMF tools. FragFit (Henzel et al. 1993), PeptideSearch (Mann and Wilm 1994), peptIdent 
(Wilkins et al. 1997) and PepFrag (Fenyo et al. 1998) use a simple score based on the number of 
common masses between the experimental and theoretical spectra. MOWSE (Pappin et al. 1993) 
exploits a scoring which accounts for the non-uniform distribution of protein and peptide molecular 
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weights in databases. Similar score schemes are exploited in MS-Fit (Clauser et al. 1999), Mascot 
(Perkins et al. 1999) and ProFound (Zhang and Chait 2000). SmartIdent (Gras et al. 1999) uses 
Genetic Algorithms to learn the scoring parameters and Aldente exploits Hough transform to 
determine the mass spectrometer deviation, to realign the experimental masses and to exclude 
outliers. 
 
 
 
 
 
Figure IV-1: Protein identification by peptide mass fingerprinting. 
Candidate protein sequences extracted from a database are digested in silico according to a protease 
specificity. Theoretical MS spectra are constructed and compared to the experimental MS spectrum, 
leading to a similarity score for each candidate protein. The candidate proteins are then sorted 
according to their score. The top-ranked protein is considered as the identification of the spectrum. 
 
 
IV.3. MS/MS protein identification 
IV.3.1. Introduction 
PMF identification is sometimes not appropriate. For example, the sample to be analyzed must 
contain one (at worst a few) purified protein (typically, a 2D gel spot). A protein mixture gives an MS 
spectrum with several mixed signals and it is difficult to determine which protein each peak belongs 
to. Moreover the proteins at the origin of the spectrum (or homologous proteins with nearly 100% 
identical sequences) have to be represented in the database. Consequently it is not recommended to 
search genomic databases (especially databases of “expressed sequence tags”) because they contain 
errors and often only partial sequence information.  
An alternative to PMF is the tandem mass (MS/MS) analysis that produces peptide specific spectra in 
which the information about the peptide sequence is present. MS/MS-based identification presents 
several advantages over PMF. It is possible to work with complex peptide mixtures, to search in 
homologous databases and, when enough coverage is obtained, it provides detailed information about 
the peptide sequence and about possible modifications and mutations. Last but not least, MS/MS 
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identification does not require all the peptides of a given protein to be confirmed to achieve confident 
identification. But MS/MS identification is also the subject of difficulties, notably in every situation 
where the peptide sequence does not correspond exactly to any candidate peptide from the database. 
Actually, a great majority of MS/MS spectra collected during an experiment cannot be confidently 
matched to theoretical peptides. Possible reasons are listed below. 
 
 
a) Non-peptide spectrum 
The spectrum may originate from a non-peptide contaminant when using, for example, contaminated 
material during separation. 
 
b) Co-eluting peptides 
The spectrum may originate from several co-eluting peptides and may therefore contain the signal of 
more than one peptide, disturbing identification algorithms.  
 
c) Spectrum quality 
The spectrum may be too noisy, or may be issued from unusual fragmentation (due for example to the 
non availability of a mobile proton to trigger fragmentation).  
 
d) Incorrect precursor mass/low accuracy precursor mass 
Non-accurate or incorrect precursor mass may cause the identification to fail, particularly if the 
identification algorithm applies a precursor mass-based filter to select candidate peptides from the 
database.  
 
e) Novel protein/alternative splicing 
The spectrum may derive from a novel protein that is not present in the database or from a protein 
issued from alternative splicing that is not annotated in the database.  
 
f) Missed or exotic cleavage sites 
During the digestion process, cleavage-sites may be skipped by the protease, leading to fragments 
composed of several peptides linked together end to end (missed-cleavages). Or the protease may cut 
at a wrong place, resulting in peptides with unpredictable ends (non specific cleavages).  
 
g) Transpeptidation 
Transpeptidation involves the grafting of a peptide fragment on another one, probably as a 
consequence of a side activity of trypsin. Schaefer et al. (Schaefer et al. 2005) recently reported 
different examples of transpeptidation observed during a mass spectrometry-based proteomic 
experiment. They notably observed one and two N-terminal amino acid addition, as well as 
combination of two peptides originally located in different regions of a protein. Such events greatly 
complicate the task of identification algorithms. 
 
h) Mutations, polymorphisms, amino acid modifications and errors in databases 
Unexpected modifications and mutations, as well as non-annotated polymorphisms (allelic variations) 
in the protein sequences to be analyzed may complicate the identification procedure, because they 
cause part of the peaks to be shifted in the spectrum compared to their expected positions. Similarly, 
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when the candidate protein sequences are obtained by automatic translation of genomic data, DNA 
sequencing errors may more or less strongly affect the obtained protein sequence, from amino acid 
replacements (“missense”-type errors) to changes of large portions of the protein sequence 
(frameshift-type errors) or to truncated protein sequences (nonsense-type errors).  
 
Luckily, software tools have been developed for most of these issues (see Appendix A3), although 
none of them is currently able to handle all issues at once. Some are specialized in reducing the 
number and complexity of MS/MS spectra while increasing their quality; others have been 
specifically designed to handle unexpected modifications or mutations; and some split the 
identification into several stages and combine different approaches.  
 
IV.3.2. Increasing spectra quality before identification 
 
Preprocessing procedures are often applied to the peak lists before performing the identification 
algorithm, with the aim to increase the quality of the spectrum. Such procedures include filtering 
background noise and removing isotopic peaks. If present, the peak representing the precursor ion is 
also deleted from the peak list. The precursor charge-state can be confirmed using information from 
the fragment ions (Sadygov et al. 2002) (Colinge et al. 2003a). Spectra that are likely to derive from 
the same peptide can be merged into a higher quality consensus spectrum. This allows avoiding 
multiple analyses of a same peptide, while improving signal-to-noise ratio and mass accuracy. 
Nevertheless, it should be noted that information is lost during the clustering procedure. The criterion 
used to decide if two spectra originate from a same peptide is based on a similarity measure. For 
example, NoDupe (Tabb et al. 2003a) represents each spectrum as a vector in a multidimensional 
space and uses as similarity measure the “contrast angle” (also called “dot product”) between pairs of 
spectra with similar precursor masses. Angles near zero degree are found for similar spectra. Another 
example of similarity score applied to spectrum clustering was proposed by Pevzner et al. in 2000 
(Pevzner et al. 2000). This method applies the Needleman and Wunsch sequence alignment algorithm 
to spectral masses. As it is also suited for open-modification searches, the algorithm will be described 
in more details in Chapter V.   
 
IV.3.3. « De novo sequencing » versus « peptide fragment fingerprinting » 
 
Two main approaches are taken to identify an MS/MS spectrum (Figure IV-2). The first one, named 
de novo sequencing, consists in inferring knowledge about the peptide sequence independently of any 
information extracted from a pre-existing protein or DNA database. Then, the inferred complete or 
partial sequences are compared to theoretical sequences using specifically developed sequence 
similarity search algorithms.  
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Figure IV-2: Conceptual representation of de novo and PFF approaches.  
Both methods contain a knowledge extraction phase and a comparison phase. In the de novo 
approach, knowledge is directly extracted from the spectrum as de novo complete or partial 
”sequences” that are then compared to theoretical sequences using a sequence similarity search 
algorithm. The PFF approach extracts knowledge from the database by building theoretical spectra 
and then compares the theoretical spectra to the experimental spectra. 
 
 
The second major way to identify a spectrum has recently been designated as “peptide fragment 
fingerprinting” (PFF) (Blueggel et al. 2004), by analogy to “peptide mass fingerprinting” (PMF). In 
the PFF approach, spectrum analysis is specifically performed for candidate peptides extracted from a 
database by building theoretical spectra from the peptide sequences and measuring the degree of 
similarity between the experimental and the theoretical spectra. For a given scoring function, the 
highest scoring theoretical peptide is then taken as the one amongst all candidates that best represents 
the experimental spectrum. 
 
IV.3.4. Methods based on de novo sequencing 
 
De novo sequencing-based identification starts by inferring sequence information from the 
experimental MS/MS spectrum. Before the nineties, when protein and genomic databases were still at 
an embryonic stage, the obtained de novo sequences were used to design oligonucleotide probes for 
gene cloning. But with the growing number of sequenced genomes, software tools have been 
conceived to correlate de novo sequences with theoretical sequences for identification purpose. 
Since they do not use database information during spectrum interpretation, de novo sequencing 
algorithms work in a search space composed of the set of all possible sequences that can be 
represented by the spectrum without any other restriction than peak disposition. Due to the size of this 
search space, de novo sequencing methods are disadvantaged compared to PFF methods. They require 
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spectra of higher quality with smaller fragment errors and a more or less continuous signal, or at least 
high-quality signal for several adjacent amino acids. Spectra with unusual fragmentation will be very 
hard or even impossible to analyze. Despite these disadvantages, de novo methods may overcome 
PFF methods, notably when searching genomic databases subjected to sequencing errors, when 
searching databases composed of homologous sequences, and when analyzing a spectrum that 
originates from a mutated protein or variant. In effect, de novo algorithms naturally extract sequences 
from the spectrum that include the amino acid replacements, which are then handled by the similarity 
search algorithm by allowing mismatches between the de novo sequences and the database sequences. 
But de novo sequencing algorithms are not well adapted to deal with the presence of modifications on 
the peptide. For each putative modification, the corresponding modified amino acid mass must be 
added to the pool of existing amino acids. This results into an expansion of the search space, and thus, 
this solution can only be used for a couple of modifications of interest, or for chemical modifications 
that were deliberately introduced during sample preparation, such as cysteine carbamidomethylation. 
De novo sequencing algorithms can be separated into two classes: the first one applies a “pseudo” 
PFF approach using a database of generated sequences, while the second one exploits the principle of 
peak succession to extract sequence information from the spectrum.  
 
IV.3.4.1. The “pseudo” PFF approach 
 
Early de novo sequencing algorithms (Hamm et al. 1986;Sakurai et al. 1984) consisted in building a 
“pseudo” sequence database on-the-fly: the sequences were generated by determining all possible 
amino acid compositions with a total mass matching the experimental precursor mass, and then, for 
each composition, by determining all possible amino acid permutations. Subsequently, as for a PFF-
approach, theoretical spectra were computed from the “pseudo” sequences and common peaks 
between the experimental and theoretical spectrum were counted. The theoretical sequences with the 
highest scores are the most likely to represent the original peptide. The main drawback of this 
approach is combinatorial complexity as the number of possible sequences increases exponentially 
with the precursor mass. This issue can be handled by using additional information, notably about the 
amino acid composition of the peptide. Thus, in an approach by Spengler (Spengler 2004), a drastic 
reduction in the number of “pseudo” sequences was achieved by using more accurate precursor 
masses and the presence of immonium ions in the spectrum. Another strategy was chosen by Heredia-
Langner et al. (Heredia-Langner et al. 2004), which proposed to build candidate sequences using a 
genetic algorithm rather than systematically enumerating all amino acid combinations. Finally, Ma et 
al. (Ma et al. 2003) computed a set of 10’000 good scoring candidate sequences using dynamic 
programming, and then reevaluated the candidate sequences using a more stringent scoring scheme. 
Their tool, named PEAKS, has the particularity to provide a confidence score to each individual 
amino acid of the candidate sequences. 
 
IV.3.4.2. The peak succession approach  
 
Since the mid-eighties the tendency has been to use an incremental approach: candidate sequences are 
built in an iterative way, amino acid by amino acid, until complete sequences that account for the 
precursor mass are obtained. During sequence building, only partial sequences whose extensions are 
validated by fragment ions in the spectrum are retained for further extension. In this way, large 
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subsets of permutations are discarded from analysis, contrary to the previous approach in which every 
possible sequence is systematically compared to the spectrum. This method is therefore much more 
sensitive to spectrum quality. Thus, a two amino acid gap in the spectrum (or in other words two 
successive non-fragmented positions on the peptide) causes the correct sequence to be discarded. 
Early implementations differ from each other by small variations. For example, Zidarov et al. 
(Zidarov et al. 1990) use the precursor mass as well as information about the amino acid composition 
deduced from observed immonium ions to limit the search space; Ishikawa’s approach (Ishikawa and 
Niwa 1986) generates a pool comprising all possible permutations of three amino acids to initiate the 
extension process and allows multiple amino acid extensions; SEQPEP (Johnson and Biemann 1989) 
includes information from side-chain losses to differentiate leucine from isoleucine, two isobaric 
amino acids; Scarberry et al. (Scarberry et al. 1995) use a neural network to assign specific ion-types 
to the observed fragment ions before starting the iterative sequencing. 
In 1990, Bartels (Bartels 1990) coined the term “spectrum graph”, which clearly illustrates the 
principle of peak succession in MS/MS spectra. The graph structure has since been widely adopted 
and refined in several de novo methods (Dancik et al. 1999; Fernandez-de-Cossio et al. 1995; Hines et 
al. 1991; Taylor and Johnson 1997). Formally, a spectrum graph is a directed acyclic graph, whose 
vertices correspond to masses of putative N-terminal fragments. Vertices that differ by the mass value 
of one or more amino acids within a given error margin are linked by an edge labeled with the 
corresponding amino acids. Each path in the graph defines a sequence that is consistent with the peak 
succession in the spectrum. Therefore, contrary to early “pseudo” PFF approaches, only a subspace of 
all possible amino acid arrangements is considered for the search. Candidate sequences are built by 
traversing the graph from low mass vertices to high-mass vertices following available edges. As a 
path exploration progresses, a score representing the adequacy between the parsed subsequence and 
the spectrum is computed. Various algorithms were proposed for parsing the graphs and scoring the 
paths. Hines et al. (Hines et al. 1991) use a recursive parsing procedure.  The authors of SeqMS 
(Fernandez-de-Cossio et al. 1995) propose using the Dijkstra algorithm “or any other single-source, 
shortest-path algorithm”. They restrict the parsing to promising area of the graph by using a score 
criterion involving the maximum scores of all paths leading to each vertex. By this mean, they 
drastically reduce the execution time, since they avoid the calculation of a huge number of sequences. 
Dancik et al. (Dancik et al. 1999) describe a scoring method based on the likelihood ratio between 
two models: the first one assumes that the peaks are a result of a peptide’s fragmentation, and the 
second one assumes that they are the result of a random process. Soon after, Chen et al. (Chen et al. 
2001) provide a dynamic programming algorithm to extract the highest scoring sequences from the 
spectrum graph, as well as sub-optimal ones (Lu and Chen 2003b).  
 
It should be noted that de novo algorithms typically try to infer the whole peptide sequence. Thus, 
methods based on peak succession build the inferred sequence in an iterative way until the precursor 
mass is reached. When a spectrum graph is used, it is typically parsed from the first node (the empty 
sequence) to the last node (the complete sequence). Missing fragmentation positions are handled by 
using combinations of two or three amino acids. But when more than a few consecutive 
fragmentation positions are missing in the spectrum, or in case of unexpected modifications, the 
correct path is split into two (or more) sections, which are (or are not) connected by alternative paths. 
The extraction process may therefore stop before completing the sequence, or produce a sequence that 
contains wrong amino acid sections. 
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IV.3.4.3. Database-search algorithms for data obtained by de novo sequencing 
 
Once sequence information has been extracted, the de novo sequence is correlated with theoretical 
sequences using database-search algorithms. Without surprise, there are numerous programs that 
propose the use of sequence information to extract theoretical peptides or proteins from a database. 
MS-Seq (Clauser et al. 1999) works on a list of masses corresponding to given ion type series (the 
masses do not have to be all contiguous). MS-Pattern, from the same authors, performs a text-based 
search with regular expression syntax. It accounts for mutations and database errors by allowing 
mismatches between the input sequence and the theoretical ones. PeptideSearch (Mann and Wilm 
1994) also accepts regular expressions, but in addition it can search the database with “sequence 
tags”, allowing either one of the flanking masses, or the sequence to mismatch. Several tools are 
based on the well known sequence similarity search algorithms BLAST (Altschul et al. 1990) and 
FASTA (Pearson and Lipman 1988) and modified BLOSUM (Henikoff and Henikoff 1992) and 
PAM (Dayhoff et al. 2005) matrices accounting for indistinguishable amino acids; MS-Blast 
(Shevchenko et al. 2001) for example is a BLAST-based protocol for using BLAST with de novo 
sequences, while FASTS (Mackey et al. 2002) is based on the FASTA algorithm; MS-Blast takes as 
input n de novo sequences assumed to be of the same protein and concatenates them into n! query 
sequences. Each permutation is then individually submitted to the BLAST program. FASTS is similar 
and allows searching the database with de novo sequences of unknown order. CIDentify (Taylor and 
Johnson 1997)  was specifically written for database searching with de novo sequences obtained with 
Lutefisk97 and is also based on the FASTA algorithm. The de novo sequences reported by Lutefisk97 
are aligned to the database sequence, and the best alignment is then reprocessed to resolve possible 
isobaric combinations of amino acids. OpenSea (Searle et al. 2004) is designed to align sequences 
reported by PEAKS. It initiates the alignments by matching tags composed of unambiguous amino 
acids to theoretical sequences, and then extends the alignments using a “breadth-first-search” 
approach based on mass correspondence between matching amino acids or groups of amino acids. 
Figure IV-3 shows two mass-based alignment examples, one obtained with CIDentify, the other one 
with OpenSea.  
 
 
 
Figure IV-3: Alignments by CIDentify and OpenSea 
Both programs handle mass equivalencies: leucine is matched with isoleucine, and combinations of 
two amino acids are matched with single amino acids or with other combinations of two amino acids. 
Bars represent amino acid matches, boxes are matches of combinations of amino acids, and crosses 
represent amino acid mismatches (Figure adapted from (Taylor and Johnson 1997) and (Searle et al. 
2004)).  
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Mascot (Perkins et al. 1999) requires each submission to start with the precursor mass of the 
experimental spectrum, to which additional high-confident information are associated, such as partial 
sequence(s), amino acid composition or ionic fragment(s). Finally, MS-Shotgun (Huang et al. 2001) 
and MultiTag (Sunyaev et al. 2003) have been designed to analyze the output of multiple sequence 
database searches with the aim to identify homologous proteins. 
 
IV.3.5. Methods based on peptide fragment fingerprinting (PFF) 
 
The apparition and expansion of protein sequence databases made de novo sequencing in most 
situations unnecessary. Why waste time and resources by considering all possible amino acid 
sequences when databases report the sequences that actually occur in Nature? The peptide-sequencing 
problem became soon changed to a database-matching problem. By exploiting information from the 
database during the spectrum interpretation, PFF methods restrain the search to a subset of the search 
space. This results into better exploration capacities and consequently, the method is generally more 
efficient than the de novo approach, as it allows interpreting the spectrum specifically (then 
optimally) for each candidate peptide. PFF methods strongly rely on a scoring function that evaluates 
the correlation between the experimental spectrum and the theoretical peptides. Many identification 
algorithms based on a PFF approach have been developed. Variations can be found at every step: in 
the way the candidate peptides are chosen from the database or the virtual spectra are modelled from 
theoretical amino acid sequences, as well as the way to score the similarity between the experimental 
spectrum and the virtual spectra, or to validate the confidence in the resulting identifications.   
 
IV.3.5.1. Choosing candidate peptides from the database 
 
PFF algorithms typically produce candidate peptides by in silico “digesting” theoretical protein 
sequences. Cleavage rules depend on the type of enzyme used for proteolysis during sample 
preparation. For example, if the enzyme was trypsin, the algorithm cleaves the protein sequence after 
each lysine (K) and arginine (R), unless the next amino acid in the sequence is proline. Generally, the 
user can choose to allow skipping one or two cleavage sites to account for peptides with one or two 
missed-cleavages. Non-specific cleavage can be taken into account by presenting as candidates all 
possible peptides that match the spectrum precursor mass within a given range, without taking into 
account any specific cleavage rule, although this results into a significant increase in computing time 
(Craig and Beavis 2004). Lu and Chen (Lu and Chen 2003a) proposed a method for database 
searching without cleavage site restrictions. They used a generalized suffix tree structure to index the 
whole set of database sequences, thus allowing direct access to all possible subsequence of any 
protein without enzyme specificity restriction. 
Most often, PFF algorithms apply filtering criteria on the database sequences. The aim is to reduce 
the analysis to a small fraction of the database that contains the correct peptide with high probability. 
Peptide sequences that go through the filter are named “candidate peptides”. Database filters reduce 
the computing time, allow for more sophisticated and computationally intensive scoring schemes, and 
diminish the possibility of a high score being achieved by chance. Various filters may be used with 
PFF methods. The user may specify the species of the sample, thus avoiding parsing the whole 
taxonomy range of the database. The measured precursor mass of the spectrum is also commonly 
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used as a filter, but this may hamper the identification in the following cases: a) when the precursor 
mass is incorrect due to a false assignment of the precursor charge state; b) when the precursor mass 
error is higher than the selected threshold; and c) when the precursor mass does not match the mass of 
the corresponding database sequence, due to the presence of a modification or a mutation on the 
peptide or to an error in the database sequence. Another possibility is to use short amino acid 
sequences –called tags- extracted from the MS/MS spectrum, using de novo sequencing approaches. 
As this filter is mainly used for open-modification searches, it will be described in greater detail in 
Chapter V. A third filtering method is to perform several analysis steps, and to use proteins identified 
in previous runs as a restrained database for subsequent runs. 
  
IV.3.5.2. Modeling virtual MS/MS spectra from theoretical sequences  
 
PFF methods try to score the similarity of a given theoretical sequence with an experimental 
spectrum. Since comparison can only be applied to similar entities, PFF methods build theoretical 
spectra from amino acid sequences. This procedure, referred to as spectrum prediction, consists in 
predicting the fragmentation of a peptide given its amino acid sequence, its charge state, as well as 
experimental conditions. The aim is to build a spectrum that approaches the corresponding 
experimental one. Most of the identification tools use basic rules for spectrum prediction: each 
cleavage position in the theoretical sequence is translated into several expected peaks according to a 
list of possible ion types, charges and molecule losses. So far little attention has been given to 
modeling the intensity of the peaks, or to measuring the influence of neighboring amino acids. 
Recently though, several authors carried out work aimed at characterizing sequence-dependent 
fragmentation patterns using statistical observations from identified MS/MS spectra. For example, 
Kapp et al. (Kapp et al. 2003) measured the extent to which specific amino acid residues promote or 
dampen the cleavage on their N- or C-terminal side, and they analyzed the influence of basic residues 
on fragment ion peak intensities. Elias et al. (Elias et al. 2004) built from a set of identified MS/MS 
spectra a probabilistic decision tree, and used it to estimate the intensity distribution of a fragment ion 
given an extended list of peptide and fragment attributes. As a last example, Zhang (Zhang 2004) 
developed a mathematical model based on classical kinetic rules and on the mobile proton hypothesis. 
There is no doubt that such studies are of great help to improve the performance of spectral 
interpretation methods by increasing the precision of spectrum prediction. They will also allow 
making scoring functions more efficient by incorporation of additional knowledge on the 
fragmentation process. 
 
IV.3.5.3. Scoring the similarity between experimental and theoretical spectra 
 
In the present section, we shall discuss how PFF algorithms score the similarity between an 
experimental and a theoretical spectrum. Ideally, a scoring scheme should provide a low number of 
both false positive and false negatives as well as a good discrimination between true and random 
matches. The three basic “peak matching” measures are i) the counting of common masses, ii) the 
cross-correlation and iii) the dot product. 
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i) Counting common masses 
The simplest way to account for the similarity between two spectra is to simply count, within a given 
margin error, masses that are shared by both spectra (see Figure IV-4).  
 
 
 
Figure IV-4: The basic shared-peak-count (SPC) score between an experimental spectrum and a 
spectrum computed from a theoretical peptide is the count of the matching peaks. 
 
An example of SPC-based scoring scheme is implemented in the PEP_PROBE method (Sadygov and 
Yates, III 2003), which assigns to each candidate peptide a score value –log(P) that depends on the 
probability P that the SPC obtained between the candidate peptide and the spectrum is random, given 
a distribution model.  The authors chose to use an hypergeometric distribution, which models a 
random sampling (without repetition) in a finite population of objects of two distinct types, given 
three parameters: N, the size of the population, K the number of items with the desired characteristic 
in the population, and N1, the number of samples drawn. Figure IV-5 establishes the correlation 
between the hypergeometric model and the PFF identification context.  
 
 
 
Figure IV-5: PEP_PROBE score. The population P is the pool of all fragment masses obtained from 
candidate peptides (filtered according to their molecular weight); P is composed of N fragments, 
which are divided in two sets: the sets of “matched fragments”, composed of all fragments that match 
peaks in the experimental spectrum, of size K, and the set of “non-matched fragments”. Comparing a 
candidate peptide to the experimental spectrum amounts to sampling N1 elements of P. The 
hypergeometric distribution PK,N(K1,N1) gives the probability to obtain a SPC of K1 matched 
fragments among the K possible matches, given the sample size N1. In other words, it gives the 
probability P that the SPC obtained between a candidate peptide and the spectrum is random. 
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ii) Cross-correlation 
A cross-correlation is a mathematical method to evaluate whether two signals exhibit common 
features. When the signals are continuous, it can be calculated according to the following equation. 
 
∫
+∞
∞−
+= τ)dtx(t)y(tCxy  
where 
 x(t) and y(t) are the two signals and  
τ is a displacement value between the signal. 
 
It the signals are equal, the correlation function should maximize at τ=0. Sequest (Eng et al. 1994), 
which was the first published MS/MS identification tool based on a PFF approach, precisely uses this 
kind of similarity measure. Sequest, as the algorithm was published in 1994, starts by selecting 
candidate peptides from the database using the precursor mass of the spectrum, without any enzyme 
cleavage specificity. Fragments of b- and y-ion types are computed for each peptide, and the latter are 
pre-scored according to a scoring scheme SP including several different criteria, as the number of 
matching fragments, the presence of consecutive fragment ion matched and of immonium ions: 
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where 
im is the intensities of the matching fragments,  
ni is the number of matching fragments 
β  is a value initially set to 0.075 that is incremented for each consecutive fragment ion 
matched,  
ρ is a value initially set to 0.15 that is incremented for matched immonium ions 
nt is the total number of predicted fragments 
 
 
The 500 top-scoring candidate peptides undergo the cross-correlation analysis. The experimental 
spectrum is processed to remove the mass-to-charge ratio of the precursor ion and to normalize the 
peak intensities. Then, approximate spectra are constructed for each high-scoring candidate peptide 
and cross-correlations of pairs of spectra are performed. Sequest reports as similarity score the value 
of the cross-correlation when τ = 0 minus the mean of the cross-correlation when τ varies from –75 to 
+75.  
 
iii) Spectral angle contrast 
A third type of score that accounts for mass correspondence between two spectra is the spectral angle 
contrast method, which was implemented in Sonar (Field et al. 2002) and GutenTag (Tabb et al. 
2003b). In this method, both spectra are represented as vectors in a N-dimensional space, N being the 
number of matched peaks. The length and direction of the vectors are determined by the m/z and 
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intensities of the peaks. The normalized spectral contrast angle between two spectra O and M is given 
by: 
 
 
 
where  
O
r
 is the vector constructed from spectrum O composed of n matching peaks oi…on, 
M
r
is the vector constructed from spectrum M composed of n matching peaks mi to mn, 
and |O| and |M| are their respective length 
 
 
θ ranges from 0 to 90 degrees. Zero degrees means that the two spectra are not discernible. As the 
angle grows, less and less similarities are found between the spectra, until the angle reaches 90 
degrees, indicating a maximal spectra differentiation. Figure IV-6 illustrates the spectral angle 
computation between two spectra composed, for simplicity, of two matching peaks. 
 
 
 
Figure IV-6: Spectral angle contrast score 
 
 
Actually, all these similarity measures are very close to each other, as Fu et al. recently pointed out 
(Fu et al. 2004). Additional information, like probabilities of ion series or the number of consecutive 
fragment matches may nevertheless complement the basic “peak matching” measure. Thus, Fu et al. 
(Fu et al. 2004) extended the spectral angle contrast method to exploit the correlative information 
among fragments. In addition, most scoring schemes are cast into a probabilistic framework. Thus, 
Mascot (Perkins et al. 1999) evaluates a probability P that the observed similarity score occurs by 
chance and reports as final score -10log(P)3. PEP_PROBE (Sadygov and Yates, III 2003) follows a 
similar approach using a hypergeometric distribution. SCOPE (Bafna and Edwards 2001), ProbId 
                                                 
3 unfortunately, no details on the exact probability model used by Mascot have been published so far 
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(Zhang et al. 2002) and Phenyx (based on the Olav scoring system) (Colinge et al. 2003b) also use 
probabilistic models, incorporating more or less the same parameters. Phenyx differs in that it 
includes physico-chemical properties of fragments into what is called an “extended” match. During 
the comparison between the spectrum and the theoretical peptides, information is used about 
matching fragments, mass errors, ion series, peptide amino acid composition, presence of 
modifications, number of missed cleavages and so on. In this way, the information present in the 
experimental spectrum is more extensively exploited, resulting into a more precise probabilistic 
model and thus reducing the number of false positive identifications.  
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Figure adapted from "Monsieur Hippopotame" by Tanikawa Shuntarô 
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C H A P T E R  
V 
 
 
 
 
 
 
OPEN-MODIFICATION 
SEARCH METHODS  
 
 
 
This chapter describes the concept of “open-modification search” approach. 
Methods based on such an approach are specifically designed to identify and 
characterize post-translationally modified or mutated peptides. More generally, 
“open-modification search” method can take into account any event that 
modifies the sequence or residue mass of a peptide analyzed by mass 
spectrometry. We show how a post-translational modification may change the 
peak pattern in an MS/MS spectrum and describe different strategies to account 
for such events during the comparison of the spectrum with candidate peptides. 
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V. “Open-modification search” methods 
V.1. Introduction 
 
Many events may occur that result into differences between an MS/MS spectrum and its 
corresponding theoretical sequence found in databases. Section IV.1 introduced well-known 
examples of such events: PTMs, mutations, database errors, polymorphisms, transpeptidation, missed 
or exotic-cleavage and alternative splicing. An “open-modification search” is an MS/MS 
identification procedure that takes into account any type and number of differences between an 
MS/MS spectrum and theoretical peptides from a database. “Open-modification search” algorithms 
are more specifically designed to identify and characterize post-translationally modified peptides.  
The chapter is organized as follows: Section V.2 illustrates the effect of a residue modification in an 
MS/MS spectrum; the next topic is the combinatorial issue inherent to PFF methods that simulate 
modifications on the database sequences; and the remaining part of the chapter describes “open-
modification search” MS/MS identification methods. 
 
 
V.2. MS/MS spectra obtained from peptides with residue modifications 
 
Many reported PTMs are characterized by the attachment of a chemical group on an amino acid 
residue. Residue modification may also be introduced deliberately (e.g. cysteine 
carbamidomethylation) or may happen as an artifact during sample preparation (e.g. oxidation of 
methionine). Most PTMs are site-specific and/or position specific. For example, oxidation is observed 
on M, H and W; phosphorylation, a much studied PTM, occurs on any S, T and Y, and methylation 
may occur at any N-terminal site and on internal C, H, K, N, Q, R (reference: UniMod). 
 
Residue modifications change the amino acid molecular mass, and consequently, the peptide mass. 
According to the modification, the mass difference varies from a few to several hundred Daltons. 
Thus, for example, deamidation of N and Q is characterized by a mass shift of 0.984 Daltons (loss of 
an hydrogen and an nitrogen, and gain of an oxygen) while glycine and lysine myristoylation is 
characterized by a mass shift of 210.198 (gain of 26 hydrogens, 14 carbons and 1 oxygen). The 
difficulty when analyzing MS/MS spectra produced from modified peptides is that the fragmentation 
pattern is affected by the presence of the modification. The modification may, for example, hamper 
the fragmentation mechanism because of biochemical or physical properties (e.g. steric hindrance). 
But it also modifies the position of the peaks (in respect with their expected position computed from a 
theoretical non-modified sequence). Figure V-1 illustrates how a modification may affect a spectrum.  
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Figure V-1: Effect of a modification on an MS/MS spectrum 
Box A shows an annotated spectrum of peptide DGIVQYEGELDTLKR. Major ion assignments are 
indicated, as well as the corresponding peak masses and sequence information that can be inferred 
from peak differences. Box B shows the same spectrum, in which we simulated a 100 Dalton 
modification on the second glycin of peptide DGIVQYEGELDTLKR. Peaks marked with a circle 
represent fragments that carry the modification and are thus shifted by a delta value from their 
expected position. It should be noted that the shifted peaks are not necessarily grouped in the 
spectrum and that the delta mass is not constant, since this depends on the number of charges in the 
fragment. Moreover, according to the type of modification (gain or loss of atoms), peaks may be 
shifted either to the left or to the right. In box B, sequence information is partly lost, as the amino 
acids GE can no more be read from the mass difference between ions y6 and y8. 
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V.3. PFF approach and combinatorial issue 
 
PFF algorithms score theoretical peptides by modeling virtual spectra and comparing them with the 
experimental one. If a modified spectrum is compared with its corresponding non-modified 
theoretical peptide, a number of peak matches are lost (on the average 50% of the masses are shifted), 
reducing the confidence in the identification score. In addition, since typical PFF approaches filter the 
database using the precursor mass, the correct theoretical peptide may merely not be selected as 
candidate for the identification. One possibility to handle modifications using a PFF algorithm is to 
specify a list of anticipated modifications (and associated masses). The identification algorithm 
generates virtual spectra of all PTM variants of the database sequences using the supplied list. This 
comes down enumerating the modifications for all candidate peptides and, for each variant, replacing 
the standard amino acid mass by the corresponding modified amino acid mass before computing the 
virtual spectrum. Certain tools, such as Phenyx (Colinge et al. 2003b) and InsPect  (Tanner et al. 
2005), allow the user to define his/her own types of modifications and/or to make use of additional 
information from databases (annotated PTMs). Generally, the user can also input information about 
the frequency of occurrence of a given modification. Thus, modifications that occur with high 
frequency (e.g. deliberately introduced during sample preparation) are handled in so-called “fix” 
mode. In such a case, all possible sites for a given modification are modified. When the frequency of 
a modification is low, the latter is handled in “variable” mode. In this mode, the program must 
compute all possible occurrence combinations according to the number of modification sites on the 
theoretical peptide.  
Variable modifications result into a huge increase of the number of peptides obtained after digestion 
and modification simulation, and then in a dramatic increase in computing time. More importantly, 
the number of random matches increases also because more candidate peptides are generated. For 
these reasons, PFF algorithms typically limit the number of different variable modifications to a small 
number (less than 10). In addition, mutations in the peptide and errors in the database cannot be taken 
into account because of combinatorial explosion.  
 
The present section illustrates the combinatorial complexity faced by MS/MS identification 
approaches that want to account for modifications. 
To evaluate the complexity arising from the introduction of PTMs into the database, we need to 
compute the probability P of having k possible sites of modification in a sequence of length L. This 
probability is given by a binomial distribution B(L, p, k), where p is the occurrence probability for a 
considered modification. Such distributions are observed in situations of the general “k successes out 
of L trials” type. For the sake of simplicity, we assume the modification sites to be independent. 
According to the binomial distribution, the number Nk of peptides containing k sites for a possible 
modification with occurrence probability p that are expected to arise in an n sized sequence database 
is given by: 
 
 
 
Figure V-2 shows distributions of Nk obtained for different modification occurrence probabilities. 
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Figure V-2: Expected number of peptides with k modification sites 
Simulation of the expected number Nk of peptides with k modification sites for different modification 
occurrence probabilities in a 100’000 sequence database (sequences are assumed to be of length 10, 
with independent amino acids). In the case of a modification that occurs on very few amino acids 
(e.g. p=0.05), one expects that most peptides will contain no modification site (k = 0), while in the 
case of a modification that occurs on many possible amino acids (e.g. p=0.95), one expects that most 
peptides will contain many modification sites (k near 10).  
 
 
When a peptide contains more modification sites than modification events, the PFF algorithm will 
have to compute the different possible permutations to find all variants. Let SM be the number of 
possible permutations for M modification events. 
 
 
 
where 
k is the number of possible modification sites 
Nk is the expected number of peptides with k modifications sites 
M is  the number of modification events 
 
An example of complexity evaluation is given below. 
Let us assume a user runs a PFF algorithm. The search is restrained to Human sequences in the Swiss-
Prot database. This corresponds to over 10’000 proteins, that produce, according to tryptic cleavage 
rules, about 800’000 peptides of size 3 to 30. A mean length of 11 amino acids is considered for the 
simulation (L=11). 
The user specifies only one modification type for the search: hydroxylation, which may occur as PTM 
on amino acids D, K, N and P, and as artifact on amino acids F,Y, without restriction on the sequence 
position. We roughly estimate the occurrence probability of hydroxylation to 6/20. In addition, the 
user sets the modification as variable (so that a maximum of 2 modification events on the peptides is 
taken into account). 
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Let M represent the number of modifications. When k is greater than M, the modification sites have 
to be permuted to produce all possible variants. Thus for example, a peptide with 5 modification sites 
(k=5) allows for 5 permutation possibilities in case of 1 modification event (M=1), and for 10 
possibilities in case of 2 modification events (M=2). The total number of peptides obtained after 
simulating modifications is given by the total sum of Table V-1. In this simulation, it is equal to 7.4 
millions.  
 
 k=0 k=1 k=2 k=3 k=4 k=5 k=6 k=7 k=8 k=9 k=10 k=11 
Nk 15818 74573 159800 205457 176106 105663 45284 13862 2970 424 36 1 
SM=1 / 1* N1 2* N2 3* N3 4* N4 5* N5 6* N6 7* N7 8* N8 9* N9 10*N10 11*N11 
SM=2 / / 1* N2 3* N3 6* N4 10* N5 15* N6 21* N7 28*N8 36*N9 45*N10 55*N11 
 
Table V-1: Expected number of peptides after modification simulation 
 
 
As the PFF method will be able to filter the 7.4 millions theoretical peptides using the precursor mass, 
the final number of candidates will stay more or less reasonable as long as the number of modification 
types taken into account remains low. If the user wishes to include more modification types, the 
number of candidate peptides must be restrained using more stringent filtering techniques. Much 
effort has been made in this direction over the last years. Notably, several programs, including 
Phenyx (Colinge et al. 2003b), Mascot (Creasy and Cottrell 2002), TANDEM (Craig and Beavis 
2004) and VEMS (Matthiesen et al. 2004) now split the identification procedure into two runs and use 
the first run as a filter for the second one. Typically, the first run is performed with low combinatorial 
parameters (regular cleavages, a few number of fixed modifications). Relatively high-scoring peptide 
matches allow isolation of proteins that are likely to be represented in the experimental mixture, and 
which are grouped in a database of limited size. The second run is then performed with loose 
parameters on the limited database. During the second run, more modifications can be considered, as 
well as possible mutations and non-specific cleavages. This approach is based on the assumption that 
all proteins represented in the experimental mixture contain at least one tryptic unmodified peptide 
and have been fished out during the first run. Another possibility to restrain the number of candidate 
peptides is to combine a de novo approach with a PFF approach. Thus, the algorithm InsPecT (Tanner 
et al. 2005) focuses on a very efficient filter, by selecting candidate peptides that match stretches of 
two or three amino acids extracted de novo from the spectrum. In addition, InsPecT applies dynamic 
programming to find out which candidate peptides can match the precursor mass, given the set of 
allowed modifications. By this mean, explicit enumeration of all peptide variants is avoided. With 
such enhanced filtering procedure, InsPecT can support more modification types during the search. 
 
But the procedure that consists in building the theoretical modified peptides from a set of possible 
modifications is simply not applicable in an “open-modification search” strategy. This would amount 
in creating, for each theoretical peptide, a huge number of modified peptides, in which every amino 
acid type, at every position, could be modified by any delta value. This clearly illustrates the tricky 
problem of the search space size for “open-modification searches”. Since the development of the first 
MS/MS identification approaches, very few methods aimed at identifying peptides without the use of 
a list containing expected modifications have been developed. However the subject is appealing. 
First, because it represents a challenge, asking for new comparison strategies. Second, because it may 
help reduce the number of non-identified spectra presenting good peak statistics. In most experiments, 
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the proportion of unidentified spectra is very high and could even reach 90% (Meyer, oral 
communication). Third because it meets the need of tools aimed at characterizing PTMs to better 
understand cellular pathways and investigate possible relations between the presence or absence of 
PTMs and disease states.  
 
The next sections detail the state-of-the-art of “open-modification search” algorithms. We present in 
this chapter all methods that have been claimed to deal with any type of residue modifications during 
the identification procedure. We do not include methods aimed at cross-species identification since 
they only deal with mutation and polymorphism. 
 
 
V.4. State of the art of  “open-modification search” approaches 
V.4.1. A pioneer work: the “sequence tag” approach 
 
As explained in Section III.3.2.2, a key property of MS/MS spectra is that they contain series of peaks 
resulting from successive fragmentation positions in the peptide sequence (see Figure V-3). This 
principle is exploited by de novo sequencing methods, which typically infer whole peptide sequences 
by running a reconstructed spectrum (in which every peak is associated to an ionic hypothesis). Mann 
and Wilm proposed, in 1994, to use de novo extracted sequence information as a substitute filter that 
would allow selecting candidate peptides independently of the presence of modified residues. Their 
idea was to exploit regions in the spectrum containing high-quality peak signal to infer partial 
sequence information rather than complete peptide sequences. They called these inferred partial 
sequences “sequence tags” and defined them as short stretches of amino acid sequences flanked by 
two “docking” masses representing the start mass (or prefix region mass) and the end mass (or suffix 
region mass) of the tag (see Figure V-3). 
 
 
 
Figure V-3: A “sequence tag” inferred from an MS/MS spectrum 
The tag is composed of two flanking masses –called prefix and suffix masses- and of a sequence. 
Masses of the prefix and suffix regions are easily computed from the first and last masses composing 
the tag (denoted as begin mass and end mass) and from the precursor mass (Mr).   
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The idea of Mann and Wilm was to use tags generated by de novo spectrum interpretation to scan the 
database using a pattern matching-type algorithm and the flanking masses instead of a precursor 
mass-based filter. Then, candidate sequences that matched one of the tags were subsequently scored 
using an SPC-type procedure. Their method dealt with modifications –even unexpected ones- by 
allowing one of the regions to mismatch during the candidate extraction procedure (see Figure V-4).  
 
 
 
Figure V-4: Candidate peptide selection using a tag filter 
The tag extracted in Figure V-3 is composed of three attributes: a) the prefix mass 286.14, b) the 
sequence VQ and c) the suffix mass 1321.61. A minimum of two attributes must match for a 
theoretical sequence to be considered as a candidate (in this case, the sequence and the prefix mass). 
The delta value observed between the theoretical and observed suffix masses can be explained by the 
presence of a modification in the suffix region of the tag. 
 
 
If both flanking masses match, the experimental peptide is supposed to be unmodified and the 
complete theoretical sequence can be evaluated against the spectrum using a PFF approach. If only 
one flanking mass matches, the comparison focuses on the matching part of the sequences, without 
attempting to include additional information by taking into account shifts between peaks of the 
experimental and theoretical spectra. Consequently, in case of modifications or mutations, as it leaves 
out one part of the candidate peptide in the scoring phase, Mann and Wilm’s algorithm does not 
maximally capture the similarity between the experimental spectrum and the corresponding 
theoretical one. Luckily, with a careful manual tag extraction, the number of candidate peptides to 
evaluate is drastically reduced, and the scoring scheme does not have to be very robust to more or less 
efficiently distinguish the correct peptide from all the other ones. Nevertheless, the manual tag 
extraction makes Mann and Wilm’s method unsuitable for automated MS/MS identification. 
 
V.4.2. GutenTag: an enhanced version of the “sequence tag” approach 
 
In 2003, Tabb et al. (Tabb et al. 2003b) implemented a similar approach (schematized in Figure V-5), 
named GutenTag, with an automatic tag extraction procedure and an enhanced scoring scheme. In 
this method, the spectrum is represented as a spectrum graph, which is recursively parsed to extract 
the tags. The size of the spectrum graph is controlled by carefully preprocessing the peaks, by 
considering all peaks as y-ion types, and by limiting the “sequence tag” lengths to a given size-range. 
Each extracted tag is then scored using a combination of two subscores: the m/z score, that takes into 
account mass errors between peak masses included in the tags and their expected position given the 
tag sequence, and an intensity score. Then, the best-scoring tags are searched in parallel against the 
sequence database using a “trie” structure (Aho and Corasick 1975), which allows locating all 
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occurrences of any of a finite number of keywords in a character string. The masses of the flanking 
sequences are determined for each matching peptide, and every sequence with at least one matching 
flanking mass is retained as candidate peptide and scored against the spectrum using the spectral 
angle contrast scoring scheme (see Section IV.3.5.3). 
 
 
 
 
Figure V-5: GutenTag’s approach 
 
 
V.4.3. PEDANTA: spectral alignment 
 
The “spectral alignment” method, from Pevzner et al. (Pevzner et al. 2000) can be considered, 
together with the Mann and Wilm’s “sequence tag” approach, as a pillar for “open-modification 
search” approaches. The method, called PEDANTA, extends the PFF matching concept by taking 
into account the possible existence of shifts (or gaps) that would allow a better peak matching. 
 
The algorithm consists in aligning the masses of the theoretical and experimental spectra by storing 
all possible matches (without considering mass similarities) in a matrix, and then searching for the 
path that best explains the similarity between both spectra using dynamic programming. Figure V-7 
shows the alignment procedure for two hypothetical spectra. In short, the procedure splits one of the 
two spectra so as to compare one spectrum with sub-regions of the other one (as illustrated in Figure 
V-6). There is a strong analogy to the global sequence alignment method of the Needleman and 
Wunsch algorithm (Needleman and Wunsch 1970).  
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Figure V-6: Principle of spectral alignment 
Spectra alignment is an extension of the PFF matching concept by allowing groups of peaks to be 
shifted to increase the number of matched peaks. 
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Figure V-7: Pedanta spectral alignment procedure  
Alignment of two hypothetical spectra A = {10, 20, 30, 40, 50, 60} and B = {10, 20, 35, 45, 65, 75}. 
All possible matches, i.e. pairs (ai, bj), are represented in a matrix Mij by a dot. The number of dots 
that are covered by the diagonal starting from the origin of the two axes is the SPC score when no 
shift is allowed. Dij(k) is defined as the k-similarity between Ai and Bj (the spectra are similar under 
the assumption that they are k modifications apart) and corresponds to the maximum number of dots 
on a path to (ai, bj) taking k+1 distinct diagonals. The dynamic programming recurrence for 
computing Dij(k) is indicated below the matrix. Two paths are shown. The optimal one, with a score 
D(k=2)=6; and a sub-optimal path, shown in gray, with a score D(k=2)=5. A basic SPC score would 
lead to a D(k=0)= 2. 
 
 
Pevzner’s approach is simple and original. Shifts observed in a path allow making hypotheses about 
the modification types. Of course, the scoring is too basic and a tag-based filter would be appreciable 
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to speed up the search, but the authors of Pedanta were undoubtedly more interested, at the time of 
publication, in describing a new original approach than in producing an “all-in-one” identification 
tool.  
 
V.4.4. OpenSea: tag extension 
 
OpenSea, which was introduced in Section IV.3.4.3 is dedicated to the alignment of de novo 
sequences against database sequences. In a recent publication, it has been adapted to account for 
known and unknown modifications. Here is given a description of the algorithm, as presented in 
(Searle et al. 2004;Searle et al. 2005).   
OpenSea takes as input de novo sequences obtained by the PEAKS sequencing software. It first 
identifies a high-scoring unambiguous tag of two or three amino acids in the de novo sequences. Then 
it selects candidate peptides by matching the tag against database sequences using a string search 
procedure. The alignment between each candidate peptide and the de novo sequence is then extended 
at both extremities of the matched tag using a breadth-first procedure (see Figure V-8).  
 
 
 
 
Figure V-8: Mass-based alignment  
Alignment procedure of a candidate peptide and the “de novo” sequence using a breadth-first search 
approach with a depth of three amino acids.  
Numerical values in the “de novo” sequence correspond to masses of amino acid combinations (e.g. 
199.1 correspond to the mass of an alanine plus the mass of a glutamine). Matches between single 
residues are represented by strokes, matches between groups of amino acids are signified by 
rectangular boxes and mismatches are represented by crosses. The alignment proceeds from the tag 
extremities (the tag is represented in bold). The path taken by the alignment follows the shadowed 
boxes. If no mass match is found by searching the first breadth level, the algorithm searches through 
the next level, until it reaches a depth of three amino acids.  If no match can yet be found, a 
substitution is assumed, and a new alignment is initiated at the next amino acid in each sequence. 
(Figure adapted from (Searle et al. 2004)). 
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Once the alignment is built and in case of mismatched amino acids, OpenSea runs an interpretation 
routine to explain the observed mass shifts either by a substitution event, or a modification. If no 
substitution or known modification can explain the observed shifts, OpenSea assumes it is the result 
of an unknown modification. Finally, the alignment is re-scored using a PFF type scoring scheme as 
if a new amino acid were to be identified (Searle et al. 2005).  
 
 
Figure V-9 illustrates how OpenSea can identify and map a methylation on a peptide.  
 
 
 
 
 
Figure V-9: OpenSea at work 
Identification and characterization of a methylated peptide by OpenSea. 
A. The “de novo” sequence derived from the experimental spectrum is aligned with a candidate 
peptide (here, the human γS Crystallin chain). Carbamidomethylation of cysteine (CysCAM) was 
introduced as an expected modification. Three consecutive mismatches are observed (crosses). 
B. The auto-interpretation process explains the mismatches of D+220+G and CysCAM+D+C by an 
unanticipated cysteine methylation on either the first C or the second C.  
C. As a result of the re-scoring procedure, methylation of the first cysteine is reported as the best 
interpretation (Figure adapted from (Searle et al. 2005)). 
 
 
Searle et al. approach is of interest and deals with the identification and characterization of peptides 
carrying unexpected modifications. However, it suffers from an awkward drawback: it uses tags 
extracted from “complete” de novo sequences as a start for the alignment rather than tags extracted 
locally. We reported in Section IV.3.4.2 the difficulty met by de novo methods for sequencing 
peptides carrying unexpected modifications. De novo sequencing methods, whether they use the 
“pseudo” PFF approach or the peak succession approach, have to introduce modified residues in their 
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amino acid pool to specifically account for modifications. Non-expected modifications of residues in 
the spectrum cause the correct path of a spectrum graph to be split into two (or more) sections, which 
are (or are not) connected by alternative paths (see  
Figure V-10).  
 
 
 
Figure V-10: Non-expected modification and split paths 
The figure shows how a non-expected modification causes the correct path in a spectrum graph to be 
split. The two original spectra were artificially created. Both spectra had complete coverage (b-ion 
series from position 1 to 6 and y-ion series from positions 1 to 5, leading to 11 peaks in the 
spectrum). The spectrum was built by Popitam. In the right graph, the path is split in two parts. There 
is no possibility of joining them by using existing edges (see also Figure VI-8). 
 
 
As a result of the splitting, the obtained de novo sequences are either truncated (these are not reported 
by the de novo algorithm because they do not match the precursor mass) or contain incorrect amino 
acid regions that come from an alternative path. Consequently, a large majority of the de novo 
sequences used by OpenSea contain such regions -the de novo sequence of Figure V-9 contains 
precisely three consecutive mismatches- and a significant number of modified spectra are probably 
not processed by the algorithm because they did not lead to any valuable de novo sequence. 
A possible solution to this problem relies on a local tag extraction procedure. Recently, Frank et al. 
(Frank et al. 2005) studied tag extraction for database sequence filtering. In particular, they worked 
on the covering property, which states that at least one of the tags in the list must be correct (which is 
necessary for the correct peptide to be presented as candidate for identification) while the list should 
be as small as possible (which is necessary for efficient filtration). Frank et al. also highlighted the 
difference between global and local tags. They noted that local paths might not be extensible into an 
optimal global path, or into any global path at all (dead-end paths). Correspondingly, the tag PEP in 
the left graph of Figure V-10 represents a global path, while the same tag in the right graph of Figure 
V10 represents a local path.  
Therefore, a more suitable approach for ”open-modification search” software like OpenSea would use 
local tag extraction, and then perform the mass alignment by looking directly in the spectrum. This is 
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the approach used by InsPecT, although the latter is not designed for an “open-modification search”, 
since it requires a list of anticipated modifications and does not, at the moment, include unknown 
modifications during the alignment procedure. 
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Figure adapted from "Monsieur Hippopotame" by Tanikawa Shuntarô 
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Popitam’s ALGORITHM 
 
 
 
 
This chapter describes in details each step of Popitam’s algorithm.  
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VI. Popitam’s algorithm 
VI.1. Introduction 
 
Popitam, whose an earlier version was published in 2003 (Hernandez et al. 2003) uses a tag-oriented 
approach to perform a database-guided spectrum interpretation. It has been specifically designed to 
identify spectra from modified and/or mutated peptides without any a priori knowledge about the 
expected type of modifications. Popitam borrows the spectrum graph from de novo methods, but it 
differs from de novo sequencing algorithms in that the graph is specifically parsed for each candidate 
peptide extracted from a database. Popitam’s algorithm searches the graph for all tags of the longest 
possible length that match subsequences of the current candidate peptide. Then, the tags are combined 
according to compatibility rules, in order to build plausible spectrum interpretation scenarios. 
Typically, a scenario is composed of one or several tags, separated by gaps. Using the flanking 
masses of the tags, Popitam evaluates if a gap contains a modification or a mutation (in which case it 
is denoted as modGap), or if it arises from a lack of information in the spectrum due to low peak 
statistics (in which case, it is denoted as lackGap). Finally, each scenario is scored. The candidate 
peptide with the highest-scoring scenario is proposed as the identification. An overview of the 
approach is presented in Figure VI-1. Popitam can be run in command line with a text-based output. It 
also allows for submission via a web interface with a parser that displays the results in html format. 
An example of Popitam’s output is shown in Appendix A4. A user-friendlier implementation is under 
development. 
 
 
 
Figure VI-1: Popitam’s approach 
Candidate peptides are selected from a database according to filtering criteria (possible criteria are 
taxonomy, a list of accession codes, sequence information, digestion rules, and maximum shift 
between the experimental precursor mass and the candidate peptide mass). For each candidate 
peptide, Popitam extracts all tags that are consistent with the candidate sequence and the peak 
pattern of the spectrum. Then it arranges the various tags according to logical rules and proposes 
scenarios that include modification hypotheses. Each scenario is scored. The peptide that obtains the 
scenario with the highest score is proposed as the identification result. 
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This chapter describes in detail Popitam’s algorithm. First, it introduces some terminology bases; then 
it describes peak preprocessing steps applied by Popitam. Section VI.5 deals with the building of the 
spectrum graph, followed by tag extraction, arrangement and scoring. In order to clearly illustrate 
each step of the algorithm, Popitam was run with an example-spectrum shown in Figure VI-2. This 
spectrum was chosen because it included two modified amino acids (a carbamidomethylated cysteine 
and an oxidated methionine). Of course, no information about the modification types had been given 
to Popitam. During the run, Popitam’s parameters were set in such a manner that the collected data 
were easily exploitable for demonstration purposes: the number of nodes and edges in the graph were 
deliberately kept low; an AC-based filter was applied, so that only peptides that belong to the correct 
protein (Swiss-Prot, P36578) were presented as candidates. With a maximum of 1 missed-cleavage 
authorized, this corresponded to a total of 85 peptides, including the correct peptide 
YAICSALAASALPALVMSK. Moreover, Popitam was run in mode MODGAPNB = 2. This means 
that two occurrences of any type of modification were considered during the analysis. 
 
 
 
Figure VI-2: An example-spectrum YAIC[cam]SALAASALPALVM[ox]SK. 
This example-spectrum comes from a real experiment but it was modified by hand to remove noise 
peaks and to add some missing peaks. The peptide that produced the spectrum is the peptide 
YAIC[cam]SALAASALPALVM[ox]SK. It carries two modifications (a carbamidomethylation on the 
cysteine and an oxidation on the methionine).  
 
 
 68
VI.2. Terminology 
 
A peptide P is a linear sequence of p amino acids taken from an alphabet Σ of size 20, with 
P={a1a2...ap}. Each amino acid has a mass μ(ai). The mass of an uncharged peptide P, denoted as 
μ(P), is the sum of all its constituent amino acids plus the mass of the N-terminal (H) and C-terminal 
(OH) groups. 
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Equation VI-1 
 
In an MS/MS experiment, P can be cleaved between each amino acid. Each cleavage leads to two 
fragments, one with the N-terminus and one with the C-terminus (we do not consider internal 
fragments as they are of no –or little– use in methods using spectrum graph). In an ideal 
fragmentation situation (cleavage occurring exactly on the peptide bond without any atom gain or 
loss), the mass of a N-terminal fragment )μ(FNtermn ending at amino acid n can be computed by adding 
the amino acid masses located before the cleavage position and the mass of the N-terminal group.  
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Equation VI-2 
 
Similarly, the mass of a C-terminal fragment ending at amino acid n can be computed by adding the 
amino acid masses located after the cleavage position and the mass of the C-terminal group.  
 
∑
=
+=
|P|
ni
i
Cterm
n μ(OH))μ(a)μ(F  
Equation VI-3 
 
A spectrum S is composed of an observed precursor peptide mass-to-charge ratio, denoted as 
)(Pμ precm/z , of an integer c representing the precursor’s charge state, and of a list L of peaks, with 
L={s1, s2, …, sl}, each of them being characterized by a mass-to-charge ratio )(sμ im/z  and an 
intensity value ι(si). The charge state corresponds to the number of protons H+ carried by the peptide. 
The non-charged molecular mass of the peptide can be computed according to: 
 ( ) μ(H)cc)(Pμ)μ(P precm/zprec ⋅−⋅=  
Equation VI-4 
 
An ionic hypothesis η is a possible interpretation of a peak (each peak can have several different 
interpretations). Interpreting a peak means assigning it a terminus side t(η), a number of charges c(η), 
and an offset value o(η). As we do not consider internal fragments, t(η) is either “N-term” or “C-
term”. The number of charges is always > 0 as mass spectrometers only detect charged fragments. 
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The offset value corresponds to an ion type, as explained in Figure III-3 and represents the mass gains 
and losses that may occur during fragmentation of the peptide (including possible losses of molecules 
by amino acids, like water and ammonium). Table VI-1 gives examples of ionic hypotheses. 
  
η t(η) c(η) o(η) 
a+ N 1 -28 [Da]
a+* N 1 -45 [Da]
a+° N 1 -46 [Da]
a++ N 2 -28 [Da]
a++* N 2 -45 [Da]
a++° N 2 -46 [Da]
b+ N 1 0 [Da]
b+* N 1 -17 [Da]
b+° N 1 -18 [Da] 
b++ N 2 0 [Da]
b++* N 2 -17 [Da]
b++° N 2 -18 [Da] 
y+ C 1 2 [Da]
y+* C 1 -15 [Da]
y+° C 1 -16 [Da]
y++ C 2 2 [Da]
y++* C 2 -15 [Da]
y++° C 2 -16 [Da]
 
Table VI-1: ionic hypotheses 
An ionic hypothesis η is characterized by a terminus side t(η),  a number of charges c(η) and an 
offset value o(η). For example, a peak interpreted as a*++ is hypothesized to be a doubly charged a-
ion type peak that lost an ammonium molecule. Ammonium losses are signified by a “*” while water 
losses are signified by a “°”. 
 
 
VI.3. Overview of Popitam’s algorithm 
 
Figure VI-3 overviews the main steps of Popitam’s algorithm. Names of functions are given in italic. 
The sections of this chapter describe each of the eight steps numbered in the Figure. 
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Figure VI-3: Overview of Popitam’s algorithm 
Preprocessing (1) is tackled in Section VI.4; The spectrum building (2) is the subject of SectionVI.5. 
The suffix tree (3) and the tag extraction process (4) are part of Section VI.6. Section VI.7 discusses 
the tag cleaning (5) and Section VI.8 is about the cliques search. The scenarios are built in Section 
VI.9, and scored in SectionVI.10.8.  
 
 
VI.4. Peak preprocessing  
 
The MS/MS spectra used for identification are the result of automated signal processing algorithms 
that transform the raw measured signal into generic lists of peaks. Peak detection software include, 
with more or less success, peak centroiding, noise filtering, calibration, deisotoping and 
deconvolution. This low-level preprocessing is a key step that can noticeably influence the outcome 
of the identification (Gentzel et al., 2003). Higher preprocessing procedures are often performed on 
the peak lists. Although they are not systematically applied by identification software, they generally 
tend to enhance the identification quality. Such procedures, which are most often empirical, include 
removing non mono-isotopic peaks, filtering background noise, and deleting the precursor ion from 
the peak list, if present. The preprocessing steps performed by Popitam, which are listed below, are 
based on simple and empirical methodologies. As shown in Figure VI-4, they greatly reduce the 
number of peaks in the spectra, thus making their subsequent analysis easier. Nevertheless, we think 
that the procedure could (and should) be enhanced in the future. Notably, the extraction of isotopic 
peaks could be more developed and could use information about the expected isotope distributions for 
a given fragment mass. 
 
a) Normalization of the peak intensities and removal of low intensity peaks 
The function starts by normalizing the intensities of the peaks (the most intense peak is given an 
intensity of 100). Peaks below a given intensity threshold (e.g. 5% of the highest intensity) are 
removed from the spectrum. 
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b) Attribution of possible charge numbers to the peaks 
Each peak is attributed possible charge numbers (1 or 2), according to their mass and the mass of the 
precursor. Peaks with masses greater than the precursor mass divided by two are considered as singly 
charged, while the other peaks are considered as either singly or doubly charged. 
 
c) Isotopic peaks removal 
The function sorts the processed peaks by mass and parses the list to locate isotopic peaks. For a peak 
sj to be considered as an isotope of a peak si, the following conditions are required: 
 
i)  ( ) ( )im/zjm/z sμsμ >  
ii)  ( ) ( )( ) ε0.5sμsμ im/zjm/z <−−   if both peaks have a possible charge number of 2 
 ( ) ( )( ) ε1sμsμ im/zjm/z <−−   if both peaks have a possible charge number of 1 
iii) ( ) ( )ij sιsι >  
 
where  
ε is an error threshold specified by the user (e.g. 0.2); 
 
d) Merging of very close masses 
It is not uncommon in a spectrum to observe peaks with very similar mass-to-charge values. When 
the signal extraction process is applied to the raw MS/MS spectrum, a single signal can be improperly 
interpreted as two different peaks (but of very similar masses). Using a greedy procedure and an error 
threshold, Popitam merges such peaks. When two peaks are merged, the new peak is given the 
average mass and the highest intensity of the two original ones.  
 
e) Categorizing peaks into intensity ranks  
Finally, peaks are sorted by intensity and are attributed a bin number according to their intensity 
category. The size n of the bins is directly computed from the precursor mass and represents the 
estimated amino acid length of the precursor peptide (rounded to the nearest integer).  
 ( )
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where 
μ(Pprec) is the uncharged precursor mass 
f(ai) is the observed frequency of amino acid i (computed for example in a reference protein 
database), with 0 ≤ f(ai) ≤ 1,  and   
μ(ai) is its monoisotopic mass. 
 
 72
The n most intense peaks were put into bin number 1, the n following into bin number 2, and so on 
until bin number 10. 
 
 
 
 
Figure VI-4: Number of peaks before and after preprocessing 
Scatter graph representing 597 spectra according to their number of peaks before and after 
preprocessing. 
 
 
VI.5. Spectrum graph building 
 
The spectrum graph is a widely used structure in de novo sequencing methods. In short, a spectrum 
graph is a structured representation of a spectrum. Nodes represent masses of N-terminal fragments, 
or “prefix residue masses” (PRM) (Bandeira et al. 2004). Given a peptide P = {a1, a2, ..., ap}, the PRM 
of a prefix ending at position n corresponds to the N-terminal fragment mass 
 
∑
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Two nodes that differ by the mass value of one or a combination of amino acids (usually two) are 
connected by an edge labeled by the corresponding amino acid(s). Paths in a graph represent all 
amino acid tags and complete sequences that can be inferred de novo from the spectrum. 
The construction of the spectrum graph in Popitam can be divided into four distinct steps. The first 
one is the re-expression of all peaks of the preprocessed spectrum as PRMs, according to a set of 
ionic hypotheses; the second one is the grouping of similar PRMs into clusters; the third one is the 
selection of clusters that will form the nodes of the spectrum graph; and the fourth one is the 
connection of the graph nodes. 
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VI.5.1. Peak re-expression as prefix residue masses 
 
In a spectrum graph, two nodes are connected when their mass differ by the mass value of one or 
several amino acids. This requires two node masses to be comparable, which is not the case if they 
represent peaks of different ionic types. Thus, the first step in the construction of a spectrum graph is 
to re-express all the peak masses into PRMs. This procedure, which amounts to attribute to each peak 
(of unknown ion type) different ionic hypotheses from a set Δ={η1, η2,..., η|Δ|}, is illustrated in Figure 
VI-5. The procedure implies the use of Algorithm VI-1 to transform peak mass-to-charge ratios 
μm/z(si) into prefix residue masses PRM(si, ηk). 
 
 
 
Algorithm VI-1: Transforming mass-to-charge ratios into PRMs 
Transformation of a peak mass-to-charge ratio μm/z(si) into a prefix residue mass PRM(s., ηk), given a 
precursor mass μ(Pprec) and an ionic hypothesis ηk composed of an offset value o(ηk), a terminus side 
t(ηk) (N-term or C-term) and a number of charges c(ηk): 
 
 
It should be noted that one of the members of the second formula being the measured precursor mass, 
its error, which is generally greater than the error observed for fragment masses, is transmitted to the 
computed PRMs. Methods exist that refine the precursor mass using complementarity between b- and 
y-ion type peaks (see (Dancik et al. 1999) for more details). Popitam handles the issue by using two 
error thresholds, FRAGMENT_ERROR1 and FRAGMENT_ERROR2. The former is used when 
comparing PRMs of similar terminus sides, while the latter, which is greater, is used when comparing 
PRMs of different terminus sides. Typical FRAGMENT_ERROR1 and FRAGMENT_ERROR2 
values are 0.2 and 0.4 [Da] respectively.  
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Figure VI-5: Peak re-expression 
YAIC[cam]SALAASALPALVM[ox]SK-spectrum before (top) and after (bottom) re-expression of the 
peaks as prefix residue masses (PRMs). 
PRMs are computed from the peak mass-to-charge ratios by applying in turn ionic hypotheses of a set 
Δ. In this case, the 18 ionic hypotheses enumerated in Table VI-1 were applied. For a given peak, at 
most one of the obtained PRMs is correct, all the other ones being issued from false hypothesis 
assignments. Arrows allow one to follow the interpretation process for three particular peaks (at m/z 
147.12, 779.36 and 1174.61), and two specific ionic hypotheses (b+ and y+). The first peak, 147.12 is 
actually the y1-fragment of peptide YAIC[cam]SALAASALPALVM[ox]SK. Then, the PRM 147.12, which 
is based on the assumption that the original peak is of b-ion type, is a false positive, while the PRM 
1008.93 is correct. Similarly, peak 779.36 being the b7-ion, the PRM 779.36 is correct, while the 
PRM 1174.69 is a false positive. When two different peaks originate from the same fragmentation 
position, their correct PRMs converge to a unique m/z value (as can be observed for PRMs of peaks 
779.36 and 1174.61). The same phenomenon happens with incorrect hypothesis assignments.  
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Given |S| the number of peaks in a spectrum, and |Δ| the number of ionic hypotheses, the re-
expression procedure leads to a set of |s|*|Δ| PRMs. As highlighted in the legend of Figure VI-5, at 
most |S| of the obtained PRMs are correct, all the other ones being issued from false hypothesis 
assignments. Such a situation is unfavorable, since most of the nodes in the graph will come from 
false assignments, thus complicating the graph interpretation. To handle this issue, we associate with 
each PRM a confidence score σ(PRM), on which we base the subsequent selection of PRMs to 
integrate in the graph. The score represents the probability that the ionic hypothesis is correct, given 
the intensity rank of the peak, the number of charges carried by the precursor peptide and the mass 
spectrometer type. These probabilities are read from pre-built tables, according to a method described 
in (Dancik et al. 1999) and explained below. 
 
We used a set of 704 doubly charged MS/MS spectra obtained with a Q-TOF mass spectrometer. 
Each spectrum of the set was confidently correlated with a peptide sequence. For each spectrum, the 
peaks were ranked by intensity and grouped into bins (see Section VI.4). Masses of N-terminal 
fragments were computed for each cleavage position on the peptide sequence assigned to the current 
spectrum according to Equation VI-2. Offsets (which are specific for ion-types) between observed 
peak masse-to-charge ratios and the computed masses were reported and incremented in a 3D plot 
(see Figure VI-6, left plot). After each spectrum has added its contribution to the 3D plot, the process 
was repeated with C-terminal fragment masses and a second 3D plot (see Figure VI-6, right plot). 
Two additional plots were created for doubly charged N-terminal and C-terminal fragment masses. 
Finally, occurrence probabilities of a given ion type were estimated by dividing the count reported for 
the corresponding offset by the number of peaks in the bin (see Table VI-2). 
 
 
 
Figure VI-6: Ion occurrence plots 
The plots count singly charged ion types observed in a set of 704 doubly charged spectra obtained 
with an ESI-QTOF mass spectrometer. With such plots, one can easily spot what ion types are 
produced during the peptide fragmentation. Moreover the relation between peak intensity and ion-
type frequency is highlighted. The distributions show that the frequencies fall with decreasing 
intensity, except for ions with water or ammonium molecule losses. For these ions, the tendency is 
reversed from bin 1 to bin 2. 
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ion type offset bin1 bin2 ... bin10 
   a -28 5.24 4.16 ... 2.4 
   a* -45 0.95 1.5 ... 1.63 
   a° -46 0.76 1.15 ... 1.73 
   b 0 12.19 11.22 ... 2.12 
   b* -17 1.43 4.36 ... 2.5 
   b° -18 3.33 3.36 ... 2.6 
   a++ -28 0.48 0.55 ... 0.38 
   a*++ -45 0.33 0.55 ... 0.48 
   a°++ -46 0.19 0.1 ... 0.38 
   b++ 0 0.71 0.7 ... 0.67 
   b*++ -17 0.38 0.6 ... 0.77 
   b°++ -18 0.48 0.45 ... 0.48 
   y 2 35.52 18.89 ... 3.75 
   y* -15 0.81 3.46 ... 2.5 
   y° -16 1.24 2.61 ... 3.08 
   y++ 2 1.76 2.4 ... 1.35 
   y*++ -15 0.24 0.95 ... 0.87 
   y°++ -16 0.52 0.9 ... 1.06 
 
Table VI-2: Occurrence probabilities (as percent)  
The table list occurrence probabilities for various ion types and peak intensities computed from a set 
of 704 doubly charged spectra (ESI-QTOF). In our dataset, 35.52% of the peaks in bin number 1 
were of y-ion type, and 12.19% of the peaks in bin number 1 were of b ion-types. The first column 
sums to 66.56%. This means that 33.44% of high intensity peaks did not correspond to either of the 
18 ion types. 
 
The methodology described above has been applied on two datasets, one from a Q-TOF and one from 
a TOF-TOF mass spectrometer, producing three tables: two for MS/MS data obtained with the Q-
TOF (one for doubly charged spectra and one for triply charged spectra), and one table for singly 
charged spectra obtained with the TOF-TOF. For each spectrum to identify, Popitam uses the 
corresponding probability file. 
  
VI.5.2. PRM clustering 
 
As shown in Figure VI-5, when a given cleavage position is represented by several different ionic 
peaks in the spectrum, their PRMs converge to single values. Consequently, after all peaks have been 
re-expressed, similar PRMs are hypothesized to represent a single fragment mass and are grouped 
into clusters. At the end of the process, an average PRM is computed for each cluster. The clustering 
algorithm used by Popitam is depicted in Figure VI-7. 
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Figure VI-7: Grouping PRMs into clusters 
This example is based on a subset of PRMs computed from the spectrum represented in Figure VI-5. 
PRMs and their associated ionic hypotheses are placed in squares (PRMs scores are not shown). 
Clusters are shown by rounded boxes. The algorithm first associates every PRM to a cluster 
(composed of itself). Then, iteratively, it searches for the two closest PRMs (in different clusters and 
of different ionic hypotheses). If the mass difference between the two clusters is lower than a certain 
threshold (FRAGMENT_ERROR1 if the terminus sides are the same, otherwise 
FRAGMENT_ERROR2), all the PRMs of one cluster are inserted into the other one, and the empty 
cluster is deleted. The process stops when there are no more PRMs in different clusters and of 
different ionic hypotheses having a mass difference smaller than the chosen threshold. 
 
VI.5.3. Node sampling  
 
Nodes of the spectrum graph are directly formed from PRMs clusters. Therefore, nodes include all 
original information of the clusters. This includes the complete list of PRMs with their confidence 
scores, and for each PRM, indices to the original peak and applied ionic hypothesis. It is therefore 
very convenient to access any piece of information from a node at any moment during the 
identification run.  
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As most clusters are issued from false ionic hypothesis assignments, only clusters including PRMs 
with high-confidence scores are selected to be part of the graph. The procedure is the following. First, 
a desired number N of nodes to include in the graph is computed. N is computed according to:   
 ( )
COVBIN
111
Pμ
N prec ⋅=  
 
where ( )precPμ  is the observed precursor mass 
111 is the average weight of an amino acid 
COVBIN is a coverage parameter 
 
The first term of this equation represents the estimated length of the precursor peptide. If COVBIN is 
set to 4, the number of nodes is chosen so as to cover 4 times the number of possible cleavages of the 
peptide sequence. 
Once N is computed, the clusters are sorted by decreasing order according to their highest σ(PRM). 
Finally, the N first PRM clusters of the sorted list are selected to form the graph. Two “virtual” nodes 
complete the set: the first one represents the empty sequence (PRM = μ(H)) and the second one 
represents the complete sequence (PRM = μ(Pprec)- μ(OH)). The former is the node with the smallest 
PRM of the graph, and the latter is the node with the largest PRM.  
 
It should be noted that PRM selection could be optimized in the future to include more information. 
For exemple, Tanner et al. (Tanner et al. 2005) estimated the ionic frequencies for different sectors of 
the spectrum. 
 
VI.5.4. Graph connection 
 
During the graph connection procedure, pairs of nodes vi and vj are connected by an edge eij if any of 
the PRMs in vi differs from any of the PRMs in vj by the mass value of one or two amino acids, given 
an error threshold. The error depends on the ionic hypothesis terminals of the two PRMs 
(FRAGMENT_ERROR1 is used when the terminals are the same, FRAGMENT_ERROR2 is used 
otherwise). Edges therefore represent amino acids, and the set of all paths in the graph represents the 
set of all possible amino acid sequences that can be inferred from the peak pattern of the spectrum. 
“Double edges” allow jumping over one missing fragmentation position (all positions in a peptide are 
not necessarily cleaved during the fragmentation process). It would be possible to extend this concept 
to triple edges and more, but since the number of edges increases exponentially with their length, this 
would not be realistic. By convention, we will refer to simple edges with upper case letters, and to 
double edges with lower case letters. Figure VI-8 shows an example of spectrum graph obtained from 
an MS/MS spectrum.  
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Figure VI-8: Spectrum YAIC[cam]SALAASALPALVM[ox]SK and its spectrum graph 
COVBIN was set two 3 (greater coverage values are generally chosen with real data) and only simple 
edges were considered during the graph construction. FRAGMENT_ERROR1 and 
FRAGMENT_ERROR2 were set to 0.2 and 0.4 respectively. For the sake of reading clarity, nodes are 
signified by their average PRM. The correct path (shown in bold edges and shadowed nodes) is the 
path that corresponds to the correct peptide sequence and that uses nodes obtained with correct ionic 
hypotheses. The effect of the presence of modified amino acids is clearly illustrated. The first 
modification (C[cam]) splits the path into two unconnected parts (it is not possible to return to the path 
from node 348.2). For the second modification (M[ox]), an alternative path (edge corresponding to 
amino acid F) can be used to go from node 1572.9 to node 1719.9.  
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VI.6. Tag extraction  
 
A first version of the algorithm (Hernandez et al. 2003), called “Full Path Algorithm”, was aimed at 
finding complete sections in the graph (a path starting from the first vertex and corresponding to a 
whole peptide sequence) that best fitted the current candidate peptide (see Appendix A5). The parsing 
was performed using an Ant Colony Optimization algorithm (ACO) (Dorigo and Di Caro 1999). 
ACO algorithms are defined as multi-agent systems inspired from real ant colony behavior. Their 
principle is the following: a population of ants explores, iteratively and simultaneously, different 
paths in the spectrum graph by moving from node to node using available edges. Ant’s exploration is 
guided by a visibility factor (represented by the score of the nodes), and by a variable associated to 
edges and representing pheromone trails deposited during previous explorations. After a certain 
number of iterations, the ACO converges to globally interesting paths. A detailed description of the 
ACO algorithm can be found in (Hernandez et al. 2003), as well as some results obtained with this 
method. A significant drawback of the “Full Path Algorithm” was that it showed limited performance 
on spectra with poor peak statistics. Popitam was struggling with the identification of spectra having 
two or more missing fragmentation positions, because they resulted into split spectrum graphs and 
then forced the ants to lose the correct path. In addition, the “Full Path Algorithm” was not able to 
handle unexpected PTMs.  
The solution came from tag extraction. By looking for local sections in the spectrum, we freed 
Popitam from several hindrances. First, calibration was not any more a problem, since the parsing did 
not necessarily include the extremities of the graph, which have arbitrary fixed masses. Then, the 
problem of split spectra due to poor fragmentation or to the presence of unexpected PTMs was 
alleviated. In (Hernandez et al. 2003), we presented results obtained with a preliminary version of 
Popitam’s “tag algorithm”. That version did not contain elaborate scoring functions and was using a 
factor oracle automaton (Allauzen et al. 1999) to index the subsequence of the candidate peptides. 
The tag extraction procedure was similar to the current version of Popitam. The spectrum graph and 
the automaton were simultaneously parsed, and only tags that were coherent with both the MS/MS 
spectrum and the current candidate peptide were extracted. As highlighted in Figure VI-9, a drawback 
of this structure is that available paths do not correspond to real subsequences of the candidate 
peptide, producing “artifact” tags. We therefore finally chose a structure based on a suffix tree 
(Gusfield, Cambridge University Press, New York, 2004) (see Figure VI-9).  
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Figure VI-9: A factor oracle and a suffix tree 
A factor oracle of a string S of length n is an automaton with exactly n states (circles). All states can 
be terminal. Starting from state 0, one can build at least all possible subsequences of S. In the 
example A, path 0-3-6-7 corresponds to sequence DYTT and is actually a subword of 
CTDCDYTTNK. Path 0-1-2-9-10 corresponds to sequence CTNK, which is not a subword of 
CTDCDYTTNK. 
A suffix tree of a string S of length n is a rooted directed tree with exactly n leaves, each of them 
representing a different suffix of the string starting at a position p. Concatenation of the edge-labels 
on a path from the root to a given internal node spells out a repeated factor of S. 
 
 
Tag extraction is performed by simultaneously parsing the graph structure and the suffix tree. The 
procedure, depicted in Figure VI-10 and Algorithm VI-2, consists in recursively parsing the graph 
and using the suffix tree as a checking table. A similar approach (with complete paths) was used in 
(Lu and Chen 2003a). In Popitam, as we are interested in tags, the search is performed from each 
node of the graph and is exhaustive (we do not use any more the ACO algorithm). By this mean, 
Popitam can extract all tags that are both consistent with the spectrum peak pattern and the candidate 
peptide (given a minimum tag length).  
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Figure VI-10: Tag extraction  
Tag extraction is performed by simultaneously parsing the suffix tree (left) and the graph (right). The 
parsing is carried out from each node of the graph. At the beginning, the first node is used as a start. 
In this example, the start node is node 409.2. Exploration proceeds recursively through the graph as 
long as the parsed path matches a subsequence of the candidate peptide (the suffix tree is used as a 
checking table). If a tag cannot be anymore elongated, it is stored. Usually, the minimum length for a 
tag to be stored is set to three nodes. Recursivity allows backtracking to an anterior state in both the 
graph and the suffix tree and exploring new paths. When all paths have been tested from a given 
node, a new search is launched from another one, until each node has been used as start for a search. 
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Algorithm VI-2: Tag extraction  
The search is launched from each node vu. Two indices, pos(G) and pos(T) store the current positions 
respectively in the graph and in the tree. The two loops enumerate the successive amino acids in the 
graph and amino acids in the tree. In the worst case, the iteration number of the suffix tree loop is Σ 
(the number of possible amino acids), and the iteration number of the graph loop is Σ2 (all possible 
two amino acid combinations). In case of match, the current path and both positions are updated, and 
the function is recursively called. In case of mismatch, the current path is stored if its length is larger 
than the parameter MIN_TAG_LENGTH.  
 
Tag extraction is the most time consuming process of Popitam: each node in the graph may start a tag, 
and the extraction process is performed for each candidate peptides. According to Algorithm VI-2, 
the “worst case” complexity (for one candidate peptide) is: 
 ( )3ΣLmO ⋅⋅  
 
where 
m is the number of nodes in the spectrum graph 
L is the length of the candidate peptides 
Σ is the number of distinct amino acids 
 
Fortunately, both the spectrum graph and the suffix tree are not fully connected and thus, the term Σ 
is overestimated. For example, in Section VIII.3.3, the spectrum graphs of the various presented 
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spectra have an average connection rate of 68 edges per node. As we used large fragment errors for 
these examples, this corresponds to a particularly high connection rate.  
 
The extracted tags have several attributes. First, they represent a sequence, obtained by concatenating 
the parsed edges. The list of parsed nodes is also stored, as well as the position of the tag in the 
peptide sequence (this information is given by the suffix tree). The mean PRM of the first node of a 
tag is called BeginMass, and the mean PRM of the last node of a tag is called EndMass.  
 
The simultaneous parsing of the spectrum graph and of the suffix tree results in a list of tags. Each tag 
of the list represents a subsequence of the candidate peptide and is consistent with the spectrum peak 
pattern. Usually, comparisons of the spectrum with incorrect candidate peptides result in tags of very 
short length, while comparison of the spectrum with a correct candidate results in longer tags. 
 
 
VI.7. Tag cleaning 
 
The tag extraction algorithm does not prevent to extract subtags of tags, i.e. tags that are completely 
included in others. This problem arises because the recursive parsing is launched independently from 
every node. For example, the tag 
 
 
   
 
 
is reported when searching from node 409.2 of the spectrum graph of Figure VI-8, while the tag  
 
 
  
 
 
is reported when the search is launched from node 480.2. As the second tag does not bring 
supplementary information, it is discarded. Figure VI-11 shows the list of tags extracted during 
comparison of the example-spectrum YAIC[cam]SALAASALPALVM[ox]SK with the correct 
(unmodified) candidate peptide.  
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Figure VI-11: List of extracted tags  
The tags were extracted during comparison of the YAIC[cam]SALAASALPALVM[ox]SK spectrum with 
candidate peptide YAICSALAASALPALVMSK.  
Values in the first column are the positions of the tags in the peptide sequence, values in shadowed 
boxes represent the tag’s beginMasses and endMasses. Among the 45 tags, 21 were retained for 
further processing, the other ones being discarded (light gray).  
 
 
The number of tags found by Popitam varies according to the minimal size of the tags (parameter 
MIN_TAG_LENGTH) and to the mass of the precursor peptide (more tags are extracted for long 
peptides). In addition, a third parameter, called MODGAPNB, fixes the number of gaps due to 
modification events in a scenario. Thus, when MODGAPNB is set to 0, Popitam does not make any 
modification hypotheses and removes from the list all tags with flanking masses not compatible with 
the candidate peptide sequence (see Figure V-4). This results into an important decrease of the 
number of tags extracted per candidate peptide (Figure VI-12).  
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Figure VI-12: Average number of tags per candidate peptide  
The plot represents the average number of tags (per candidate peptide) computed for 70 spectra (x-
axis). Data were collected from runs performed for Chapter VIII. Minimum tag length was set to 3. 
When run in mode MODGAPNB=0, Popitam discards all tags with flanking masses not compatible 
with the candidate peptide sequence. Consequently, the average number of tags is very low (about 
1.45 tag per candidate peptide). In mode MODGAPNB = 1 and MODGAPNB = 2, the average 
number of tags reaches 25.2 per candidate peptide. 
 
 
VI.8. Listing possible “run-and-jump” paths 
 
The next step is to test different possible interpretations of the spectrum, given the current candidate 
peptide, the list of extracted tags, and compatibility rules between the tags. A possible interpretation 
is a path of the spectrum graph that runs trough edges or jumps from node to nodes (see Figure 
VI-18). We call such a path a “run-and-jump” path. Jumps correspond either to a lack of information 
in the spectrum (in which case they are called lackGaps), or to the presence of one or several 
modifications (modGaps). The parsed edges correspond to the tags. Run-and-jump paths are built by 
determining combinations of tags that are compatible with each other.   
 
If all tags were compatible, this would amount to enumerate all ways of selecting k (unordered) tags 
among n (n is the number of extracted tags), for k varying from 0 to n, therefore producing  
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interpretations. Fortunately, by defining tag compatibility rules, most of the combinations can be 
discarded.  
 
We use four logical rules: the overlap rule, the contiguity rule, the node sharing rule and the 
precedence rule. The first three rules are based on the fact that there is only one correct interpretation 
of the spectrum in the graph. The fourth rule is based on the tag positions and flanking masses. Each 
rule is described below and illustrated with a concrete example. The examples refer to the comparison 
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of the YAIC[cam]SALAASALPALVM[ox]SK spectrum (Figure VI-8) with the correct unmodified 
candidate peptide sequence. 
 
a) Logical rule number 1: Overlap rule 
Logical rule number one states that two overlapping tags are not compatible (Figure VI-13). Lets 
consider the spectrum graph of Figure VI-8. In this graph, a certain number of nodes were obtained 
by assigning correct ionic hypotheses to the set of peaks in the spectrum, all the other ones being false 
positive nodes. Correct nodes are represented in shadowed ovals and correspond to a correct 
interpretation that runs-and-jumps through a path from the first node (with PRM 1.0) to the last node 
(with PRM 1935.0 corresponding to the precursor mass minus OH). In an interpretation built by 
Popitam, the tags are considered “a priori” to be on the correct path (although there is no indication of 
where the correct path is in the spectrum). Therefore, since there can be only one correct path in the 
spectrum and subtags have been discarded, two overlapping tags cannot belong to the same 
interpretation and are said to be incompatible.  
 
 
 
Figure VI-13: Overlapping tags  
Only the first tag corresponds to the correct path in the graph. The three other tags (AASAL, ALA, 
LAA) may come from “random” connections, or from paths due to repeated false interpretations of 
peak series (see Figure III-5 for a definition of peak series). 
 
 
b) Logical rule number 2: Contiguity rule 
Logical rule number two states that two contiguous tags are not compatible (Figure VI-14). The 
reason is that two contiguous tags that would belong to the correct path would not be reported by the 
extraction process, since the latter always looks for the longest possible tags that match a subsequence 
of the candidate peptide. Consequently, instead of two contiguous tags, it would have reported only 
one.  
 
 
 
Figure VI-14: Two contiguous tags.  
If both tags were on the correct path, the tag extraction process would have reported one tag 
(ALAASA) instead of two tags 
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c) Logical rule number 3: Node-sharing rule 
Logical rule number three states that two tags sharing one or more nodes are not compatible (Figure 
VI-15). The thought process is similar to the first rule. As there can be only one correct path, a node 
cannot belong to two “correct” tags.  
 
 
 
Figure VI-15: Tags that share nodes 
Tag AI and tag AS do not fulfill the node-sharing rule because they share the node with PRM 1287.7 
(see alsoFigure VI-8). 
 
 
c) Precedence rule 
The precedence rule states that two tags are considered as incompatible if there is incoherence 
between their respective positions on the sequence and their beginMasses and endMasses (Figure 
VI-16). 
 
 
 
Figure VI-16: Tags with non logical positions 
Tag AASAL and tag ALV do not fulfill the precedence rule: ALV is positioned after AASAL on the 
peptide sequence, but its beginMass is smaller. 
 
 
In order to enumerate groups of compatible tags, we build a tag compatibility graph in which each 
node represents a tag and edges connect tags that fulfill the four logical rules. Then, we look for all 
cliques in the tag compatibility graph, a clique being a fully connected region of the graph (see Figure 
VI-17). We start by looking for cliques of size 2. Then we increase the clique size until it is equal to 
the total number of tags. The search is stopped if no clique is found for a given size s (it is clear that 
this process guarantees that no longer clique can exist). Although this computation is NP-complete, it 
is performed in a reasonable time, since the number of tags is kept quite low by using appropriate 
filtering parameters (MIN_TAG_LENGTH sets the minimal size of the tags, COVBIN sets the 
number of nodes in the graph and the FRAGMENT_ERRORs set the connection rate of the graph). 
Furthermore, the compatibility rules make cliques of important sizes unlikely.  
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Figure VI-17: A tag compatibility graph and a four-tag clique 
The compatibility graph was built from the tag list of Figure VI-11. The four-tag clique is shown in 
bold edges and shadowed nodes, and is reproduced in the table below the graph. The graph contains 
13 cliques of size four, 53 cliques of size three. There are as many cliques of size two as edges, and as 
many cliques of size one as nodes. 
 
 
VI.9. Scenario building 
 
For each candidate peptide, a list of possible arrangements of tags has been constructed using the list 
of extracted tags and compatibility rules. Each arrangement (or clique) is a possible interpretation of 
the spectrum (i.e. a run-and-jump path in the spectrum graph), given a candidate peptide. Figure 
VI-18 shows a clique and the corresponding path in the spectrum graph, highlighting sections that are 
parsed in the graph, and jumps that connect two parsed sections.  
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Figure VI-18: A run-and-jump path 
A run-and-jump path in a spectrum graph corresponding to a clique of four compatible tags. Jumps 
may either correspond to modification events, or to missing peaks in the MS/MS spectrum.  
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The task of scenario building is to compute a shift value associated with each gap. If the value is very 
low, then the gap is considered as arising from a lack of information in the spectrum and is denoted as 
lackGap. Otherwise, the gap is considered as arising from the presence of a (or several) modified 
amino acid(s). In such a case, the gap is denoted as modGap, and the reported shift value represents 
the mass of the modification (or modifications).   
 
Given two tags Ti and Tj delimiting a gap Gij. The aim is to compute a shift δ(Gij) associated to Gij.  
Ti and Tj have several attributes:  
     a start position bP on the candidate peptide sequence,  
     an end position eP on the candidate peptide sequence, with eP(Ti) < bP (Tj);  
     a sequence S = {a1, a2, ..., a|S|} 
     a list of parsed nodes nL = {v1, v2, ..., v|nL|}, with meanPRM(vu) < meanPRM(vw) for all u < w;  
     a begin mass bM = meanPRM(v1)  
     an end mass eM = meanPRM(vL), with eM(Ti) < bM(Tj). 
 
Also, each node vu contains the list of included PRMs, as well as their associated ionic hypotheses 
and peaks. 
 
A first method to evaluate the mass shift δ(Gij) associated to the gap consists in: 
 
1) computing μobs(Gij), the observed mass of the gap, using the flanking masses of the two tags 
 
)eM(T)bM(T)(Gμ ijijobs −=  
 
2) computing μexp(Gij), the expected mass of the gap using the tag position and the candidate sequence 
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3) and subtracting the latter from the former  
 
)(Gμ)(Gμ)δ(G ijexpijobsij −=  
 
This method has a drawback, because inaccuracy on δ(Gij) relies solely on two nodes. Instead, we 
would like to share the error on all nodes included in the tags (in other words, we want to reduce the 
variance by increasing the sample size).  
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A second method, which is described below, handles this issue. It consists in: 
 
1) listing the observed PRMs contained in tag Tj (Algorithm VI-3) 
 
 
 
Algorithm VI-3: Building PRM_Lobs 
 
 
2) listing the expected PRMs of tag Tj using the candidate peptide sequence, the tag position and  
previous mass shifts  (Algorithm VI-4) 
 
 
 
Algorithm VI-4: Building PRM_Lexp 
This algorithm lists expected PRMs of a tag Tj. Expected PRMs are computed by adding masses of 
amino acids that compose the sequence of the tag and previous mass shifts. GapNb is the number of 
gaps in the scenario, and δg is the shift value associated with gap g. 
 
 
3) Matching elements from PRM_Lobs with elements from PRM_Lexp; 
 
4) Reporting δ(Gij), the mean of the differences computed by subtracting each element of PRM_Lexp 
from their matched element in PRM_Lobs 
 
 
Using this second approach, Popitam reports for each gap a shift value δ. By definition, if 
δ<FRAGMENT_ERROR2, the shift is imputed to internal error measurements and the gap is 
reported as missing information in the spectrum and is signified by ‘-‘ letters in the scenario 
(lackGap). Otherwise, the gap is reported as a modification event and signified by ‘*’ letters 
(modGap). Figure VI-19 shows examples of scenarios obtained with the example-run.  
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Figure VI-19: Scenarios  
The scenarios were obtained during the example-run performed with Popitam. 84 candidate peptides 
were presented to the spectrum graph, leading to a total of 1463 collected scenarios. Four of them 
are presented in this figure (the correct peptide is represented twice). For each scenario, the 
candidate peptide sequence is given in black letters. The run-and-jump paths are indicated below the 
peptide sequences. Red stars represent gaps associated to modification events (modGaps) that 
correspond to jumps in the spectrum graph. For each modGap, a shift value is reported. In scenario 
0, the correct sequence was presented, and the correct path was followed in the graph. The first shift 
corresponds to a carbamidomethylation, and the second one corresponds to an oxidation.  Scenario 1 
shows a different –and false- spectrum interpretation for the same peptide. Scenarios 2, 3 and 4 
correspond to interpretation attempts for incorrect peptides. Note that the number of modGaps is not 
always correlated to the number of modifications. Inversely, one modGap does not systematically 
correspond to only one modification event. 
  
 
As currently implemented, Popitam asks for the number of modGaps allowed in a scenario to be 
entered as argument (0, 1 or 2). During a run, Popitam will only consider scenarios with a 
corresponding number of modGaps (the other ones are discarded). 
 
Moreover, three parameters are used to reduce the number of scenarios to be scored by Popitam. A 
first one, MIN_ARR_COV, is the minimal coverage of the candidate peptide sequence by simple 
edges. The reason of this filtering is to avoid evaluating scenarios that are likely to give a poor score.   
Two other parameters, MAX_ADD_MOD and MAX_LOSS_MOD, are set by the user and 
correspond to the maximum mass gain and loss allowed for a modGap (respectively). 
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VI.10. Scenario scoring 
 
The previous section explains how Popitam builds possible interpretation scenarios for each candidate 
peptide. Figure VI-19 shows five of them, out of a total of 1463. The challenge for Popitam is to 
succeed in spotting the best scenario (the one that corresponds to the correct peptide and uses the 
correct path in the spectrum) among all obtained ones. This is achieved by attributing to each scenario 
a score that measures the quality of the spectrum interpretation given the candidate peptide. The 
peptide with the highest-scoring scenario is then reported as the identification result.  
The scoring function plays an essential role in the efficiency of an MS/MS identification method. In 
Popitam, the scenario’s scoring must be all the more efficient as Popitam authorizes any type of 
modifications during the search, thus greatly increasing the search space. As we wanted to capture a 
maximum of information for the scoring procedure, we defined a set of twelve basic subscores. Each 
of them is based on a particular aspect, such as the coverage of the candidate peptides by the tags, the 
pertinence of the ionic hypotheses used in the nodes participating to a scenario, and so on.  
 
The subscores have been defined empirically and deserve to be improved in the future. Several 
methods (Colinge et al. 2003;Elias et al. 2004;Tanner et al. 2005) use log-odd ratios between a null 
hypothesis (the match is random) and an alternative hypothesis (the match is correct).  
 
VI.10.1. Scores based on sequence coverage 
 
Five scores are based on the coverage of the candidate sequence by the scenario. Here follows a short 
description for each of them, and a concrete computation example (Figure VI-20). 
 
lackScore (KS1) corresponds to the number of gaps due to missing information in the spectrum.  
 
modScore (MS1) corresponds to the number of gaps due to modification events.  
 
covScore1 (CS1) is computed by determining covsE, the number of amino acids in the candidate 
sequence that are covered in the scenario by simple edges. This number is divided by the candidate 
sequence length. 
 
covScore2 (CS2) is computed by determining covsE+dE, the number of amino acids in the candidate 
sequence that are covered in the scenario by either simple or double edges. This number is divided by 
the candidate sequence length. 
 
covScore3 (CS3) is computed by determining covsE+dE+’-‘, the number of amino acids in the candidate 
sequence which are covered in the scenario either by simple and double edges, or by gaps due to 
missing fragments in the MS/MS spectrum. This number is divided by the candidate sequence length. 
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Figure VI-20: Score computations 
Examples of computation of the first five scores for a given scenario. “sE” means “simple edges” 
and corresponds to the number of upper case letters in the scenario, while “dE” means “double 
edges” and corresponds to the number of lower case letters. 
 
 
VI.10.2. Score based on node pertinence 
 
perScore (PS1) is based on the PRM’s confidence scores of nodes parsed by the scenario (Algorithm 
VI-5). Its computation implies three loops, one for the tags included in the scenario, one for the nodes 
included in each tag, and one for the PRMs included in each node. The score corresponds to the sum 
of the PRMs confidence scores σ(PRMm) (the latter are defined in Section VI.5.1). 
 
 
 
 
Algorithm VI-5: Computation of perScore 
 
 
VI.10.3. Score based on peak intensity 
 
intScore (IS1) is a score based on the intensity of the peaks included in the parsed nodes (Algorithm 
VI-6).  It represents the percentage of total intensity covered by the scenario. The score is the sum of 
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the intensities ι(sm) obtained from the peaks included in the scenario, divided by the total sum of 
intensities in the spectrum (this number is pre-calculated once for each spectrum). 
 
 
 
Algorithm VI-6: Computation of intScore 
 
 
VI.10.4. Score based on PRM clustering 
 
Scenarios that include nodes with several PRMs are more likely to be correct than scenarios including 
“orphans” nodes. Similar PRMs issued from different ionic hypotheses mean that a fragmentation 
position was represented in the spectrum by several peaks, thus confirming that the peaks 
corresponded to true fragments.  
famScore (FS1) is simply the number of PRMs included in the scenario (Algorithm VI-7). 
 
 
 
Algorithm VI-7: Computation of famScore 
 
 
VI.10.5. Score based on errors 
 
errScore (ES1) is based on errors reported between observed and expected PRMs (Algorithm VI-8). 
Experimental measures reported by mass spectrometers are subject to errors due to calibration and 
internal error of the device. A good fitting between the observed PRMs included in a scenario and 
expected ones computed from the candidate sequence plays in favor of correctness. To compute the 
score, we first build pairs of observed and expected PRMs using Algorithm VI-3 and Algorithm VI-4. 
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Then we compute a linear regression of these values. The score reported is then based on the 
deviation of the values from the linear regression. 
 
 
 
 
Algorithm VI-8: Computation of errScore.  
PRM_Lexp and PRM_Lobs are built according to Algorithm VI-3 and Algorithm VI-4. The function 
buildPairs() associates each observed PRM with the closest experimental PRM, given delta, the sum 
of the previous shift masses. 
REG represents the linear regression computed from the pairs of expected and observed PRMs. The 
function dev() returns the distance from the point defined by the pair to the regression line.  
 
 
VI.10.6. Score based on peak redundancy 
 
redScore (RS1) is based on the multiple presence of given peaks in the scenario (Algorithm VI-9). 
For example, peak 480.24 in the spectrum shown in Figure VI-2 could (given a certain error margin) 
represent two different fragments: an a4 ion type (of mass 480.23), or an y4 ion type (of mass 480.25). 
The peak will therefore result in two different PRMs, one representing the prefix mass ending at 
position 4 of the peptide, and one representing the prefix mass ending at position 15. But such a 
situation is unlikely to occur. Consequently, if a peak is shared by multiple nodes in the scenario, the 
final score should be lowered. To compute the redScore, a table (denoted as redTab in Algorithm 
VI-9) of size peakNb and filled with 0 is prepared. Then the peaks included in the scenario are parsed 
using the three loops. For each peak index ind(sm), the corresponding case of redTab is incremented. 
At the end, the table is parsed to compute the redScore, which is finally divided by the number of 
different peaks used in the scenario. 
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Algorithm VI-9: Computation of redScore. 
 
 
VI.10.7. Score based on peak series 
 
Peptide fragmentation tends to produce series of peaks of similar ionic types, coming from successive 
cleavage positions on the peptide. Tags that include peak series are more likely to be correct than tags 
formed from isolated peaks of different ionic types.  
serScore1 (SS1) is the length of the longest series of b-ions observed in the scenario, 
serScore2 (SS2) is the length of the longest series of y-ions observed in the scenario. 
 
VI.10.8. Scenario scoring 
 
Combining all the subscores into an efficient scoring function is a challenging task. We therefore first 
tested the subscores independently, and then tried to define empirical scoring functions as the one 
represented below.  
 
SS2SS1FS1PS1IS1
RS1ES1
1
3
CS3CS2CS1S ⋅⋅⋅⋅⋅⋅⋅
++=  
 
Equation VI-5: Empirical scoring function 
 
 
We also used Genetic Programming to explore the space of the possible combinations of subscores 
using supervised learning. Chapter VII presents in detail the GP methodology. Results obtained with 
the various scoring functions are presented in Chapter VIII. 
 
 
 99
 100
 
 
 
 
 
Figure adapted from "Monsieur Hippopotame" by Tanikawa Shuntarô 
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C H A P T E R  
VII 
 
 
 
 
 
 
GENETIC 
PROGRAMMING 
 
 
 
 
This chapter deals with Genetic Programming, a method that belongs to the 
class of Evolutionary Algorithms. These algorithms are stochastic global 
optimization methods and are freely inspired from the Darwinian evolution 
theory. We used Genetic Programming to tailor scenario-scoring functions 
specifically adapted for Popitam. 
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VII. Genetic Programming 
VII.1. Introduction to Evolution theory 
 
Evolution is not a modern discovery. Its inception dates back to a long time. People agree that one of 
the first proponents of a concept of evolution is Anaximander of Miletus (611-547 B.C.), a pupil of 
Thales. Anaximander believed that life arose from warm water and earth. According to Anaximander, 
human beings were not present at the earliest stages because human offspring requires a long period 
of nursing to survive, and then the first human generation would inevitably have died. For 
Anaximander, the first forms of live were fish-like creatures, and human beings grew inside them. 
When they became able to feed and take care of themselves, they left the creatures and came forth 
onto dry land. Antiquity’s thinking was dominated by other theories. Aristotle (384-322 B.C.) 
proposed a “finalist”4 vision of nature in which chance had no place. Species were “fixed”, each of 
them representing a level from the simplest forms of life to the most complex ones. Organs were 
fabricated with a precise aim. Thus, according to Aristotle, roots exist because plants need to take 
water from the ground and human have teeth because they need to be fed with solid aliments. Like 
Aristotle, Lucretius (99-55 B.C.) did not believe in the production of new species from previously 
existing ones. But he anticipated the natural selection theory when he proposed that species were 
formed by the combination by chance of elements and that once living “monstrous” organisms are 
now extinct while others survive because of their strength, speed or dexterity.  
 
 
 
Figure VII-1: Three Greek philosophers 
Anaximander (611-547 B.C.) Aristote (384-322 B.C.) and Lucrece (~98-55 B.C.) 
 
                                                 
4 Finalism" is a philosophical term related to a belief in ultimate purpose or design behind everything, including, 
the evolution of the cosmos and of life 
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In the 18th century, an astronomer and mathematician, Pierre de Maupertuis (1698-1759), refuted the 
idea of a purposeful design and suggested that new species arise from successive mistakes occurring 
randomly during body formation. He wrote in 1750 in his «Essai de cosmologie»:   
 
"Le hasard, dirait-on, avait produit une multitude innombrable d'individus; un petit nombre se 
trouvait construit de manière que les parties de l'animal pouvaient satisfaire à ses besoins; dans un 
autre infiniment plus grand, il n'y avait ni convenance, ni ordre: tous ces derniers ont péri; des 
animaux sans bouche ne pouvaient pas vivre, d'autres qui manquaient d'organes pour la génération 
ne pouvaient se perpétuer... les espèces que nous voyons aujourd'hui ne sont que la plus petite partie 
de ce qu'un destin aveugle avait produit..."  
 
“Chance apparently turned out a vast number of individuals; a small proportion of these were 
organized in such a manner that the animals organs could satisfy their needs. A much greater number 
showed neither adaptation nor order; These last have all perished -- thus the species that we see 
today are but a small part of all those that a blind destiny produced."  
(adapted from http://www.mlahanas.de/Greeks/Evolution.htm) 
 
Eventually, a new conception of the living world, known as the Transformism, arose. Fossils became 
recognized as concrete evidence that organisms change over time, and scientists realized that 
organisms once lived are now extinct, while new species seem to derive from common ancestors. The 
changes are gradual and slow, because no one ever observed the sudden appearance of new species. 
But the mechanisms of such changes had yet to be described and demonstrated. Jean-Baptiste 
Lamarck (1744-1829) drew an evolution theory in which organisms transmit to their descendants 
characters that are acquired by interacting with the environment.  
 
 
 
Figure VII-2: The astronomer Pierre de Maupertuis (1698-1759) and the naturalist Jean-Baptiste 
Larmarck (1744-1829) 
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The acknowledged founder of the modern evolutionism is the naturalist Charles Darwin (1809-1882), 
who elaborated a theory from observations made during his five-year trip around the world on the 
ship “Beagle”. Darwin wondered about the geographic distribution of species, notably on the 
Galapagos Islands, and about their similarities and differences. Based on many concrete observations, 
on proof accumulation and on a strong argumentation, as well as on a great knowledge of 
contemporaneous works, Darwin formalized a complete theory of evolution, supported by many 
specific examples. In his book “On the origin of species by means of natural selection or the 
preservation of favored races in the struggle for life”, published in 1859, he suggested that the 
mechanism of evolution is natural selection. Based on the observation that individuals in a population 
are not all similar and that variations can be inherited, his theory stated that the variations result in 
differential survival and reproductive success rates, which leads to shifts in the frequency of 
characters. Darwin’s theory of evolution postulated that even very small variations can result in 
differential reproductive success. By accumulating small changes over a large number of generations, 
the individuals can no longer interbreed and new species are formed.  
 
 
 
Figure VII-3: The naturalists Charles Darwin (1809-1882) and Alfred Wallace (1823-1913) 
 
 
This chapter is about evolution, natural selection and survival of the fittest. As we will see in the next 
sections, these principles can be applied to solve difficult optimization problems. Examples of 
Evolutionary Algorithms are Genetic Algorithms (GA) and Genetic Programming (GP). We were 
interested in using Genetic Programming to generate optimal functions for scoring Popitam’s 
scenarios.  
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VII.2. Genetic Programming 
VII.2.1. Introduction 
 
Optimization problems are characterized by a set Ω of possible solutions –the search space- and an 
objective function f: Ω→ℜ that associates a value to each possible solution x. The aim is to find the 
solution(s) x*∈ Ω that maximizes or minimizes the objective function. When the size of Ω is 
reasonable, an exhaustive approach can be used. Such an approach consists in successively 
enumerating all possible solutions x ∈ Ω and keeping the best one(s). But optimization problems 
often have such a huge search space that they cannot be solved in a reasonable computing time or 
memory space. In the most difficult cases, where no deterministic approaches can discover the 
optimal solution in reasonable time, non-deterministic approaches have to be used. These possess the 
advantage to give good sub-optimal solutions in a rather short time.  
 
Genetic programming, which was introduced by Koza in 1992 (Koza 1992), is a non deterministic 
approach that is inspired from the evolution of species. Evolution theory is an attractive model 
because it can be considered as an optimization method that causes organisms to bet better adapted in 
a changing environment. Key ingredients for an evolution process to take place are: a) overproduction 
(more offsprings are produced than will ultimately survive and reproduce, generating a struggle for 
existence); b) inheritance (characteristics are transmitted to the descendants) and c) variation 
(inheritable features vary from individual to individual). Genetic programming (GP) models these key 
ingredients and applies them on a population of solutions to a given problem. The solutions are 
created from a set of available functions (mathematical operators, statements, routines...) and 
variables. The search space to explore is composed of all possible combinations (with repetition) of 
the functions and variables. Using evolution principles –differential reproduction, variation and 
character inheritance -, GP makes the population of solutions evolve. With generations, solutions 
become more and more specialized for the problem (adaptation to the environment). A typical GP 
workflow (Figure VII-4) starts with the generation of a population of random solutions. Each solution 
is evaluated using an objective function and receives a fitness value. The objective function is 
dependent of the problem under consideration. It gives a measure on how well (or how badly) a 
solution succeeds in solving the problem. Solutions that will reproduce are selected according to their 
fitness, and variation is introduced by applying genetic operators. The aim of this procedure is to 
sample new points of the search space. The genetic operators are generally inspired from genetic 
events, such as the crossing-over, source of chromosomal exchange during meiosis, or mutational 
events. The crossing-over allows solutions to exchange parts of themselves. Intuitively, if two 
solutions are good performer on a problem, then subparts of these solutions are susceptible to form, 
by random recombinations, solutions even more performing than the parent solutions. A new 
population (called daughter population) is formed from the modified solutions and replaces the parent 
population for the next generation. After several generations, the solutions become more and more 
adapted and the average fitness of the population increases. The fittest solution(s) over all generations 
is (are) designated as the result of the GP process.  
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Figure VII-4: Genetic programming workflow 
The algorithm starts with an initial population of solutions (randomly built or using a priori 
knowledge) (1). Each solution is evaluated and assigned a “fitness” value that measures the 
adequacy of the solution to solve the problem. Typically, each solution is tested in heterogeneous 
conditions using a set of examples (a learning set) (2). Selection of solutions to reproduce is 
probabilistic and biased towards solutions with high fitness (3). Genetic operators are applied on the 
selected solutions and generate variants solutions (4). The latter form the “daughter” population (5). 
The population generation process is repeated until some criterion is met (e.g. convergence of the 
system, number of iterations reached or quality of the best solution) (6). 
 
 
We used a specific model of GP, called parallel multi-objective GP. The next sections describe the 
particularities of this model and explain the different steps of the workflow.  
 
VII.2.2. Parallel GP 
 
A drawback of GP is the considerable amount of computing time that can be required for each 
generation, as a certain number of them must be completed before the algorithm produces a satisfying 
solution. However, a parallel algorithm approach can be applied to classical GP to reduce processing 
time by dividing the population of solutions into several subpopulations and sharing subpopulations 
between several processors. This technique is known as ‘coarse-grained parallel GP’ (Cantu 1999). 
Figure VII-5 charts a GP process performed by a given subpopulation in a parallel GP workflow. We 
describe in this section the part of the figure that concerns communication between the populations. 
Section VII.2.3 explains how the solutions are coded, while their evaluation, their selection and the 
genetic operators are described in Sections VII.2.4, VII.2.5 and VII.2.6, respectively. 
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Figure VII-5: Multi-objective parallel genetic programming (flowchart) 
This flowchart depicts the actions performed by a subpopulation in a multi-objective parallel Genetic 
Programming context. GenNb represents the number of generations to produce and M is the 
population size. Two counters are used: gen (counts the number of generation) and i (counts the 
solutions).  
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The principle of parallel GP is the following: each subpopulation independently runs a classical GP 
process with its own parameters. Subpopulations communicate with each other by sending and 
receiving promising solutions. We use an original topology model, called pyramidal model (Frey et 
al. 2003), in which subpopulations are distributed among several processors and organized in several 
superimposed layers to form a pyramid. Communication flows from the base of the pyramid to the 
top (the head-subpopulation) (see Figure VII-6).   
 
 
 
Figure VII-6: Communication topology of a pyramidal model  
Figure taken from (Frey et al. 2003) 
 
 
Each time a subpopulation has completed a given number of generations, it sends its stack of 
solutions to higher-level subpopulations (except if the subpopulation is the head-subpopulation), 
which returns a receipt. After receiving the receipt, the subpopulation starts a new process. If the 
receipt is not returned, this means that the above populations are not running anymore, and the 
subpopulation ends its GP process. Correspondingly, the whole GP process is not ended as long as the 
head-population has not produced its complete number of generations. 
 
The parameters in each subpopulation are adapted according to the depth of their layer. Parameters of 
low-level subpopulations are set such as to intensively explore the search space of possible solutions. 
The promising solutions are sent to higher-level subpopulations whose parameters are set such as to 
exploit this information. 
 
VII.2.3. Coding of the solutions 
 
In GP, solutions are coded as trees. This hierarchical and evolutional structure is well suited to 
represent a series of instructions (see Figure VII-7). The trees are composed of nodes, taken from a 
set of predefined functions, and of leaves, taken from a set of predefined terminals. 
 
Functions are usually of the following types: 
a) mathematical operators (+, -, *, /, ^,...) 
b) mathematical functions (sin, cos, exp, log,...) 
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c) boolean operators (and, or, not,...) 
d) conditional operators (if then else, case, switch, ...) 
e) loop statements (while...do, repeat...until, for...do) 
f) any subroutine (any function defined for the problem under consideration) 
 
and terminals are of the following types: 
a) integers 
b) reals 
c) vectors 
d) any predefined structure 
 
 
 
 
Figure VII-7: A solution coded as a tree  
 
 
VII.2.4. Evaluation of a solution 
 
To emulate evolution, GP algorithms must determine which solutions best solve the problem under 
consideration. Evaluation of a solution is performed through the computation of a fitness value by an 
objective function. The higher the fitness of the solution, the higher its chance of being selected and of 
transmitting information to the next generation (principle of survival of the fittest). 
 
In certain cases, one would like to optimize a solution according to several criteria taken 
simultaneously. For example, a first objective (to maximize) would be the capacity of the solutions to 
solve the problem, and a second objective (to minimize) would be the size of the solutions. The aim 
of such a multi-objective optimization scheme is to avoid the bloating of solutions, which tend to 
become larger and larger as generations pass. In multi-objective optimization, the solutions receive as 
many fitness values as the number of criteria to optimize, and each of these fitnesses is measured by a 
specific objective function.  
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If a unique measure regrouping these fitnesses cannot be defined, Pareto optimality (Miettinen 1999) 
can be used to define the best solution. Given F*={F1, F2, ..., Fm} the set of m objective functions to 
be simultaneously optimized, a solution xp is said Pareto optimal if there is no other  possible solution 
x for which: 
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In words, a solution xp is said Pareto optimal if no solution x has one of its fitnesses higher than the 
corresponding fitness of xp and if every possible solution x has at least one of its fitnesses smaller 
than the corresponding fitness of xp. 
 
The Pareto dominance states that a solution x1 dominates a solution x2 if: 
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In words, a solution x1 dominates a solution x2 if all the fitnesses of x2 are smaller or equal than the 
corresponding fitnesses of x1 and if at least one fitness of x1 is better than the corresponding fitness of 
x2 (the solutions have not equal fitnesses).  
 
The sampling of the search space of possible solutions by a GP process leads to the collection of a 
number of co-dominating solutions forming a Pareto optimal set. None of the solutions in the Pareto 
optimal set dominates another solution of the set. In parallel GP, each subpopulation maintains its 
own stack of co-dominating solutions. Each time a solution is evaluated during the GP process, the 
stack is updated according to the two following rules: 
a) if the new solution is not dominated by any of the stack solutions, it is integrated in the stack.  
b) if the new solution dominates any of the stack solution, the stack solution is deleted. 
When a subpopulation completes its number of generations, it sends the solutions contained in the 
stack to the subpopulations of the above layer and starts a new process.  
When the head-population has completed its assigned number of generations, its stack of co-
dominating solutions is saved in a text file that represents the result of the whole GP process. 
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VII.2.5. Selection 
 
At each iteration, solutions are chosen to form the next generation. In multi-objective parallel GP, 
there are three sources from which solutions can be chosen: the current population, the stack of co-
dominating solutions, and the solutions that have been received from other subpopulations and are 
stored in a waiting list. First, the solutions in the waiting list are selected until the list is emptied (the 
maximal number of solutions in a waiting list is set by a parameter). Then, the algorithm picks 
solutions either from the current population or from the stack of co-dominating solutions according to 
a probability parameter called p(elitism). If the stack is chosen, the solution is randomly selected 
among the stack solutions. Otherwise, the solution is selected among the current population using a 
rank-based procedure and a biased lottery wheel. The procedure is the following: the solutions of the 
current population are ranked according to the number of other solutions they dominate. Then the 
solution is randomly chosen using a biased lottery wheel, according to: 
 
1n
1)(r1)(PS2PS2p(r) −
−⋅−⋅+⋅=  
 
where 
p(r) is the probability to choose a solution with rank r 
n is the total number of solutions 
PS is a parameter (called Selective pressure) that controls the influence of the fitnesses on the 
selection. If PS is set to 1, the solutions are randomly selected (independently of their 
fitnesses). A PS between 0 and 1 would favor the selection towards solutions with low 
fitnesses, while a PS between 1 and 2 favors the selection towards solutions with high 
fitnesses. 
 
Once a solution is selected, it is “cloned” (copied) so that the genetic operators modify the clones 
rather than the parent solution. Consequently, a solution can be chosen several times during the 
selection process. 
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VII.2.6. Genetic operators 
 
Genetic operators are used to generate variability in selected solutions (=clones). The set of possible 
operators that can be defined is unlimited, but most often, a GP algorithm includes all or part of the 
following three genetic operators: the crossing-over operator (CO), the mutation operator (MUT) and 
the permutation operator (PER).  
Each operator may or may not modify a solution according to a probability value. For example, if 
p(MUT) is set to 0.2, a given solution has 1 chance out of 5 to be mutated. Once each genetic operator 
has had the opportunity to modify the solution, the latter is inserted into the growing daughter 
population and a new solution is selected from the parent population. 
 
Here follows a short description of each of the three genetic operators (Figure VII-8, Figure VII-9, 
Figure VII-10). If none of the three genetic operators is applied, the function is inserted 
untransformed into the daughter population. 
 
 
 
 
 
Figure VII-8: Crossing-over operator 
The crossing-over operator generates variation by exchanging information between two randomly 
selected solutions.  
In each selected solution, a crossover point (either a node or a leaf) is randomly chosen (black 
nodes). The subtrees defined by the crossover points are exchanged between the two solutions, 
generating two “new” solutions. 
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Figure VII-9: Mutation operator 
The mutation operator generates variation by modifying a node or a leaf of the tree. First, a mutation 
point is randomly defined (in black). Then the algorithm chooses between a transition event and a 
conversion event. The choice is probabilistic (p(transition)=p(conversion)=0.5). In case of transition, 
the value of the node defined by the point mutation is randomly changed, but the type (node or leaf) is 
kept.  In case of conversion, both type and value of the node are changed, leading to a modification of 
the tree structure. If the conversion point was a node, the subtree is deleted and replaced by a 
randomly chosen leaf. If the conversion point was a leaf, the latter is deleted and replaced by a node 
from which a new subtree is randomly generated.  
 
 
 
 
Figure VII-10: Permutation operator 
The permutation operator modifies the order of the arguments of a node. It starts by randomly 
selecting a node as a permutation point (black node). If the node has two arguments, the left-son is 
permuted with the right-son. If the node has four arguments (IF_LESS), their order is randomly 
modified among the 4!-1 permutation possibilities. The structure of the subtree defined by the 
permutation point is then modified accordingly.  
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VII.3. GP application for Popitam 
VII.3.1. Introduction 
 
Genetic Programming appeared to be an attractive way to build functions for scoring scenarios 
produced by Popitam. The solutions are thus scenario-scoring functions built from a set of 6 different 
nodes, comprising the mathematical operators addition, subtraction, multiplication division, power, 
and conditional statement IF_LESS, and from a set of 13 different leaves, represented by the 12 
scenario’s subscores described in Section VI.10 and a random coefficient. This choice presents the 
advantage that it is possible to use equally positive or negative values, as well as integers or floats, 
except for the division operator that does not accept a division by 0. When such a situation arises for a 
tree, the latter is labeled as “inconsistent” and its associated fitnesses are set as “very bad”, thus 
avoiding the selection of that tree for reproduction. Figure VII-11 presents a possible solution. The 
search space is formed by all consistent scoring functions that can be built from the set of nodes and 
leaves (with repetition). The aim of the GP process is to find scoring functions that not only give the 
highest score to the correct candidate peptide, but also efficiently discriminates the correct peptide 
from all the other ones.  
 
 
 
Figure VII-11: A scenario-scoring function written as a tree structure 
The conditional operator “ifless” is read as follows: if ES1 is less than SS2, then return FS1*PS1 ; 
else return SS1/FS1 ; solutions in a population are of various sizes and forms. 
 
 
VII.3.2. Evaluation of solutions 
 
The solutions produced during the GP process are evaluated using a set of “examples” (called sample 
set). The sample set is built from a set of MS/MS spectra with known identifications (called learning 
set) (see Section VII.4). The evaluation procedure, which is depicted in Figure VII-12, is the 
following: before launching the GP algorithm, Popitam is run on the spectra of the learning set. For 
each candidate peptide, a list of possible scenarios is built by Popitam and for each of them, the 12 
subscores (CS1, CS2, ... SS2) are computed and saved in a text file. One sample file is created per 
original spectrum. The learning itself is thus executed on the text files composing the sample set, thus 
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avoiding unnecessary Popitam runs for each solution to be evaluated and for each generation (the 
subscores are not dependent on the GP process, hence the interest to compute and save them once 
only). During the GP process, the solutions are evaluated by “reading” the subscores in the files and 
computing the scenario’s scores. The identification score of a candidate peptide is given by its best 
scoring scenario. Thus, for each sample, a list of scored peptides is obtained. One among the peptides 
is the correct one (posPep), all the others are negative peptides (negPep). The solution fitnesses 
express how well the solution was able to give a good rank to the correct peptide (rankFitness) and 
how well it can separate the correct peptide score from the distribution of negative peptide scores 
(discFitness). 
 
 
 
 
Figure VII-12: Evaluation of a function 
Evaluation is based on examples (sample files) prepared with Popitam. Each sample file contains 
lists of subscores computed by Popitam for candidate peptides (the correct one, denoted as positive 
peptide, or posPep, and the negative ones). All the other subscores were obtained for negative 
peptides. The solution is used to compute a global identification score for each positive and negative 
peptide. The solution’s fitnesses measure how well the solution can discriminate the score of the 
positive peptide with the scores of the negative ones. 
 
 
The next Sections describe the objective functions that are used to compute the fitnesses in our GP 
algorithm. 
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VII.3.2.1. rankFitness  
 
The rankFitness measures the capacity of the solution to give the highest score to the correct peptide. 
It is based on the rank of the correct candidate peptides. For each sample k of the learning set, the 
candidate peptide scores are sorted by decreasing order and the rank of the positive candidate peptide 
is reported. The rankFitness is computed by adding a contribution from all samples, according to:  
 
 
∑
=
=
sampleNb
0k
2i ptide)rank(posPe
1)s(SrankFitnes  
 
where  
Si is a solution 
sampleNb is the number of spectra in the learning set, and 
rank(posPeptide) is the rank of the correct candidate peptide for the sample k. 
 
This fitness is comprised between 0 and 1; its optimum is 1, which signifies that all spectra of the 
learning sets were correctly identified (first rank). 
 
VII.3.2.2. discFitness 
 
The discFitness is related to the capacity of the solution to discriminate the correct scenario from all 
the other ones. It is based on the value of the positive score relative to the distribution of the negative 
scores, and corresponds to a p-value. P-values give the probability of obtaining by chance a score 
greater than or equal to an observed score, in a given distribution. The function we use to compute the 
p-values presumes that the distribution is gaussian. As we are not guaranteed that the negative 
distribution is gaussian (actually, as shown in Figure VIII-8, it is not), the p-value is consequently not 
a “true” probability, but a measure that gives an idea of the deviation between the score of the correct 
peptide and the negative distribution. DiscFitness corresponds to the mean of p-values reported for 
first ranked positive scores. It is comprised between 0 and 1, and its optimum is 0. 
 
VII.3.2.3. sizeFitness 
 
The third fitness, called sizeFitness, is equal to the number of nodes in the solutions. It was used as a 
third objective to optimize to avoid bloating of the solutions. 
 
VII.3.3. Topology and parameters 
 
The GP topology we used included three subpopulations placed at three levels (see Figure VII-13). 
We designate the first level subpopulation “head-population”, and the two others “low-level 
populations”. As shown in the figure, parameters were chosen to favor the exploration of new 
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solutions in the low-level populations and the exploitation of solutions in the head-population. 
Notably, selective pressure (PS), elitism probability (p(elitism)) and crossing-over probability 
(p(CO)) were increased in the head-population. This means that the head-population will tend to 
include more good solutions in the next generations, and will focus on combinations of these 
solutions. Low-level populations will focus less on solutions, but will keep exploring the search 
space, notably by adding diversity due to a higher probability of mutation (p(MUT)).  
 
 
 
Figure VII-13: Topology and parameters chosen for the three populations 
The head-population is the ID 0. Communication flows from low-level populations to high-level 
populations (black arrows). The parameters are the selective pressure (PS), the probability of elitism 
(p(elitism)), of crossing-over (p(CO)), of mutation (p(MUT)), and of permutation (p(PER)). A last 
parameter is p(MUT_COEFF), the probability that a random coefficient is changed (random 
coefficient are one of the possible leaves). 
 
 
As shown in Figure VII-13, the head-population contains more solutions and fills more generations 
that the other ones. When one of the low-level populations has completed its generations, all solutions 
contained in the stack of co-dominating solutions are sent to the next level population and a new GP 
process begins in this low-level subpopulation.  
 
Figure VII-14 shows the convergence of the GP algorithm towards high-fitness solutions for the three 
subpopulations. Data were collected during runs performed for Chapter VIII. The process starts with 
a bi-objective optimization (rankFitness is maximized and discFitness is minimized). During these 
early generations, the algorithm freely and deeply explores the search space and produces solutions  
that are more and more adapted and complex. When two thirds of the generations have been 
completed, the third objective (sizeFitness) is taken into account. From this point on, the selection 
process favors small solutions, even if they have poor rank- and discFitnesses. As a result, a decrease 
of the mean rankFitness and mean discFitness of the population is observed. Nevertheless, as 
generations progress, new solutions continue to be created, which have a small size and better and 
better rank- and discFitnesses. At the end of its GP process, the head-population stack of co-
dominating solutions contains a wide range of different kinds of scenario-scoring functions, from the 
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most complex ones, comprising about one hundred nodes, to the most parsimonious ones, comprising 
about ten or even only one or two nodes. By this mean, we had the possibility to compare the 
performance of very complex learned functions with more simple ones (see Section VIII.2.3.3). 
 
 
 
Figure VII-14: Examples of convergence of the GP algorithm 
Each column represents a subpopulation. Topology and parameters correspond to Figure VII-13. The 
graphs in first row show the mean rankFitness (whose optimum is 1) and the mean discFitness 
(whose optimum is near 0) reported for the population at each generation. As low-level populations 
perform several runs until the head-population ends its own run, several curves are drawn, each of 
them corresponding to the values reported for a run. The graphs in the second row represent the 
maximum rankFitness obtained over all generations. As generations are completed, more and more 
efficient scoring functions are discovered by the algorithm. At generation 33, a third objective, 
sizeFitness, is considered during the selection procedure. At this point, the algorithm tries to find 
smaller trees, resulting in a decrease of mean rankFitness and mean discFitness. 
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VII.4. Learning sets 
VII.4.1. Introduction 
 
The evaluation of solutions in our GP algorithm requires the use of a learning set composed of 
MS/MS spectra with known identifications. The learning has to be diversified such as to cover as well 
as possible the space of MS/MS spectra. It follows that the set should contain various spectrum 
qualities, from various peptides of various amino acid compositions and arrangements. The 
prerequisite requirement is that the correct identification for each spectrum be known. This means 
that the set has first to be identified using one or several identification algorithms that provide a high 
level of confidence and/or be manually validated. This is an important requirement, since including 
false positive identifications in the set would result in a bias in the GP process, and therefore lead in 
the learning of less discriminating scoring functions. 
 
VII.4.2. MS/MS spectrum gathering 
 
To build such a learning set, we used MS/MS data obtained for a proteomic and transcriptomic study 
(Scherl et al. 2005) performed in the “Laboratoire Central de Chimie Clinique des Hôpitaux 
Universitaires de Genève” on Staphylococcus aureus strain N315. This pathogen causes frequent and 
potentially severe infections while rapidly acquiring antibiotic resistance (Naimi et al. 2003).  
 
Scherl et al. applied various proteomic analyses on protein sets extracted from the pathogen. In one of 
them, a membrane extract, proteins were separated by SDS-PAGE, in-gel digested with trypsin, and 
analysed with a Q-TOF mass spectrometer. Among the 2088 MS/MS spectra acquired, 751 were 
correlated with peptide sequences leading to the identification of 269 different proteins. The peptide 
identifications were performed using Mascot 1.85 with the following parameters: precursor mass 
tolerance was set to 2.0 Da, and fragment error was set to 1.0 Da. A maximum of one missed-
cleavage was accepted. Cysteine carbamidomethylation was set as a variable modification and 
methionine oxidation was set as a fixed modification. The combined Swiss-Prot and trEMBL 
databases were searched without species restriction. Identifications were validated when the top-
scoring peptide corresponded to the correct species (Staphylococcus aureus) or to known 
contaminants, and when the score was above the significance threshold given by Mascot. To 
minimize the presence of false positives in the learning set, we performed a new identification run on 
the 751 spectra using Phenyx (November 2004 release6). Parameters were set similarly than for 
Mascot, but the search was limited to the Firmicutes taxonomy (+ contaminants). 29 spectra were 
removed from the learning set because the best-scoring peptide proposed by Phenyx did not 
correspond to the assignment of Mascot. Since the fragmentation pattern strongly depends on the 
number of charges carried by the precursor, we decided to focus the learning phase on doubly charged 
spectra. New scoring functions will have to be learned in the future to optimize Popitam for working 
with other precursor charge states (as well as with other spectrometer types). We also removed from 
the learning set spectra with modifications (such spectra could interfere with our modification 
                                                 
5 http://www.matrixscience.com/search_form_select.html 
6 http://phenyxbeta.vital-it.ch/phenyx/login/login.jsp 
 120
simulation methodology, described in Section VII.4.4), as well as contaminants (some spectra 
corresponded to peptides from the Lysostaphin protein, which is a murolytic enzyme used during 
sample preparation to degrade the staphylococcal cell). At the end, the learning set was composed of 
597 MS/MS identified spectra. Figure VII-15 illustrates the various processing steps for building the 
learning set.     
  
 
 
 
 
Figure VII-15: Learning set building 
A total of 597 among the 2088 initial MS/MS spectra were selected to form the learning set. The 597 
selected spectra fill the following requirements: they obtained a significant score with Mascot and 
their identification was validated by Phenyx; their precursor mass was doubly charged; the assigned 
peptides were not modified and were present in the Staphylococcus aureus (N315) database. 
 
 
The ideal size of a learning set can be subject to discussion. We observed that methods that employ 
learning sets to optimize parameters generally use sets of several hundreds or even several thousands 
of spectra. One hundred MS/MS spectra may nevertheless be sufficient, in given conditions, to build 
efficient scoring functions (Masselot et al. 2003). But the number of spectrum is not the only criterion 
to meet. Redundancy, which measures the presence of multiple spectra for a given peptide sequence, 
is a characteristic that should also be considered and minimized. Our learning set contains rather few 
redundant spectra, as shown in Figure VII-16, since a total of 501 different peptides are represented 
by the 597 spectra. 
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Figure VII-16: Peptide redundancy 
This histogram shows the distribution of peptide redundancy in the set of 597 spectra. The total 
number of distinct peptides represented in the set is 501. 428 spectra come from  unique peptides, 56 
peptides are represented each by 2 spectra, 12 are represented each by 3 spectra, 4 are represented 
each by 4 spectra and finally, one peptide is represented by 5 spectra. 
 
 
VII.4.3. Spectrum quality 
 
Spectrum quality is another important criterion that should be taken into account during the building 
of a learning set. Ideally, a learning set should include spectra of various qualities. The latter can be 
estimated in different ways. For example, Pevzner et al. (Pevzner et al. 2001) introduced a basic 
quality measure, denoted here as pby, which is computed according to: 
 
 
 
where  
mb and my are the sequence coverage observed with b-ion type and y-ion type fragments (two 
peaks with very similar values are counted as one match), and  
l is the number of amino acids in the identified peptide (in (Pevzner et al. 2001) the 
denominator is l instead of l-1).  
 
The quality measure pby varies between 0 (no b- and y-ions are observed for any of the cleavage 
positions) and 1 (both b- and y-ions are observed for each cleavage position).  
 
Figure VII-17 represents the cumulative graph and the histogram of the quality measure pbys 
computed for the 597 spectra using the corresponding assigned peptide sequences. The odd pattern 
observed in the cumulative curve, notably at position 0.5, is due to the presence (in the equation used 
to compute pby) of the discrete variable l that represents the peptide length and is comprised in our 
learning set between 7 and 25 (see Figure VII-18). This results in a discontinuous curve and in 
statistically over-represented positions (vertical trails visible in positions 0.5, 0.6, 0.625, and 0.667).  
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Figure VII-17: Quality indices 
Cumulative graph and the corresponding histogram of the quality index pby computed for the 597 
spectra of the learning set. About one third of the spectra have a quality measure below 0.5. One 
third have a quality value between 0.5 and 0.6, and a third have a quality value above 0.6.  
 
 
 
 
Figure VII-18: Peptide length 
This histogram shows the distribution of length of the 501 non-redundant peptides. In this dataset, the 
mean peptide length falls between 13 and 14 amino acids. The shortest peptide was 8 amino acids 
and the longest one was 26 amino acids.   
 
 
As it is defined, pby possesses the great advantage to give direct knowledge about the sequence 
coverage by the peaks (a pby of 0.5 means that, when taking into account b and y ions, half of the 
positions are not represented in the spectrum). But is has two drawbacks: first it does not take into 
account minor ion types (e.g. a-ion type, ion types with molecule losses, doubly-charged ion types); 
second, it is not weighted by the presence of contiguous fragmentation positions. Additional terms 
could therefore be introduced to more completely reflect the quality of spectra. For example, the 
observed number of a-ion types can be taken into account in the same way than b- and y-ion types. 
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Moreover, a continuity measure qby taking into account the presence of ion series (continuous 
fragmentation) can be computed according to: 
 
 
 
where  
cb and cy are the cumulated number of fragmentation positions in peak series (see Figure 
III-5 for the definition of a peak series) and mb and my are the sequence coverage by b-ion 
and y-ion fragments.  
 
 
The continuity measure qby varies between 0 (each peak match is isolated) and 1 (all b- and y-peak 
matches are contiguous). Figure VII-19 gives an example of computation of pby and qby for a given 
spectrum.  
 
 
 
 
Figure VII-19: Example of computation of pby and qby 
Example of computation of the quality measure pby and continuity measure qby for a given spectrum. 
This snapshot of the “Peptide match details” window from Phenyx shows matched peaks between an 
experimental spectrum and its corresponding identified peptide ISEVLELPNLIEIQTK. Coverage by 
b-ion types is 6. Coverage by y-ion types is 10. Number of possible fragmentation positions is 16 
(peptide length minus 1). The quality measure pby for this spectrum is (6/16+10/16)/2 = 0.5. The 
continuity measure qby is (5/6 + 7/10)/2 =0.77.   
 
 
The observed quality values for the learning set are quite high. This shows the presence of a bias 
toward good quality spectra, as expected, since we selected only spectra that were confidently 
identified by both Mascot and Phenyx. Lowering the confidence level would have resulted in 
introducing false negatives in the set, which was precisely what we wanted to avoid. In addition, such 
a bias is not really awkward in the context of our study, since Popitam was not designed to 
specifically identify poor quality spectra, but rather spectra with unexpected modifications resulting 
in mass shifts that complicate their interpretation. Moreover, a key feature of Popitam is to locate and 
characterize the modifications. This requires spectra with high-quality fragmentation. 
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VII.4.4. Modification simulation 
 
As it was built, the learning set of 597 spectra did not contain spectra of modified peptides. Because 
Popitam is designed to find unexpected modifications, we need to have learning sets specifically 
composed of spectra obtained from modified peptides. Moreover, we want to optimize scoring 
functions according to the run mode of Popitam. In mode MODGAPS=0, the scenarios contains 
mainly long tags, possibly separated by lackGaps. In mode MODGAPS=1, Popitam only considers 
scenarios with exactly one modGap (due to one or several modification events) and zero or more 
lackGaps. In mode MODGAPS=2, Popitam considers only scenarios with exactly two modGaps 
(each of them due to one or several modification events) and zero or more lackGaps. Three different 
learning sets have then to be built. A first one, composed of unmodified spectra, that will serve to 
learn a function for runs launched in mode MODGAPS=0. A second one, with spectra carrying one 
modification, for runs launched in mode MODGAPS=1; and a third one with spectra carrying two 
separate modifications for runs launched in mode MODGAPS=2.  
The current subscores being dependent on the number of modGaps, we have to learn a separate 
scoring function for each considered number of modGaps. Nevertheless, it is certain that learning a 
unique function for scoring the scenarios would be more convenient. This issue could be tackled in 
future developments. 
 
Collecting several hundreds of spectra with one, two or three post-translational modifications or 
mutations, moreover confidently identified, is quite a difficult task.  
A first method to avoid this issue was to use spectra with expected chemical modifications and to run 
Popitam without specifying what kind of modifications are present. The 726 confidently identified 
doubly charged spectra comprised 59 spectra issued from peptides with carbamidomethylated 
cysteines or oxidated methionines. Unfortunately, this option was not satisfying, because the number 
of such spectra in our set was too low to ensure efficient learning.  
A second possibility was to simulate the presence of modifications on the very spectra. A simple 
procedure is described by Algorithm VII-1. S={s1, s2, ..., s|S|} is the spectrum to modify, and P={a1, 
a2, ..., al} its assigned peptide sequence. The aim is to model a modification on amino acid m with a 
delta value δ (m and δ are randomly chosen), given Δ a set of available ionic hypotheses. The 
algorithm computes the expected peak mass μ(sexp) for a cleavage position p and an ionic hypothesis 
ηk (the fragment must include the modified amino acid). Then it searches in the spectrum for a similar 
peak mass μ(si) and shifts the latter according to the delta value δ and the charge of the current ionic 
hypothesis.  
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Algorithm VII-1: Simulating a modification by acting on the spectrum 
 
 
Despite its attractiveness, this solution presented an annoying drawback: peak selection is dependent 
on two adjustable parameters, a mass tolerance error and a set of possible ionic hypotheses. An 
incomplete set Δ would lead to missing shifted peaks. On the other hand, setting too large an error 
threshold could lead to random matches and then incorrectly shifted peaks. For these reasons, we 
finally chose yet another solution: the spectra remained unchanged, but their assigned peptide 
sequences were mutated together with all occurrences of the sequences in the database. In order to 
maintain the same cleavage positions, amino acid K, R, and P were not allowed to mutate nor to be 
chosen as amino acid replacements. In addition, when the number of modifications was equal to 2, the 
mutation positions were chosen so that they were separated from each other by at least three amino 
acids. 
 
Using this method, we built three databases from our initial set of spectra (Table VII-1). The first set, 
LS_597_MOD0.pop comprises all the original spectra and assigned sequences. For the second and 
third ones (558_MOD1.pop and 471_MOD2.pop), we discarded spectra with overlapping peptide 
sequences, since their presence was disturbing our database modification algorithm. In the third one, 
spectra with too short amino acid sequences were also discarded. In addition, spectra for which no 
scenario was proposed for the correct candidate peptide were discarded. Such a situation can happen 
because of the scenario coverage filter (see Section VI.9). Each set was then used independently to 
learn and test scoring functions for evaluating scenarios, given a number of modGaps. The 
methodology and results are presented in Chapter VIII. 
 
Data sets Database 
597_MOD0.pop FIRM_MOD0.fas (Swiss-Prot + trEMBL Firmicutes) 
558_MOD1.pop STAPH_N315_MOD1.fas (Swiss-Prot + trEMBL Staphylococcus aureus N315) 
471_MOD2.pop STAPH_N315_MOD2.fas (Swiss-Prot + trEMBL Staphylococcus aureus N315) 
  
Table VII-1: The data sets and corresponding databases.  
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Figure adapted from "Monsieur Hippopotame" by Tanikawa Shuntarô 
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C H A P T E R  
VIII 
 
 
 
 
 
 
RESULTS AND 
DISCUSSION 
 
 
 
 
This chapter presents various results obtained in the context of scoring 
functions tailoring with Genetic Programming and peptide identification and 
characterization with Popitam. The potential of our method is shown and 
discussed using specific examples. 
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VIII. Results and discussion 
VIII.1. Introduction 
 
This section presents various results we obtained in the context of scoring function tailoring with 
Genetic Programming and peptide identification and characterization with Popitam. The first part of 
the chapter concerns the scoring functions. Using a procedure that includes ten learning runs and 
cross-validations, we learned and tested 60 scoring functions aimed at scoring scenarios with 0, 1 or 2 
modGaps. We show that Genetic Programming is robust and that the learned functions are efficient 
when used with unseen data. We compare the efficiency of the learned functions with the empirical 
function shown in Section VI.10.8 and with a basic one. The second part of the chapter presents 
results obtained with Popitam on a different set of MS/MS data containing real modified peptides. We 
notably show representative identification results of peptides with PTMs, as well as peptides that 
underwent non-conform cleavage or transpeptidation 
 
 
VIII.2. Scoring functions tailoring 
VIII.2.1. Procedure 
 
Three independent experiments, named EXP_MOD0, EXP_MOD1, EXP_MOD2 and aimed at 
discovering efficient functions for scoring scenarios with 0, 1 or 2 modGaps have been performed. 
Each of the experiments comprises four steps (charted in Figure VIII-2): a) random sampling, b) 
sample file building, c) function learning and d) validation. In the first step, a learning set and a 
testing set are built by randomly sampling spectra from the data sets presented in Table VII-1. The 
sets are not overlapping; therefore, the functions are tested on unseen data. In the second step, the 
spectra of the learning sets are inputted to Popitam in order to create the “training examples” that will 
be used by the Genetic Programming algorithm. The third step is the GP learning process. Topology 
and parameters are the ones presented in Section VII.3.3. Section VIII.2.2 in the present chapter 
discusses the convergence of the GP towards solutions with high-fitnesses in all three experiments. 
Finally, the fourth step (validation) is thoroughly covered by Section VIII.2.3.  
To assess the robustness of the GP approach, we repeated the procedure “random sampling-learning-
testing” ten times (runs 0 to 9).  
 
As shown in Figure VIII-1, Popitam intervenes twice: a first time during the creation of the sample 
files for the GP algorithm, and a second time during the validation phase. Popitam’s parameters are 
kept unchanged across the two runs, but they are differently tuned in each experiment (see Table 
VIII-1). For example, EXP_MOD0 uses a tight precursor mass filter. This filter is relaxed in the two 
other experiments, which is a necessary condition for open-modification search.. 
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Figure VIII-1: The sampling-learning-validation procedure.  
 
 
On the other hand, the database is smaller in EXP_MOD1 and in EXP_MOD2. Notably, an AC filter 
is used in EXP_MOD2. The filter is composed of a list of 160 authorized protein accession codes 
(ACs). The ACs correspond to the proteins identified by at least one spectrum in the data sets of 
Table VII-1. By this mean, the number of proteins to be effectively digested is reduced from 2’600 to 
160. The tuning is necessary to control the size of the sample files that are used as “training 
examples” by the GP process (Figure VII-12 explains how the sample files are obtained). If the AC 
filter is removed in EXP_MOD2, the total size of the sample files is about 3Gb and the time required 
to complete one GP generation is too important (several days). Also, the COVBIN and 
FRAGMENT_ERRORs parameters are differently tuned in the various experiments. COVBIN is 
increased when looking for scenarios with two modGaps, leading to bigger spectrum graphs and more 
complete scenarios. On the other hand, the use of smaller fragment errors results in a decrease of the 
graph connection rate, and consequently in the number of possible paths to explore, thus 
counteracting the expansion of the search space caused by the allowed jumps in the spectrum. 
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EXP_MOD0_runs0..9: 
 dataset: 597_MOD1.pop DBs and FILTERS Popitam’s PARAMETERS  
LS: 450 spectra,  
representing 132 Mb of sample files 
TS: 147 spectra 
Firmicutes_MOD0 
(non modified peptides) 
~175’000 proteins 
PREC_MASS: +/-2.5 Da 
AC_FILTER: NO 
MOD_GAPS = 0 
COVBIN:6 
FRAGMENT_ERROR1:0.6 Da 
FRAGMENT_ERROR2:1.2 Da 
MAX_ADD_MOD: 0 Da 
MAX_LOSS_MOD: 0 Da 
MIN_COV_ARR: 0.3 
 
EXP_MOD1_runs0..9: 
dataset: 558_MOD1.pop DBs and FILTERS Popitam’s parameters 
 LS: 450 spectra,  
representing 126 Mb of sample files 
TS: 108 spectra 
Staph_N315_MOD1 
(peptides modified once) 
~2’600 proteins 
PREC_MASS: +/-150 Da 
AC_FILTER: NO 
MOD_GAPS = 1 
COVBIN:6 
FRAGMENT_ERROR1:0.2 Da 
FRAGMENT_ERROR2:0.4Da  
MAX_ADD_MOD: 150 Da 
MAX_LOSS_MOD: 150 Da 
MIN_COV_ARR: 0.3 
 
EXP_MOD2_runs0..9 
dataset: 471_MOD2.pop DBs and FILTERS Popitam’s parameters 
LS: 400 spectra,  
representing 245 Mb of sample files 
TS: 71 spectra 
Staph_N315_MOD2  
(peptides modified twice) 
~2’600 proteins 
PREC_MASS: +/- 250 Da 
AC_FILTER: YES (160 ACs) 
MOD_GAPS = 2 
COVBIN:7 
FRAGMENT_ERROR1:0.2 Da 
FRAGMENT_ERROR2:0.3 Da 
MAX_ADD_MOD: 150 Da 
MAX_LOSS_MOD: 150 Da 
MIN_COV_ARR: 0.5 
 
Table VIII-1: Conditions and parameters of the three experiments  
Overview of the different experiment conditions and parameters set for the sample file building and 
the validation phase.The first column provides indications about the size of the learning and testing 
sets (respectively LS and TS). The second column lists the databases and the filters used with 
Popitam. The third column gives the settings of Popitam’s parameters.  
 
 
VIII.2.2. Convergence of the GP process 
 
Statistics collected during the generations of the GP process give information about the evolution of 
the populations of scoring functions. The mean rank- and discFitnesses show the convergence of the 
exploration towards efficient scoring functions, and the mean sizeFitness is a measure of the 
function’s diversity. Figure VIII-2 shows the algorithm convergence towards high rankFitness values 
and low discFitness values for the three experiments. RankFitness optimum is 1 (all spectra of the 
learning sets are correctly identified) while discFitness’s optimum is close to 0 (all correctly 
identified spectra have a very small p-value). Although convergence is quite rapid, solutions with 
better rankFitness are found every few generations (vertical arrows). After two-thirds of generations, 
the introduction of a third objective to optimize (the sizeFitness) disrupts the convergence. From this 
point on, the algorithm is expected to produce smaller functions with more or less comparable 
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performance rather than keeping exploring the search space. In the EXP_MOD2 experiment, the GP 
algorithm struggles in discovering efficient scoring functions. In this mode, more scenarios are 
created for each candidate peptide, because two jumps are allowed for each path in the spectrum 
graph. Consequently, it is more difficult to build scoring functions able to efficiently separate the 
correct scenarios from all the incorrect ones. 
 
 
 
Figure VIII-2: Evolution of a GP process (head-subpopulation). 
The plots show the evolution of the head-subpopulation for the three experiments. The first row shows 
the evolution of the mean rankFitness and discFitness computed from the population of functions for 
each generation. The second row shows the “best-so-far” rankFitness at each generation. 
 
 
VIII.2.3. Testing phase  
VIII.2.3.1. Selecting promising solutions 
 
At the end of a GP process, a list of co-dominating functions is reported (see Table VIII-2). Each of 
the co-dominating functions is characterized by a rankFitness, a discFitness and a sizeFitness. The 
problem is to choose the most promising ones from the set of proposed functions.  
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run ID EXP_MOD0 EXP_MOD1 EXP_MOD2 
run0 16 34 24 
run1 30 17 18 
run2 21 26 21 
run3 33 40 43 
run4 34 33 23 
run5 29 15 28 
run6 30 29 38 
run7 38 29 30 
run8 28 38 27 
run9 32 42 16 
 
Table VIII-2: Co-dominating functions 
Number of co-dominating scoring functions reported by the head-population for each experiment and 
each run.  
 
 
Figure VIII-3 highlights a correlation between the sizeFitness and the other two fitnesses: as the 
number of nodes of a scoring function increases, the rankFitness tends to increase and the discFitness 
tends to decrease. In other words, complex functions give better identification rates and show higher 
discrimination capacities than more parsimonious ones (on the learning sets). The most evident 
explanation for this is that complex functions catch a greater amount of information and can therefore 
better respond to the variability of the presented cases. 
 
 
 
Figure VIII-3: Fitness variations in co-dominant functions 
The plot shows the fitnesses of the 21 co-dominant functions reported by EXP_MOD0 run2. Each disc 
in the graph represents a scoring function. The discFitness is represented by the disc diameters.  
 
 
Nevertheless, the disc- and rankFitness decrease very slowly compared to the sizeFitness. Therefore, 
functions of very different sizes may have more or less similar performance. We decided to select for 
each run and each experiment two functions, a complex one and a parsimonious one (see Figure 
VIII-4) and to perform the different validation tests on both categories of functions. For each run, we 
selected as complex function the function with the best rankFitness among all co-dominating 
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functions, and as parsimonious function the function with the best rankFitness among the set of co-
dominating function of 15 nodes or less. The choice of the 15-node size was motivated by the fact 
that it appeared to be a good compromise between small size and good rank- and discFitnesses. Using 
this method, we collected 10 different complex functions and 10 different parsimonious functions for 
each experiment. 
 
 
 
 
Figure VIII-4: A complex and a parsimonious function  
The functions come from experiment EXP_MOD2 (run3). Both functions are co-dominants (the 
complex one is better in rankFitness and discFitness, but the parsimonious one is better in 
sizeFitness).  
 
 
To be tested, the various functions are fed to Popitam, which is run with the corresponding testing 
sets and databases. During or after the identification, various statistics are collected, like the number 
of correct candidate peptides with first rank (rank-based performance) or the score distributions for 
correct candidate sequences (positive peptides) and incorrect candidate sequences (negative peptides). 
Based on these statistics, several topics are discussed: Section VIII.2.3.2 tackles the eventuality of 
overfitting by comparing the rank-based performances of the functions in the learning sets and testing 
sets; Section VIII.2.3.3 compares the different categories of functions in terms of rank-based 
performance and in terms of score distributions; and Section VIII.2.3.4 focuses on specific learned 
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functions and analyzes their individual performance in terms of true positive and false positive rates 
(ROC curves).  
 
VIII.2.3.2. Overfitted functions 
 
A critical issue with supervised learning methods is that the learned functions adjust to very specific 
features of the learning set. Such a situation is denoted as overfitting (Banzhaf et al. 1998). This may 
happen when the learning was performed for too many generations, when the learning set is too small 
or when there are too many parameters (in our case, subscores). Overfitted functions fit perfectly to 
the characteristics of the learning set, but are not capable of generalizing to unseen situations.  
As highlighted in Figure VIII-3, as a result of the introduction of the third fitness (sizeFitness), the 
GP process reports scoring functions of very different sizes with similar performances. This 
observation led us to suppose that the complex functions might be overfitted. This issue is well-
known in machine-learning methods such as decision trees, where the trees are regularly pruned to 
avoid overfitting. In order to confirm or invalidate the overfitting hypothesis, we compared the rank-
based performance of the two classes of functions (COMP and PARS) in the learning sets and in the 
testing sets. Figure VIII-5 describes the procedure used to construct the boxplots represented in 
Figure VIII-6. 
 
 
 
Figure VIII-5: Procedure used to construct a boxplot 
The boxplot synthesizes the performance (here in the testing sets) of the complex functions reported 
for the 10 runs. The line in the box is the median performance value (the upper and lower quartiles 
are the upper and lower edges). The point represents a suspected outlier. The ends of the vertical 
lines indicate the minimum and maximum data values (unless outliers are present). Various boxplots 
are obtained by changing the category of functions or replacing the testing sets (TS) by the learning 
sets (LS). 
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We detected a clear example of overfitting for only one scoring function of the EXP_MOD2 
experiment (see Figure VIII-6). This function is actually the complex function shown in Figure 
VIII-4. It should be noted that it is the one with the greatest number of nodes among the set of co-
dominating functions reported by the GP algorithm for the third run. 
 
Figure VIII-6 also shows that:  a) each of the ten runs leads to functions of similar performance on the 
learning sets. Correspondingly, the GP approach can be considered as robust; b) the values are more 
spread out in the testing sets than in the learning sets; and c) the learned functions are slightly less 
performing on unseen data. Notably, the decrease in performance between the learning sets and the 
testing sets (computed as the difference between the median values of the 10 runs, and expressed as 
percentage) can be assessed to 3.1% (complex functions) and 1.8% (parsimonious functions) for the 
EXP_MOD1, and 10.4% (complex functions) and 8.9% (parsimonious functions) for the 
EXP_MOD2. No decrease in performance is observed for the EXP_MOD0. 
 
 
 
Figure VIII-6: Example of overfitting in EXP_MOD2 
The boxplot shows the performance (in percentage of first ranked correct peptides) in the learning 
sets (LS) and the testing sets (TS) of the 10 complex (COMP) functions and 10 parsimonious (PARS) 
functions selected from experiment EXP_MOD2. One of the complex functions obtained a very bad 
performance in its test set (only 7% of correct identifications) while having a high performance in its 
learning set (around 69% of first ranked peptides), suggesting a strong overfitting for this function. 
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VIII.2.3.3. Performance of learned functions compared to empiric functions 
 
In order to validate the Genetic Programming approach, we compared the learned functions with the 
empirical scoring function presented in Section VI.10.8 and with a basic function composed of a 
single subscore (CS2). Figure VIII-7 shows that the learned functions obtain better results in the test 
sets than the empirical and basic ones (except for the COMP outsider function of EXP_MOD2). The 
complex and parsimonious functions obtain similar results in terms of rank-based performance, 
although the complex functions have tendency to give more spread out values than the parsimonious 
functions. 
 
 
 
Figure VIII-7: Comparison of scoring functions 
In this figure, the rank-based performance of the four types of scoring functions (in the test sets) is 
compared. For each experiment, the boxplots are built by running Popitam on the ten test sets with 
the different functions (for the empirical and basic functions, the same function was used for each test 
set). The four categories correspond to the 10 complex (COMP) functions, the 10 parsimonious 
(PARS) functions, the empirical (EMP) function presented in Section VI.10.8 and a basic (BAS) 
function corresponding to a single subscore (CS2). 
 
 
Table VIII-3 shows the gain reached by the complex and parsimonious functions over the empirical 
and basic ones for the three experiments.  
 
 EXP MOD0 EXP MOD1 EXP MOD2
% gain EMP BAS EMP BAS EMP BAS
COMP +19.10 +23.80 +31.50 +31.05 +28.85 +35.25 
PARS +20.10 +24.80 +31.50 +31.05 +28.85 +35.25 
 
Table VIII-3: Gain of the complex and parsimonious functions  
Gain in terms of rank-based performance of the complex and parsimonious functions over the 
empirical and basic ones (computed as the difference between the median values of the 10 runs, and 
expressed as percentage). 
 137
 
As shown in Table VIII-3 and Figure VIII-7, the complex and parsimonious functions are equivalent 
in terms of rank-based performance. Actually, the difference between the complex and parsimonious 
functions lies more in the score distributions they produce than in the percentage of correct first 
ranked peptides. As shown in Figure VIII-8, the complex functions usually give more outlier scores 
than the parsimonious ones. This complicates the interpretation of the results, because several high-
ranked peptides may receive very low p-values (<1e-12). Such p-values are also observed for 
parsimonious functions when the number of analyzed candidate peptides is important.  
In Popitam, finding out whether a match is true or random is difficult. The p-value estimates the 
probability to obtain a given score by chance. But due to the score distributions and to the function 
used to approximate it (the function assumes a gaussian distribution), the computed p-values may be 
of little help (see Figure VIII-17). For these reasons, Popitam also displays a score based on the ratio 
of adjacent scores (similar to the Sequest’s delta score). We observed that Popitam’s deltaScore, and 
more particularly the distribution of high-ranked peptides, are often efficient at distinguishing a 
correct match from a random one. Furthermore, the proposed scenario and the reported mass shifts 
associated with modGaps may help in confirming a result. At the moment, the decision remains 
subjective and requires manual interpretation. More work on this issue needs to be done, and notably, 
the function to approximate the p-value has to be improved. 
 
 
Figure VIII-8: Score distributions 
Typical distribution of scores obtained for negative peptides with a complex (left) and a parsimonious 
(right) function. The distributions are composed of the scores of negative peptides collected for a 
given spectrum. Popitam’s output for the 4 first ranked candidate peptides is shown below the plots. 
In both cases, the first ranked candidate peptide is the correct one. The complex function produces 
more extreme scores (arrows) than the parsimonious one. Correspondingly, in the left output, second 
and third ranked negative candidate peptides also receive a p-value (PVAL) above 1e-12. 
Fortunately, the deltaScore (dS) computed from the ratio between the first score and the second one 
suggests that the identification is correct.  
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VIII.2.3.4. Examples of learned functions  
 
The benefits of methods like Genetic Programming for scoring function optimization are shown in 
Figure VIII-7 and Table VIII-3. Another interest is that the learned function can provide information 
about the importance of the different subscores. To discuss the results obtained with GP, we selected 
for each of the three experiments one complex function and one parsimonious function that showed 
good performance on their testing sets. The functions are shown below (Figure VIII-9, Figure 
VIII-10, Figure VIII-11): 
 
 
 
Figure VIII-9:  Two learned functions for scoring scenarios without modGaps 
 
 
 
 
Figure VIII-10: Ttwo learned functions for scoring scenarios with 1 modGap 
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Figure VIII-11: Two learned functions for scoring scenarios with 2 modGaps 
 
 
The COMP functions are too complex to be easily interpretable. But it is possible to make certain 
general observations. For example, it is evident that each of them uses a large part of the available 
subscores, and that none of the subscores is systematically discarded. We expect the error score (ES1) 
and the redundancy score (RS1) to be used “negatively” (either as denominator or in subtraction), 
because their optimal values are small. This rule is not always observed, notably in the complex 
function. Consequently, the performance of these functions could probably be manually improved. In 
the parsimonious functions, the rules are better respected; PS1 is often chosen and is always used 
“positively”; ES1 and RS1 are used “negatively”, as expected. In addition, one of the coverage scores 
intervenes in each parsimonious function.  
 
We evaluated the performance of the functions charted in Figure VIII-9, Figure VIII-10 and Figure 
VIII-11 using the receiver operating characteristic (ROC) curve (Baker 2003) method. ROC plots 
show, for varying score cut-offs, the true positive fraction (TPF) and the false positive fraction (FPF) 
of a scoring scheme. As cut-off, the deltaScore was used instead of the usual p-value, because of the 
reasons explained in Section VIII.2.3.3. Figure VIII-12 gives some details about the methodology. 
The true positive (TP) and false positive (FP) fractions were computed from true and random matches 
collected by running Popitam with the different functions on their corresponding testing sets, as 
described in (Colinge et al. 2003b).   
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Figure VIII-12: Example of ROC curve computation 
Example (based on invented data) of the computation of a discrete point in a ROC curve. True and 
random deltaScores are collected for a given scoring function and sorted by increasing order. Then, 
for various threshold values, the number of true positive (TP), false negative (FN), false positive (FP) 
and true negative (TN) matches are counted and the corresponding TP and FP fractions are reported 
in the plot. 
 
 
True matches are obtained with the correct peptide sequence, and random matches are obtained with 
candidate peptides with a shuffled sequence. For a given deltaScore threshold, the TP fraction and FP 
fraction are computed according to: 
 
TPF= TP/(TP+FN)  
FPF = FP/(FP+TN) 
 
where  
TP is the number of true matches that are accepted by the threshold value  
FN is the number of true matches that are rejected by the threshold value 
FP is the number of random matches that are accepted by the threshold value 
TN is the number of random matches that are rejected by the threshold value 
 
 
The obtained ROC curves are shown in Figure VIII-13. The TP fraction corresponds to the sensitivity 
of the scoring, while the FP fraction is the 1 minus the specificity. The shift of the curve towards the 
right when going through the three graphs expresses the growing difficulty for Popitam to identify 
peptides as the number of modification sites increases. The three tables show the false positive 
fraction and the true positive fraction (in percentage) reported for deltaScore thresholds varying from 
0.1 to 0.9 with steps of 0.1.  
 
In addition to measuring the performance of a scoring scheme, ROC curves can be used to select 
thresholds for accepting or rejecting candidate peptides for various TPF and FPF levels in automated 
identification experiments. In our case, the table can be used to give an idea about the TPF and FPF 
expected for a given deltaScore and scoring function. Notably, they show that the TPF and FPF 
associated with a given deltaScore obtained with a given scoring function can be very different from 
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the TPF and FPF observed for the same deltaScore threshold but another scoring function. But for the 
moment, the decision to accept or reject a scored candidate peptide should not be taken only based on 
the deltaScore thresholds. The p-value, and overall the scenario and shift values proposed are of the 
greatest importance to assess the validity of a peptide match by Popitam.  
 
 
 
Figure VIII-13: ROC curves for the complex and parsimonious functions 
The x axis scale is logarithmic. Beside each plot, a table shows the false positive fraction (FPF) and 
true positive fraction (TPF) observed for deltaScore thresholds varying from 0.1 to 0.9 (some of the 
table values are outside the plots).  
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VIII.3. Peptide identification and characterization 
VIII.3.1. Introduction 
 
This section gives examples of Popitam’s potentiality with real data and databases. In Section 
VIII.3.2, Popitam’s operating mode is illustrated on a spectrum with two carbamidomethylations 
coming from a study on human nucleolar proteins (Scherl et al. 2002). In Section VIII.3.3, we show 
how Popitam identified spectra with PTMs, unexpected cleavage and transpeptidation in MS/MS data 
from a study on transpeptidation (Schaefer et al. 2005). All identification runs were performed on a 
bi-processor AMD Athlon MP 2000+ (1.4 GHz).  
VIII.3.2. Identification and characterization of a peptide with two modifications 
 
As a first example, we illustrate how Popitam can deal with two modifications located on different 
parts of a same peptide. For this aim, we used the spectrum of the peptide 
VFNC[cam]ISYSPLC[cam]K (Scherl et al. 2002). No hint about the place, number or type of 
modifications was given to Popitam, except that we were looking for any modifications in a range of 
–100 to 200 Daltons. The parameters were set as follows: 
 
PM RANGE:       -100 to 200 
FRAGMENT_ERROR1: 0.4 Da 
FRAGMENT_ERROR2: 0.6 Da 
MIN_COV_ARR:     0.3 
COVBIN:           9 
MIN_TAG_LENGTH:   3 
MAX_ADD_MOD:    200 
MAX_LOSS_MOD:   100 
 
We performed two independent runs: the first one with MODGAPS set to 1, and the second one with 
MODGAPS set to 2. The spectrum and its spectrum graph (with the highest-scoring run-and-jump 
path found by Popitam) are charted in Figure VIII-14. Popitam’s outputs are summarized in Table 
VIII-4. 
 
When run with MODGAPS set to 1, the scores are quite similar for all high-ranked candidate peptides 
and the associated deltaScores are consequently all bad. In such a situation, it can be deduced that 
none of the peptides fits the spectrum better than any other, given the number of modGaps to include 
in the scenarios. The p-values are quite good, but they are not relevant (see Section VIII.2.3.3). 
When Popitam searches for scenarios with two modGaps, the deltaScore of the second candidate 
stands out because it is significantly smaller (and thus better) than the others. Actually, both first and 
second candidate peptides have similar scores and actually correspond to the same peptide (except 
that the second one has an additional amino acid due to a missed-cleavage).  
Concerning the characterization of the peptide, the best-scoring scenario (for modGaps=2) indicates 
that a mass of 57.05 Da should be added to the first cysteine and a mass of 57.04 Da should be added 
either to the second cysteine, the terminal lysine or the C-terminus group. As we know that 
carbamidomethylation was used to break disulfide bridges during sample preparation, and that such a 
modification results in a mass shift of 57.02, the evident conclusion is that both cysteines are 
carbamidomethylated. To best fit the data, the second ranked peptide (VFNCISYSPLCKR) should 
have its first and second cysteine carbamidomethylated (+ 57.05 ; +57.04) and lose its last amino acid 
(-156.10) (this represents three modification events). The -99.06 shift of the second modGap is 
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explained by the second carbamidomethylation (57.04) minus the molecular weight of arginine 
(156.10). Although this scenario is theoretically possible, preference is given to the less intricate one 
(parsimonious principle).  
Presently, Popitam does not propose automated explanations for modGaps, which have to be done 
manually. But we expect to add an interpretation module in future developments. 
 
 
 
Figure VIII-14: A spectrum and its spectrum graph 
Spectrum of peptide VFNC[cam]ISYSPLC[cam]K and the run-and-jump path corresponding to the 
best scenario found by Popitam (to facilitate the representation of the spectrum graph, only simple 
edges are drawn except for edges belonging to the run-and-jump path). 
 
 
Scoring functions: parsimonious (Figure VIII-10 and Figure VIII-11) 
Database:          Swiss-Prot 
Taxonomy:          Homo sapiens 
Spectrum:          744.39 (2+) (Q-TOF) 
Graph:             128 nodes, 301 + 3768 edges 
 
MODGAPS:                     1 
AC filter:                  NO 
Peptides (digested):   2299426 
Peptides (candidates):  121362 
Scenarios (evaluated):   10995 
Running time:              493 (8mn)          
MODGAPS:                     2 
AC filter:                  NO 
Peptides (digested):   2299426 
Peptides (candidates):  121362 
Scenarios (evaluated):  724897 
Running time:              848s (14mn)           
rank score (dS;PVAL) shifts Scenario rank score (dS ;PVAL) shifts Scenario 
1 130.16 (1.00; <1e-12) 
 
178.08  
NEVLHISRGER 
***LhiSR--- 1 
3.24e05 
(0.87; <1e-12) 
57.05  
 57.04 
VFNCISYSPLCK 
vfN*ISYSpl** 
2 129.60 (0.84; <1e-12) 
 
133.08 
INPLTGEIELKK 
*NP-----ELkk    2 
2.81e05 
(0.44; <1e-12) 
 57.05  
-99.06 
VFNCISYSPLCKR  
vfN*ISYSpl***        
3 108.72 (0.90; <1e-12) 
  
12.06 
MDQPEAPCSSTGPR 
MD******SS---- 
 
 
 
 
 
 
3 1.23e05 (0.84; <1e-12) 
-26.95 
 5.07 
MDGGRTCSCSSFCR 
MDggRtc**SS*** 
 
Table VIII-4: Popitam’s output for spectrum of  
Figure VIII-14 
The left output was obtained with MODGAPS set to 1 and the right output was obtained with 
MODGAPS set to 2). The score column contains Popitam’s score and the associated deltaScore (dS) 
and p-value (PVAL) (the p-value was computed from the negative score). The shifts column gives the 
mass of the modGap(s).  
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VIII.3.3. Concrete examples of identification and characterization 
 
We illustrate here the potentiality of our method on a set of 1248 MS/MS spectra from a study on 
transpeptidation (Schaefer et al. 2005). This study focuses on the murine Alpha crystallin A chain 
protein (P24622). The protein was extracted from mice eye lens, isolated by 2-D gel electrophoresis 
and analyzed with an ion trap mass spectrometer. Its function is not well known, although it is 
annotated in Swiss-Prot as possibly contributing to the transparency and refractive index of the lens. 
It can be found in two forms due to alternative splicing. The 196 amino acid variant represents a 
minor form while the 173 variant (represented below) is the major form.  
 
        10         20         30         40         50         60  
         |          |          |          |          |          |  
MDVTIQHPWF KRALGPFYPS RLFDQFFGEG LFEYDLLPFL SSTISPYYRQ SLFRTVLDSG 
 
        70         80         90        100        110        120  
         |          |          |          |          |          |  
ISEVRSDRDK FVIFLDVKHF SPEDLTVKVL EDFVEIHGKH NERQDDHGYI SREFHRRYRL 
 
       130        140        150        160        170  
         |          |          |          |          |  
PSNVDQSALS CSLSADGMLT FSGPKVQSGL DAGHSERAIP VSREEKPSSA PSS 
 
As the spectra were obtained with an ion trap mass spectrometer, Popitam was in a tricky situation. 
First, no ion probability file was available for ion traps; then the scoring functions were not 
specifically adapted since they were trained with Q-TOF data; and finally, both fragment errors had to 
be significantly increased due to the lower accuracy of these spectrometers compared to Q-TOFs.  
Popitam’s parameters were set as follows: 
 
MODGAPS:         1 
PM RANGE:       -100 to 400 
FRAGMENT_ERROR1: 0.8 Da 
FRAGMENT_ERROR2: 1.5 Da 
MIN_COV_ARR:     0.3 
COVBIN:           9 
MIN_TAG_LENGTH:   3 
MAX_ADD_MOD:    400 
MAX_LOSS_MOD:   100 
 
Analyzing the complete set of spectra with Popitam was difficult because of the important processing 
time needed per spectrum. Fortunately, all the acquired spectra corresponded to a single protein. We 
therefore performed a first run with Popitam on a subset of 839 doubly and triply charged spectra 
using the correct AC (P24622) as a filter. With this filter, only peptides from the correct candidate 
protein were presented to Popitam. The run took 77 minutes. The aim was to quickly spot spectra that 
were likely to produce interesting results for illustration purpose. Using these preliminary results, we 
spotted high-scoring scenarios (with one modGap) and isolated the corresponding spectra. Two 
independent identification runs were then performed on the spectra against the mouse database 
(Swiss-Prot). In the first run, an AC filter of 33 proteins (including the correct one) was used while 
the second run was performed without AC filter. In each output, the number of candidate peptides 
presented to Popitam is given. When the AC filter is applied, their average number is 810. When no 
AC filter is applied, it is 169’437. Popitam’s scenarios were finally manually interpreted and 
validated with Phenyx. Amino acid replacements were simulated in Phenyx by adding user-defined 
modifications to the pool of available ones. For example, the exchange of a Q (128.05 Da) by a P 
(97.12 Da) was simulated by creating a +30.93 modification occurring on P amino acids. 
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VIII.3.3.1. Identification of N-acetylated peptides 
 
This first example shows the identification and characterization of two peptides with “unexpected” 
modifications. The spectra are represented in Figure VIII-15. Both of them correspond to the peptide 
sequence MDVTIQHPWFK. For spectrum A, Popitam reports a one amino acid modGap of 42.50 
(Table VIII-5). The interpretation of this shift is obvious, since the protein is actually annotated in 
Swiss-Prot as being N-acetylated (see Figure II-8), which corresponds to a modification weight of 
42.01 Da.  
For spectrum B, Popitam announces a shift of 58.60 (Table VIII-6). Such a value can be attributed to 
two modification events: a N-acetylation plus a methionine oxidation. This case illustrates that one 
modGap may correspond to several modification events (output B). Popitam’s results were confirmed 
by Phenyx (Phenyx parameters were set as follows: taxonomy=Eukaryote Swiss-Prot and TrEMBL; 
scoring=esquire 3000+-1.0 Da; variable modifications=N-terminal acetylation and methionine 
oxidation).  
 
 
 
Figure VIII-15: Two spectra of N-acetylated peptides 
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A Scoring functions: complex (Figure VIII-10) Database:          Swiss-Prot Taxonomy:          Mus musculus Spectrum:          722.94 (2+) (ION TRAP) 
Graph:             128 nodes, 658 + 8818 edges 
 
AC filter: YES (P24622 + 32 ACs) 
Peptides (digested):   7178 
Peptides (candidates):  761 
Scenarios (evaluated):  921 
Running time:            31 sec 
AC filter: NO 
Peptides (digested):   1401817 
Peptides (candidates):  158955 
Scenarios (evaluated):  198130 
Running time:               81 min 
rank score (deltaS; PVAL) shifts Scenario rank score (deltaS; PVAL) shifts Scenario 
1 
507.79  
(0.35; <1.00e-12)  42.50 
MDVTIQHPWFK 
*DVTIqhPwfK     1 
507.79  
(0.62; <1e-12)  42.50 
MDVTIQHPWFK 
*DVTIqhPwfK     
2 
179.03  
(0.34; 1.09e-02) -52.40  
EVLVTSRSSGTFSK 
***VTS--------  2 
311.28  
(0.91; <1e-12) 259.92 
KTSGLVSLHSR 
*TSGL------     
3 
 61.35  
(0.82; 1.00e00)  98.20 
WGVFSGRTPPSR 
---FSGR*****    
 
 
 
 
 
 
3 282.95  (0.95; <1e-12) 259.92 
MDAATLTYDTLR 
----TLtyDT**    
 
Table VIII-5: Popitam’s outputs for spectrum A of Figure VIII-15 
In the left output, a tight AC filter was set. This results in less candidate peptides, and thus in smaller 
computing time and fewer high-scoring random matches (random matches are candidate peptides 
that receive high scores by chance). The best-scoring scenarios map the modification either on the N-
terminus group or the initial methionine. The 42.50 shift corresponds to an N-acetylation.   
 
 
B 
Scoring functions: complex (Figure VIII-10) 
Database:          Swiss-Prot 
Taxonomy:          Mus musculus 
Spectrum:          730.87 (2+) (ION TRAP) 
Graph:             128 nodes, 650 + 9049 edges 
 
MODGAPS:     1 
AC filter: YES (P24622 + 32 ACs) 
Peptides (digested):   7178 
Peptides (candidates):  761 
Scenarios (evaluated):  987 
Running time:            60 sec 
MODGAPS:    1 
AC filter: NO 
Peptides (digested):   1401817 
Peptides (candidates):  156975 
Scenarios (evaluated):  207924 
Running time:               86 min 
rank score (deltaS; PVAL) shifts Scenario rank score (deltaS; PVAL) shifts Scenario 
1 
821.27  
(0.09;<1.00e-12)  58.60 
MDVTIQHPWFK 
*DVTIQHPwfK 1 
821.27  
(0.34;<1.00e-12)  58.60 
MDVTIQHPWFK 
*DVTIQHPwfK 
2 
 74.31  
(0.95; 2.96e-11) 208.96  
TLGPANLPLAQR 
****anLPlaqr 2 
275.47  
(0.92;<1.00e-12) 288.75 
NSSGILLVALGK 
*ssGILLVA--- 
3 
 70.29  
(0.97; 9.64e-10) 376.76 
SLWPQIKGR 
**WPQ----     
 
 
 
 
 
 
3 252.60  (0.88;<1.00e-12)  23.05 
SHSSGVGKPLSPER 
*****VGKPLsper 
 
Table VIII-6: Popitam’s outputs for spectrum B of Figure VIII-15 
The +58.60 modGap corresponds to two modification events: an N-acetylation (+42.01) plus a 
methionine oxidation (+16.01). 
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VIII.3.3.2. Identification of half-cleaved peptides 
 
Usually, trypsin cleaves peptides at C-terminal side of K and R amino acids. Therefore, any peptide 
(except for the first peptide of the protein) should follow a K or a R on the protein sequence. 
Similarly, any peptide (except for the last peptide of the protein) should end with a K or a R. When 
one of these two rules is not met, the peptide is said “half-cleaved”. PFF methods can identify half-
cleavage peptides if they are parameterized to do so (in this case, all possible half-cleaved peptides 
are generated and matched to the spectrum). In Popitam, half-cleavage is one of the numerous 
unexpected events that can occur to a peptide sequence and cause a shift between the peak pattern and 
the candidate peptide. The mass difference between the half-cleaved peptide of the spectrum and the 
tryptic peptide of the database is reported as a modGap and it is mapped either on the first amino 
acid(s) or the last amino acid(s) of the database peptide. Of course, if the mass difference is larger 
than the allowed modification range, the scenario is not scored and identification fails (see Section 
VI.9). Figure VIII-16 shows a spectrum of the tryptic peptide VLEDFEVEIHGK (spectrum A) and of 
a half-cleaved peptide LEDFEVEIHGK (spectrum B). Popitam’s outputs for spectrum B are 
summarized in Table VIII-7.  In both runs, Popitam suggests a modGap of 98.30 Da in the N-terminal 
or first amino acid of the candidate peptide. This corresponds to the removal of the amino acid valine. 
 
 
 
Figure VIII-16: Annotated spectra of a tryptic peptide VLEDFVEIHGK (A) and of a half-cleaved 
peptide LEDFVEIHGK (B).The b2 ion in spectrum A (m/z 212.8 Da) corresponds to the fragment 
NtermVL, while the b2 ion in spectrum B (m/z 242.7 Da) corresponds to the fragment N-termLE. 
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B 
Scoring functions: complex (Figure VIII-10) 
Database:          Swiss-Prot 
Taxonomy:          Mus musculus 
Spectrum:          594.29 (2+) (ION TRAP) 
Graph:             101 nodes, 609 + 5852 edges 
 
MODGAPS:    1 
AC filter: YES (P24622 + 32 ACs) 
Peptides (digested):      7178 
Peptides (candidates):     867 
Scenarios (evaluated):    1229 
Running time:               17 sec 
MODGAPS:    1 
AC filter: NO 
Peptides (digested):   1401817 
Peptides (candidates):  186674 
Scenarios (evaluated):  257568 
Running time:               43 min 
rank score (dS;PVAL) shifts Scenario rank score (dS;PVAL) shifts Scenario 
1 234.98  (0.26;<1.00e-12) -98.30 
VLEDFVEIHGK 
*LEDFVEIHgk 1 
234.98  
(0.89; <1e-12) -98.30 
VLEDFVEIHGK 
*LEDFVEIHgk 
2  61.01  (0.89; 5.85e-10)  68.20 
NQAMADALER 
NQ-----LE* 
 
 
 
 
 
 
2 208.51  (0.94; <1e-12)  211.11 
DEDFVKPK 
DEDFVkp* 
3  54.57  (0.90; 1.81e-07)  91.20 
DKDDELSFK 
DKDDEL***  3 
196.61  
(0.96; <1e-12)  95.11 
NEDFVEIAR 
NEDFVEI** 
4  49.16 (0.91; 1.16e-05) -71.70 
EWDLKPMADR 
**DLKpm---  4 
189.56  
(0.89; <1e-12) -32.99 
NEDFVEIARK 
NEDFVEI*** 
 
Table VIII-7:  Popitam’s outputs for spectrum B of Figure VIII-16 
 
 
VIII.3.3.3. Identification of transpeptidated peptides 
 
Transpeptidation was introduced in Section IV.3.1 as the grafting of a peptide fragment on another 
one. It is not proven that transpeptidation naturally occurs in a protein lifetime. According to Schaefer 
et al. (Schaefer et al. 2005), it probably occurs during sample preparation as a side activity of trypsin. 
Popitam identified several cases of transpeptidation in the data given by Schaefer and colleagues. 
This section presents three examples. Interestingly, while the first two were reported in Schaefer’s 
publication, the third one was not. 
 
The first example shows the identification of a spectrum corresponding to the transpeptided peptide 
R+VLEDFVEIHGK. When the peptide VLEDFVEIHGK is compared to the spectrum, Popitam 
suggests a 156.66 modGap mapped on the initial part of the peptide (see Table VIII-8). This shift can 
be explained by the addition of a R at its N-terminus. For unknown reasons, the scoring function did 
not give a higher score although the spectrum fragmentation is good. Consequently, the correct 
candidate peptide bluntly falls to the seventh position when the search is performed against the 
complete mouse database. Importantly, although the first ranked peptide’s scenario seems of good 
quality, the similar values of the scores suggest that Popitam didn’t succeed in identifying the correct 
peptide in this very case. Two indices play in favor of the seventh peptide: first its scenario is as or 
even more complete as the preceding ones, with many single edges; second, the reported shift can be 
explained by a reasonable hypothesis (addition of an arginine as the result of transpeptidation). The 
same result was reported in Schaefer’s publication, and confirmed using Phenyx (user variable 
modification: +156.19 Da on valine). 
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Figure VIII-17: Annotated spectra of peptide VLEDFVEIHGK (A) and of the transpeptidated peptide 
RVLEDFVEIHGK (B).   
The more complete b-ion series in spectrum B suggests the presence of a basic amino acid among the 
first amino acids of the peptides. 
 
 
B 
Scoring functions: complex (Figure VIII-10) 
Database:          Swiss-Prot 
Taxonomy:          Mus musculus 
Spectrum:          721.94 (2+) (ION TRAP) 
Graph:             128 nodes, 663 + 7238 edges 
 
MODGAPS:    1 
AC filter: YES (P24622 + 32 ACs) 
Peptides (digested):   7178 
Peptides (candidates):  829 
Scenarios (evaluated):  666 
Running time:            22 sec 
MODGAPS:    1 
AC filter: NO 
Peptides (digested):   1401817 
Peptides (candidates):  159150 
Scenarios (evaluated):  156654 
Running time:               64 min 
rank score (deltaS) shifts Scenario rank score (deltaS) shifts Scenario 
1  58.80  (0.48; <1e-12) 156.66 
VLEDFVEIHGK 
**EDFveIHGK 1 
 96.70  
(0.87;<1.00e-12) -98.29 
WRLLYEELYEK 
WrLlyEELY** 
2  28.16  (0.51; <1e-12) 101.29 
KVLLTCHDDAAR 
---LtcH*****  2 
 84.32 
(0.84;<1.00e-12)  24.45 
LNGGLGTSMGCKGPK 
----Lgt—GCK*** 
3  14.36  (0.94; 1.61e-03) 194.0 
FIEGEVVSALGK 
*IEGE------- 
 
3  71.23  (0.89;<1.00e-12) 193.61 
LGGDLGTYVINK 
----LgtyvIN* 
4  13.50  (0.93; 6.49e-03)  77.83 
LQNLDRAVLPPK 
-----RA*LppK  4 
 63.34  
(0.98;<1.00e-12)  37.60 
GQRDLYSGLNQR 
---DlysgLN** 
5  12.51  (0.92; 2.84e-02) -22.17 
RALIESYQNLTR 
---IE*******  5 
 62.29  
(0.97;<1.00e-12)  95.41 
DGTVQLGDFGIAR 
----QlgdfgI** 
6  11.48  (0.97; 1.09e-01) 305.83 
FEVIIKMQK 
*evIIK---  6 
 60.61  
(0.97;<1.00e-12) -21.49 
FGHLVKCSMVNTK 
FGHLvkCSM**** 
7  10.78  (0.95; 2.41e-01) 170.63 
NGLEDGYGEYR 
**Ledg----- 
 7  58.80  (0.93;<1.00e-12) 156.66 
VLEDFVEIHGK 
**EDFveIHGK 
 
Table VIII-8: Popitam’s outputs for spectrum B of Figure VIII-17 
The modGap of 156.66 can be explained by the N-terminal addition of an arginine residue.  
 
 
 150
The second example shows a successful and confident identification of the spectrum charted in Figure 
VIII-18 (B) corresponding to the transpeptided peptide (PR)+VQSGLDAGHSER. The scenario 
proposes a 26.05 [Da] modGap mapped on the two first amino acids or N-terminus of the peptide (see 
Table VIII-9). Such a gap can be explained by the exchange of VQ by PR (or RP). The identification 
was reported in Schaefer’s publication, was consistent with the spectrum interpretation (enhanced b-
ion series, indicating the presence of a basic amino acid at the beginning of the peptide) and was 
confirmed using Phenyx with user defined variable modifications.  
 
 
 
Figure VIII-18: Annotated spectra of the tryptic peptide VQSGLDAGHSR (A) and of the 
transpeptidated peptide (PR)SGLDAGHSER (B).   
 
 
B 
Scoring functions: complex (Figure VIII-10) 
Database:          Swiss-Prot 
Taxonomy:          Mus musculus 
Spectrum:          641.73 (2+) (ION TRAP) 
Graph:             110 nodes, 574 + 7012 edges 
 
MODGAPS:    1 
AC filter: YES (P24622 + 32 ACs) 
Peptides (digested):   7178 
Peptides (candidates):  817 
Scenarios (evaluated):  686 
Running time:            15 sec 
MODGAPS:    1 
AC filter: NO 
Peptides (digested):   1401817 
Peptides (candidates):  176641 
Scenarios (evaluated):  146667 
Running time:               37 min 
rank score (deltaS) shifts Scenario rank score (deltaS) shifts Scenario 
1 
415.54  
(0.14;<1.00e-12)  26.54 
VQSGLDAGHSER 
**SGLDAGH--- 1 
415.54  
(0.28;<1.00e-12)  26.54 
VQSGLDAGHSER 
**SGLDAGH--- 
2 
 56.60 
(0.52;<1.00e-12) 236.76  
LVELGRSSGK 
LvelgRSS**    
 
 
 
 
 
 
2 117.48  (0.89;<1.00e-12) 166.25 
VRVSADAMLR 
vrvsADAml* 
3 
 29.28  
(0.61; 1.01e-06) 227.25 
AALEQRGLAK 
---eqR****     3 
104.93  
(0.90;<1.00e-12) 
 
291.67 
HDSGLDSMK 
--SGLD*** 
 
Table VIII-9: Popitam’s output for spectrum B of Figure VIII-18  
The 26.54 Da modGap can be explained by the exchange of amino acids VQ by amino acids (PR). 
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In the last example, Popitam matches the spectrum charted in Figure VIII-19 (B) against the peptide 
VQSGLDAGHSER and reports a 11.92 Da modGap mapped somewhere between the N-terminus and 
the second amino acid (see Table VIII-10). Although Schaefer et al. did not report this 
transpeptidation event in their publication, we are confident in our result: the deltaScores are low in 
both outputs; the shift can be explained by a two-amino acid exchange (VQ against HT) (with a 0.94 
Da error); spectrum B has enhanced b-ions compared to the unmodified spectrum, which indicates the 
presence of a basic amino acid at the beginning of the peptide (in our case H); and finally, the match 
was confirmed using Phenyx with user defined variable modifications.  
 
 
 
Figure VIII-19: Annotated spectra of the tryptic peptide VQSGLDAGHSR (A) and of a 
transpeptidated peptide (HT)SGLDAGHSER (B).   
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B 
Scoring functions: complex (Figure VIII-10) 
Database:          Swiss-Prot 
Taxonomy:          Mus musculus 
Spectrum:          634.42 (2+) (ION TRAP) 
Graph:             110 nodes, 491 + 7385 edges 
 
MODGAPS:    1 
AC filter: YES (P24622 + 32 ACs) 
Peptides (digested):   7178 
Peptides (candidates):  829 
Scenarios (evaluated):  666 
Running time:            13 sec 
MODGAPSS:    1 
AC filter:                  NO 
Peptides (digested):   1401817 
Peptides (candidates):  178232 
Scenarios (evaluated):  140983 
Running time:               39 min 
rank score (deltaS) shifts Scenario rank score (deltaS) shifts Scenario 
1 
651.93  
(0.19;<1.00e-12)  11.92 
VQSGLDAGHSER 
**SGLDagH--- 1 
651.93  
(0.40; <1e-12)  11.92 
VQSGLDAGHSER 
**SGLDagH--- 
2 
122.24  
(0.80;<1.00e-12) 108.10  
GESDDEKPRK 
***DDEK--- 
 
 
 
 
 
 
2 257.75  (0.96; <1e-12) 197.60  
WINQHLMK 
*INQH--- 
3 
98.18  
(0.93;<5.79e-11) 108.10 
HDGTSNGTAR 
---TSNgt**  3 
247.81  
(0.98; <1e-12)  28.26 
VLAALDELGLAR 
**aaLDE----- 
3 
91.75  
(0.53;<3.06e-09) 113.47 
LVLGDNSPAIR 
---GDN*****  4 
243.16  
(0.97; <1e-12) 110.81 
VLSSLKHLCR 
**SS-KH--- 
 
Table VIII-10: Popitam’s outputs for the spectrumB of Figure VIII-19  
The modGap of 11.92 can be explain by the exchange of amino acids VQ by amino acids (HT).  
 
 
 
 
The various results shown in this section highlight potential applications of Popitam. We showed that 
its use is not limited to post-translationally modified or mutated peptides, but can be extended to other 
phenomena, such as transpeptidation and non-specific cleavages. The difficult process of scoring has 
been detailed. In particular, a function aimed at scoring all types of scenario is presently not available. 
Also we have problems in attributing a significance level to the scores, and thus in automating 
acceptance or rejection of a match. 
 
It would have been most interesting to compare Popitam’s results with other “open-modification 
search” algorithms. Unfortunately, at present there are many few such algorithms (see Section V.4). 
Among those, PEDANTA and OpenSea are not publicly available, while GutenTag was unstable on 
our machines. However, the comparison with GutenTag is of less interest, as this tool is based on 
efficient filtering rather than a scoring taking into account shifts between peaks. 
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Figure adapted from "Monsieur Hippopotame" by Tanikawa Shuntarô 
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IX. Perspectives and conclusion 
IX.1. Perspectives 
 
Future developments of our method should focus on the following points: 
 
1) code optimization 
The development of Popitam took several years of research. During these years, emerging ideas were 
rapidly implemented, tested and eventually kept, transformed or discarded. As a result, less 
importance has been put on code optimization. Re-thinking some structures and redesigning some 
functions will undoubtedly result in a significant gain in computing time.  
 
2) result list management 
A future and necessary optimization of Popitam will concern the management of the result list. 
During the analysis of a candidate peptide, scenarios with any number of modGap are produced.  
Most of them are discarded, because they do not contain the correct modGap number according to the 
parameter MODGAPNB. Consequently, if the user wishes to test scenarios with 0, 1 or 2 modGaps, 
Popitam must be launched three times. The next version of Popitam will score the scenarios 
independently of the MODGAPNB parameter, and produce several result lists. In a first stage, the 
result lists will be outputted without further analysis; in a second stage, a procedure to compare the 
different scores produced by scenarios with 0, 1 or 2 modGaps will be implemented. 
 
3) implementing supplementary filters 
In Popitam, the comparison between the spectrum and a database sequence comprises three steps: a) 
tag extraction, b) clique search and c) scenario building. Such an analysis is performed for each 
candidate peptide. Consequently, when run against large databases, the identification procedure 
requires too long a computing time, especially if the precursor mass filter is relaxed. In such a case, a 
sequence-based filter would be an appropriate mean to reduce the number of analyzed peptides.  
 
4) scoring 
One of the challenges of “open-modification search” methods is to score peptides of various sizes. 
The larger the range of modifications to take into account, the more the size of the candidate peptides 
may differ. At the moment, some of Popitam’s subscores favor small peptides (e.g. the coverage 
scores), while others favor large peptides (e.g. the series scores). A new scoring based on log-odd 
ratios would probably lead to interesting results.   
 
5) result’s interpretation  
Popitam proposes p-values based on score distributions of negative or random peptides. 
Unfortunately, most often, extreme scores contaminate the distribution and too many negative 
peptides receive p-values near 0. Consequently, the confidence of a peptide assignment remains a 
subjective interpretation based on the distributions of high-scoring peptides and on the proposed 
scenarios. We should establish new criteria to separate assignments that are likely to be correct from 
assignments that are likely to be incorrect. 
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6) shift interpretation module 
Last but not least, a shift interpretation module has to be implemented. At present, Popitam reports a 
list of shifts and their location on the peptide sequence. In a near future, it should be able to propose, 
when possible, explanations for the shifts, such as amino acid(s) replacements, known PTMs, 
chemical modifications due to sample preparation, putative transpeptidations, and so on. 
 
 
IX.2. Conclusion 
 
In this thesis, we charted the general context of MS/MS protein identification and expounded some of 
the issues faced by identification algorithms. We more specifically focused on “open-modification 
search”, which represents a particular challenge for peptide identification and characterization. Most 
MS/MS identification algorithms require the preselection of a number of possible modifications to be 
taken into account during the comparison of the spectrum with database sequences. “Open-
modification search” algorithms are designed to take into account any type of modification that would 
allow a better match between the spectrum peak pattern and a candidate peptide. We proposed a new 
and original method for “open-modification search”, called Popitam. By correlating MS/MS spectra 
with candidate peptides through a spectrum graph structure, Popitam is to our knowledge the first 
algorithm that combines a de novo sequencing and a PFF approach. Other original features of 
Popitam are: a) the sequence-guided tag extraction performed by the simultaneous parsing of the 
spectrum graph and of an indexed representation of a candidate sequence, and b) the tag compatibility 
graph in which cliques represent possible interpretation scenarios of the spectrum.  
The large number of scenarios to be tested, notably when searching candidate peptides with more 
than one modification events, led us to devote a significant part of our work to optimizing scenario-
scoring functions using parallel multi-objective Genetic Programming. This approach gave interesting 
results. Sixty promising functions were selected among a set of more than 800 co-dominating 
functions reported by the GP process. Using a procedure of repeated sampling and cross-validation, 
we showed that Genetic Programming is a robust method. Only one of the learned functions was 
obviously overfitted. We also demonstrated the superiority of the learned functions in terms of rank-
based performance over an empiric and a basic function. Nevertheless, this does not mean that it is 
not possible to design empirical functions that may surpass the learned ones. An interesting feature of 
Popitam is that it is possible to define one’s own scoring functions, as long as they are in an 
appropriate format and based on the list of Popitam’s subscores. By this mean, new scoring functions 
can be freely tested using the web interface. Defining subscores is currently not possible but could be 
considered in future developments. 
We finally showed that Popitam is a suitable peptide identification and characterization method, not 
only in case of post-translational modifications or mutations, but also in case of missed- or half-
cleavages and transpeptidation. This list can be extended to other events, like errors in databases, 
badly calibrated data or imprecise precursor masses, and in a general way, in case of any event that 
modifies the sequence or residue masses of a peptide analyzed by mass spectrometry. Popitam has 
been implemented in the C++ language and has been made available through a web interface.  
 
Before concluding this work, we would like to stress that Popitam should not be confused with a 
high-throughput MS/MS identification method. The use of a classic PFF approach or an “open-
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modification search” method is a question of strategy. The different methods complement each other 
rather than being in competition. Popitam in its present form is not adapted to be used on a large 
number of spectra, neither against large databases. Neither is it adapted to identify spectra with poor 
peak statistics. Its use should be parsimonious, on specific good quality but recalcitrant spectra, and 
against targeted protein lists. Popitam could find its place in an expert identification system or as an 
additional round of a PFF identification tool. Convinced that improvement in MS/MS identification 
can arise from a judicious use and combination of complementary algorithms involving tactics 
mixing, task sharing, search space splitting and result compilation, we imagined in (Hernandez et al. 
2005) a cyclic identification system in which several identification strategies would be coherently 
used according to criteria like the number of spectra to process, their quality, the size of the searched 
database, the analysis type to carry out as well as scores obtained by previous identification attempts. 
The last figure of this work shows an example of such a system.  
 
 
 
 
 
Figure IX-1: A cyclic system for MS/MS identification 
Spectra enter the system and remain there until a given criterion is met (typically, a confident 
identification or on the contrary, a definitively non-identifiable spectrum). The system splits the 
search space of peptides into two databases, a large one and a small one. Spectra that obtain a high 
enough identification score to be assigned without doubt to a peptide (high-IDs) are used to feed the 
limited list of proteins that are potentially present in the sample. Once a spectrum has been classified 
as “high IDs”, it definitively leaves the system and participates to the final list of identifications. The 
“low/no IDs” remain in the cycle and follow a different path. As they circulate inside the system, the 
spectra are annotated to keep trace of the applied algorithms, the obtained scores and the used 
parameters. These annotations help the system to decide what next path a spectrum should follow.  
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X. APPENDICES 
 
Appendix A1: List of abbreviations 
 
 
CE capillary electrophoresis 
HPLC high-performance liquid chromatography 
ESI electrospray ionization 
MALDI matrix-assisted laser desorption/ionization 
FAB fast atom bombardment 
CID collision induced dissociation 
FD field desorption  
TQ triple quadrupole 
Q-TOF quadrupole/time-of-flight 
TOF-TOF time-of-flight/time-of-flight 
Q-IT quadrupole ion trap 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
PMF peptide mass fingerprinting  
PFF peptide fragment fingerprinting 
SPC shared peak count 
EM expectation-maximisation 
GP genetic programming 
 
 
 
 
 
 
 
 
 
 
Appendix A2: MS (PMF) identification algorithms and URLs 
 
FragFit N/A 
PeptideSearch http://www.mann.embl-heidelberg.de/GroupPages/PageLink/peptidesearchpage.html
Peptident http://www.expasy.org/tools/peptident.html 
PepFrag http://prowl.rockefeller.edu/prowl/pepfragch.html 
MOWSE N/A 
MS-Fit http://prospector.ucsf.edu/ 
Mascot http://www.matrixscience.com 
ProFound http://prowl.rockefeller.edu/profound_bin/WebProFound.exe 
SmartIdent N/A 
PepMapper http://wolf.bms.umist.ac.uk/mapper/ 
Aldente http://www.expasy.org/tools/aldente/ 
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Appendix A3: MS/MS (PFF) identification algorithms and URLs 
 
PFF  
Phenyx http://phenyx.vital-it.ch/
Sequest http://fields.scripps.edu/sequest/index.html
Mascot http://www.matrixscience.com/search_form_select.html
PepFrag http://prowl.rockefeller.edu/prowl/pepfragch.html
MS-Tag http://prospector.ucsf.edu/ucsfhtml4.0/mstagfd.htm
ProbID http://projects.systemsbiology.net/probid/
Sonar http://65.219.84.5/service/prowl/sonar.html
TANDEM http://www.thegpm.org/TANDEM/
SCOPE N/A 
PEP_PROBE  N/A 
VEMS http://www.bio.aau.dk/en/biotechnology/vems.htm
InsPecT http://peptide.ucsd.edu/inspect.py
  
MS/MS “open-modification search” algorithms and URLs 
GutenTag http://fields.scripps.edu/GutenTag/index.html
PEDANTA http://peptide.ucsd.edu/ 
OpenSea NA 
Popitam http://www.expasy.org/tools/popitam/ 
  
de novo sequencing algorithms  
SeqMS http://www.protein.osaka-u.ac.jp/rcsfp/profiling/SeqMS.html
Lutefisk http://www.hairyfatguy.com/Lutefisk
Sherenga N/A 
PEAKS http://www.bioinformaticssolutions.com/products/peaksoverview.php 
  
sequence similarity search algorithms 
PeptideSearch http://www.narrador.embl-heidelberg.de/GroupPages/PageLink/peptidesearchpage.html
PepSea http://www.unb.br/cbsp/paginiciais/pepseaseqtag.htm
MS-Seq http://prospector.ucsf.edu/ucsfhtml4.0/msseq.htm
MS-Pattern http://prospector.ucsf.edu/ucsfhtml4.0/mspattern.htm
Mascot http://www.matrixscience.com/search_form_select.html
FASTS N/A 
MS-Blast http://dove.embl-heidelberg.de/Blast2/msblast.html
OpenSea N/A 
CIDentify http://ftp.virginia.edu/pub/fasta/CIDentify/
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Appendix A4: Popitam’s command line output 
 
A typical text output of Popitam is given below with explanations: 
 
File processed                : MOD1/data_pop_7.pop 
Initial number of spectra     : 1 
Instrument                    : Q-TOF 
COVBIN                        : 6 
Edges_type                    : 1,2 aa 
Fragment error1               : 0.2 
Fragment error2               : 0.4 
Minimal tag length            : 3 
 
This first header summarizes the parameters used for the search, such as the errors set on the 
fragments during graph connection.  
 
 
DTB                           : SPROTREMBL, Staphylococcus aureus (strain N315)  
AC FILTER?                    : NO 
Peptide error                 : -150 to +150 Da 
 
This header gives information about different filters applied to the peptides. Candidate peptides are 
the ones that go through all these filters (species, ACs (if any) and peptide error). 
 
MODGAPS                       : 1 
MAX_LOSS_MOD                  : 150.00 
MAX_ADD_MOD                   : 150.00 
MIN_ARR_COV                   : 0.3 
 
This header concerns filters on the scenarios. Valuable scenarios that are finally evaluated are the 
ones that contain exactly 1 modGap with a shift comprised between -150 and +150 Da, and that cover 
at least a third of the candidate peptide. 
 
The next header is about the spectrum being analyzed. The title, number of peaks (before and after 
preprocessing), parent mass and graph sizes are displayed. Then, some statistics are given, notably the 
number of candidate peptides and valuable scenarios.  
 
 
SpectrumTitle            : TFE_Pellet_Band01_ESI.txt_1380.926000 Q99XA3 LPIPNTVSDLSPK 
initPeakNb               :  93 (102) 
ParentMass(M)/Charge     : 1379.93 / 2       
NodeNb                   :      80  
EdgeNb (simple/double)   :     106 / 1442    
 
 
Number of protein processed      :      2577 
Peptide obtained after digestion :    168500 
Number of candidate peptides     :     14610 
Number of valuable scenarios     :       377 
 
 
Finally, a table presents the first ranked candidate peptides. The first column gives the ranks of the 
peptides, the second gives their scores. Finally, the last column displays the peptide sequence and the 
interpretation scenario. When one or several modGaps are present, the associated shifts are also 
given. The p-values and deltaScores associated with the final score are useful to assign confidence to 
the result. The p-values can either be computed from the distribution of negative scores obtained 
during the run, or from the distribution of random scores. In that case, Popitam generates random 
peptides by randomly shuffling the amino acids of candidate peptides. The deltaScores are obtained 
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by dividing the final score by the final score of the next ranked peptide. Both p-values and 
deltaScores are ranked between 0 and 1. 
 
 
 
# |       scores      |    Mr   | access | id              | dbSeq/scenarios  
- | ----------------- | ------- | ------ | --------------- | --------------------  
1.|  805.49           | 1407.76 | Q7A873 | Q7A873_STAAN    |  LPIPNTVDDLSPK                 
  |  0.00e-38 ; 0.08  |         |        |                 |  lpIpnTV*DLSpk     -27.89  
- | ----------------- | ------- | ------ | --------------- | --------------------  
2.|   69.95           | 1258.63 | Q7A5Z8 | Q7A5Z8_STAAN    |  TTPNTGERVER 
  |  8.73e-10 ; 0.92  |         |        |                 |  **pnTge----       121.12  
- | ----------------- | ------- | ------ | --------------- | --------------------  
3.|   64.33           | 1496.89 | Q7A8B4 | Q7A8B4_STAAN    |  ILGRVLATDIDIAK 
  |  8.45e-08 ; 0.87  |         |        |                 |  **grvl---ID---   -117.13 
- | ----------------- | ------- | ------ | --------------- | --------------------  
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Appendix A5: Popitam’s "full path" algorithm 
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